<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Gabapentin</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Gabapentin">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Gabapentin</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Gabapentin</b>, sold under the brand name <b>Neurontin</b> among others, is an anticonvulsant medication used to treat partial seizures, neuropathic pain, hot flashes, and restless legs syndrome.<span class="mw-ref" id="cite_ref-AHFS2015_5-0"><a href="#cite_note-AHFS2015-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> It is recommended as one of a number of first-line medications for the treatment of neuropathic pain caused by diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.<span class="mw-ref" id="cite_ref-Attal2010_7-0"><a href="#cite_note-Attal2010-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> About 15% of those given gabapentin for diabetic neuropathy or postherpetic neuralgia have a measurable benefit.<span class="mw-ref" id="cite_ref-Wiffen2017_8-0"><a href="#cite_note-Wiffen2017-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> Gabapentin is taken by mouth.<span class="mw-ref" id="cite_ref-AHFS2015_5-1"><a href="#cite_note-AHFS2015-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>


<p>
</p>
<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Gabapentin</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline class="mw-default-size"><img src="../I/m/Gabapentin2DACS.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Gabapentin2DACS.svg.png" data-file-width="512" data-file-height="409" data-file-type="drawing" height="176" width="220"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline class="mw-default-size"><img src="../I/m/Gabapentin3Dan.gif" tppabs="https://ptable.com/wiki/compounds/I/m/Gabapentin3Dan.gif" data-file-width="256" data-file-height="256" data-file-type="bitmap" height="220" width="220"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Neurontin, others<span class="mw-ref" id="cite_ref-Drugs.com_1-0"><a href="#cite_note-Drugs.com-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td>CI-945; GOE-3450; DM-1796 (Gralise)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/gabapentin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/gabapentin.html'" tppabs="https://www.drugs.com/monograph/gabapentin.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a694007.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a694007.html'" tppabs="https://medlineplus.gov/druginfo/meds/a694007.html" class="external text external">a694007</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span>DailyMed:<span>&nbsp;</span><span><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Gabapentin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Gabapentin'" tppabs="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Gabapentin" class="external text external">Gabapentin</a></span></li>
<li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span><span>FDA:<span>&nbsp;</span><a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Gabapentin&SearchType=BasicSearch  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Gabapentin&SearchType=BasicSearch'" tppabs="https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Gabapentin&SearchType=BasicSearch" class="external text external">Gabapentin</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>B1<span> </span><span class="mw-ref" id="cite_ref-Drugs.com_Pregnancy_2-0"><a href="#cite_note-Drugs.com_Pregnancy-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>C (Risk not ruled out)<span> </span><span class="mw-ref" id="cite_ref-Drugs.com_Pregnancy_2-1"><a href="#cite_note-Drugs.com_Pregnancy-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Dependence<br>liability</th><td>Low</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Addiction<br>liability</th><td>Low</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Drug class</th><td>Gabapentinoid</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>N03AX12<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=N03AX12  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=N03AX12'" tppabs="https://www.whocc.no/atc_ddd_index/?code=N03AX12" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S4 (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">CA</abbr></small>:<span> </span> ℞-only<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>Class C<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span>/<span>&nbsp;</span>Schedule V in some states</li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>27–60% (inversely proportional to dose; a high fat meal also increases bioavailability)<span class="mw-ref" id="cite_ref-MSR_3-0"><a href="#cite_note-MSR-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-drugs93_4-0"><a href="#cite_note-drugs93-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>Less than 3%<span class="mw-ref" id="cite_ref-MSR_3-1"><a href="#cite_note-MSR-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-drugs93_4-1"><a href="#cite_note-drugs93-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Not significantly metabolized<span class="mw-ref" id="cite_ref-MSR_3-2"><a href="#cite_note-MSR-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-drugs93_4-2"><a href="#cite_note-drugs93-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>5 to 7 hours<span class="mw-ref" id="cite_ref-MSR_3-3"><a href="#cite_note-MSR-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-drugs93_4-3"><a href="#cite_note-drugs93-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Renal<span class="mw-ref" id="cite_ref-MSR_3-4"><a href="#cite_note-MSR-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-drugs93_4-4"><a href="#cite_note-drugs93-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">1-(Aminomethyl)cyclohexaneacetic acid</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=60142-96-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=60142-96-3'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=60142-96-3" class="external text external">60142-96-3</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/3446  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/3446'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/3446" class="external text external">3446</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5483  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5483'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5483" class="external text external">5483</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00996  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00996'" tppabs="https://www.drugbank.ca/drugs/DB00996" class="external text external">DB00996</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.3328.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.3328.html'" tppabs="http://www.chemspider.com/Chemical-Structure.3328.html" class="external text external">3328</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=6CW7F3G59X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=6CW7F3G59X'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=6CW7F3G59X" class="external text external">6CW7F3G59X</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D00332  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D00332'" tppabs="https://www.kegg.jp/entry/D00332" class="external text external">D00332</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:42797  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:42797'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:42797" class="external text external">CHEBI:42797</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL940  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL940'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL940" class="external text external">ChEMBL940</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PDB ligand</th><td><div class="plainlist"><ul><li>GBN (<span><a href="javascript:if(confirm('https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=GBN  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=GBN'" tppabs="https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=GBN" class="external text external">PDBe</a></span>, <span><a href="javascript:if(confirm('http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=GBN&polymericType=Any  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=GBN&polymericType=Any'" tppabs="http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=GBN&polymericType=Any" class="external text external">RCSB<span>&nbsp;</span>PDB</a></span>)</li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID0020074  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID0020074'" tppabs="https://comptox.epa.gov/dashboard/DTXSID0020074" class="external text external">DTXSID0020074</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.056.415  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.056.415'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.056.415" class="external text external">100.056.415</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>9</sub><span>H</span><sub>17</sub><span>N</span><span>O</span><sub>2</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">171.240</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28O%29CC1%28CN%29CCCCC1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28O%29CC1%28CN%29CCCCC1'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28O%29CC1%28CN%29CCCCC1" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C(O)CC1(CN)CCCCC1</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C9H17NO2/c10-7-9(6-8(11)12)4-2-1-3-5-9/h1-7,10H2,(H,11,12)<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:UGJMXCAKCUNAIE-UHFFFAOYSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=461115603&page2=Gabapentin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=461115603&page2=Gabapentin'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=461115603&page2=Gabapentin" class="external text external">(verify)</a></span></span></td></tr></tbody></table>


<p>Common side effects include sleepiness and dizziness.<span class="mw-ref" id="cite_ref-AHFS2015_5-2"><a href="#cite_note-AHFS2015-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Serious side effects include an increased risk of suicide, aggressive behavior, and drug reactions.<span class="mw-ref" id="cite_ref-AHFS2015_5-3"><a href="#cite_note-AHFS2015-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> It is unclear if it is safe during pregnancy or breastfeeding.<span class="mw-ref" id="cite_ref-9"><a href="#cite_note-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> Lower doses are recommended in those with kidney disease associated with a low kidney function.<span class="mw-ref" id="cite_ref-AHFS2015_5-4"><a href="#cite_note-AHFS2015-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Gabapentin is a gabapentinoid.<span class="mw-ref" id="cite_ref-pmid27345098_10-0"><a href="#cite_note-pmid27345098-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> It has a molecular structure similar to that of the <a href="Gamma-Aminobutyric_acid.htm#Neuotransmitter" tppabs="https://ptable.com/wiki/compounds/A/Gamma-Aminobutyric_acid#Neuotransmitter" title="Gamma-Aminobutyric acid">inhibitory neurotransmitter</a> <a href="Gamma-Aminobutyric_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Gamma-Aminobutyric_acid" title="Gamma-Aminobutyric acid">gamma-aminobutyric acid</a> (GABA) and acts as a calcium channel blocker.<span class="mw-ref" id="cite_ref-Sneader2005_11-0"><a href="#cite_note-Sneader2005-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-pmid27345098_10-1"><a href="#cite_note-pmid27345098-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-pmid21150315_12-0"><a href="#cite_note-pmid21150315-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>


<p>Gabapentin was first approved for use in 1993.<span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-Neurontin_label_14-0"><a href="#cite_note-Neurontin_label-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> It has been available as a generic medication in the United States since 2004.<span class="mw-ref" id="cite_ref-AHFS2015_5-5"><a href="#cite_note-AHFS2015-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span>  In 2017, it was the eleventh most commonly prescribed medication in the United States, with more than 46 million prescriptions.<span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> During the 1990s, Parke-Davis, a subsidiary of Pfizer, began using a number of illegal techniques to encourage physicians in the United States to use gabapentin for unapproved uses.<span class="mw-ref" id="cite_ref-Hen2006_17-0"><a href="#cite_note-Hen2006-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> They have paid out millions of dollars to settle lawsuits regarding these activities.<span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc"></div>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<p>Gabapentin is approved in the United States to treat seizures and neuropathic pain.<span class="mw-ref" id="cite_ref-AHFS_19-0"><a href="#cite_note-AHFS-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-:0_20-0"><a href="#cite_note-:0-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-:1_21-0"><a href="#cite_note-:1-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> It is primarily administered by mouth, with a study showing that "rectal administration is not satisfactory".<span class="mw-ref" id="cite_ref-22"><a href="#cite_note-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> It is also commonly prescribed for many off-label uses, such as treatment of anxiety disorders,<span class="mw-ref" id="cite_ref-Sobel2012_23-0"><a href="#cite_note-Sobel2012-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span><span class="mw-ref" id="cite_ref-ReynoldsColeman2011_24-0"><a href="#cite_note-ReynoldsColeman2011-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> insomnia, and bipolar disorder.<span class="mw-ref" id="cite_ref-Sobel2012_23-1"><a href="#cite_note-Sobel2012-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> About 90% of usage is for off-label conditions.<span class="mw-ref" id="cite_ref-:1_21-1"><a href="#cite_note-:1-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> There are, however, concerns regarding the quality of the trials conducted and evidence for some such uses, especially in the case of its use as a mood stabilizer in bipolar disorder.<span class="mw-ref" id="cite_ref-Vedula_1963–71_25-0"><a href="#cite_note-Vedula_1963–71-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Seizures">Seizures</h3></summary>
    
<p>Gabapentin is approved for treatment of focal seizures<span class="mw-ref" id="cite_ref-26"><a href="#cite_note-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> and mixed seizures. There is insufficient evidence for its use in generalized epilepsy.<span class="mw-ref" id="cite_ref-27"><a href="#cite_note-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Neuropathic_pain">Neuropathic pain</h3></summary>
    
<p>A 2018 review found that gabapentin was of no benefit in sciatica or low back pain.<span class="mw-ref" id="cite_ref-28"><a href="#cite_note-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> It may be effective in reducing pain and spasticity in multiple sclerosis.<span class="mw-ref" id="cite_ref-evid_29-0"><a href="#cite_note-evid-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></p>

<p>A 2010 European clinical guideline recommended gabapentin as a first-line treatment for diabetic neuropathy, postherpetic neuralgia, or central pain. It found good evidence that a combination of gabapentin with <a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">morphine</a>, <a href="Oxycodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxycodone" title="Oxycodone">oxycodone</a>, or <a href="Nortriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Nortriptyline" title="Nortriptyline">nortriptyline</a> worked better than either drug alone; the combination of gabapentin and <a href="Venlafaxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Venlafaxine" title="Venlafaxine">venlafaxine</a> may be better than gabapentin alone.<span class="mw-ref" id="cite_ref-Attal2010_7-1"><a href="#cite_note-Attal2010-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>

<p>A 2017 Cochrane review found evidence of moderate quality showing a reduction in pain by 50% in about 15% of people with postherpetic neuralgia and diabetic neuropathy.<span class="mw-ref" id="cite_ref-Wiffen2017_8-1"><a href="#cite_note-Wiffen2017-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> Evidence finds little benefit and significant risk in those with chronic low back pain.<span class="mw-ref" id="cite_ref-30"><a href="#cite_note-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> It is not known if gabapentin can be used to treat other pain conditions, and no difference among various formulations or doses of gabapentin was found.<span class="mw-ref" id="cite_ref-Wiffen2017_8-2"><a href="#cite_note-Wiffen2017-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>

<p>A 2010 review found that it may be helpful in neuropathic pain due to cancer.<span class="mw-ref" id="cite_ref-31"><a href="#cite_note-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> It is not effective in HIV-associated sensory neuropathy<span class="mw-ref" id="cite_ref-32"><a href="#cite_note-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> and does not appear to provide benefit for complex regional pain syndrome.<span class="mw-ref" id="cite_ref-33"><a href="#cite_note-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span></p>

<p>A 2009 review found gabapentin may reduce opioid use following surgery, but does not help with post-surgery chronic pain.<span class="mw-ref" id="cite_ref-ReferenceA_34-0"><a href="#cite_note-ReferenceA-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span> A 2016 review found it does not help with pain following a knee replacement.<span class="mw-ref" id="cite_ref-35"><a href="#cite_note-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span></p>

<p>It appears to be as effective as <a href="Pregabalin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregabalin" title="Pregabalin">pregabalin</a> for neuropathic pain and initially costs less.<span class="mw-ref" id="cite_ref-36"><a href="#cite_note-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span> Both uses are off-patent and their costs are comparable as of 2020. Doses between 900 and 3,600<span>&nbsp;</span>mg per day appear to result in similar pain relief.<span class="mw-ref" id="cite_ref-37"><a href="#cite_note-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Migraine">Migraine</h3></summary>
    
<p>The American Headache Society (AHS) and American Academy of Neurology (AAN) guidelines classify gabapentin as a drug with "insufficient data to support or refute use for migraine prophylaxis".<span class="mw-ref" id="cite_ref-38"><a href="#cite_note-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> A 2013 Cochrane review concluded that gabapentin was not useful for the prevention of episodic migraine in adults.<span class="mw-ref" id="cite_ref-39"><a href="#cite_note-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Anxiety">Anxiety</h3></summary>
    
<p>Gabapentin has been used off-label for the treatment of anxiety disorders. However, there is dispute over whether evidence is sufficient to support it being routinely prescribed for this purpose.<span class="mw-ref" id="cite_ref-Sobel2012_23-2"><a href="#cite_note-Sobel2012-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span><span class="mw-ref" id="cite_ref-ReynoldsColeman2011_24-1"><a href="#cite_note-ReynoldsColeman2011-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span><span class="mw-ref" id="cite_ref-pmid17502773_40-0"><a href="#cite_note-pmid17502773-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span><span class="mw-ref" id="cite_ref-SchatzbergCole2010_41-0"><a href="#cite_note-SchatzbergCole2010-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span> While pregabalin may have efficacy in the treatment of refractory anxiety in people with chronic pain, it is unclear if gabapentin is equally effective.<span class="mw-ref" id="cite_ref-42"><a href="#cite_note-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span>
Gabapentin may be useful in the treatment of comorbid anxiety in people with bipolar; however, it is not effective as a mood-stabilizing treatment for manic or depressive episodes themselves.<span class="mw-ref" id="cite_ref-Vedula_1963–71_25-1"><a href="#cite_note-Vedula_1963–71-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span><span class="mw-ref" id="cite_ref-GoldbergHarrow1999_43-0"><a href="#cite_note-GoldbergHarrow1999-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span><span class="mw-ref" id="cite_ref-pmid11869778_44-0"><a href="#cite_note-pmid11869778-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span><span class="mw-ref" id="cite_ref-Sobel2012_23-3"><a href="#cite_note-Sobel2012-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Drug_dependence">Drug dependence</h3></summary>
    
<p>Gabapentin may reduce symptoms of alcohol withdrawal (but it does not prevent the associated seizures), alcohol dependence and craving.<span class="mw-ref" id="cite_ref-45"><a href="#cite_note-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span><span class="mw-ref" id="cite_ref-:3_46-0"><a href="#cite_note-:3-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span> There is some evidence for its role in the treatment of alcohol use disorder; the 2015 VA/DoD guideline on substance use disorders lists gabapentin as a "weak for" and is recommended as a second-line agent.<span class="mw-ref" id="cite_ref-47"><a href="#cite_note-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span> Use for smoking cessation has had mixed results.<span class="mw-ref" id="cite_ref-48"><a href="#cite_note-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span><span class="mw-ref" id="cite_ref-49"><a href="#cite_note-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span> There is insufficient evidence for its use in cannabis dependence.<span class="mw-ref" id="cite_ref-50"><a href="#cite_note-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Other">Other</h3></summary>
    
<p>Gabapentin may be effective in acquired pendular nystagmus and infantile nystagmus (but not periodic alternating nystagmus).<span class="mw-ref" id="cite_ref-51"><a href="#cite_note-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span><span class="mw-ref" id="cite_ref-52"><a href="#cite_note-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span></p>

<p>It is effective for treating hot flashes.<span class="mw-ref" id="cite_ref-53"><a href="#cite_note-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span><span class="mw-ref" id="cite_ref-54"><a href="#cite_note-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span><span class="mw-ref" id="cite_ref-55"><a href="#cite_note-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span></p>

<p>It is an established treatment of restless legs syndrome.<span class="mw-ref" id="cite_ref-pmid23179641_56-0"><a href="#cite_note-pmid23179641-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> Gabapentin may help sleeping problems in people with restless legs syndrome and partial seizures due to its increase in slow-wave sleep and augmentation of sleep efficiency.<span class="mw-ref" id="cite_ref-57"><a href="#cite_note-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span><span class="mw-ref" id="cite_ref-Edinger2013_58-0"><a href="#cite_note-Edinger2013-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span><span class="mw-ref" id="cite_ref-MorinEspie2012_59-0"><a href="#cite_note-MorinEspie2012-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span></p>

<p>Other psychiatric conditions, such as borderline personality disorder, have also been treated off-label with gabapentin.<span class="mw-ref" id="cite_ref-:1_21-2"><a href="#cite_note-:1-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> There is insufficient evidence to support its use in obsessive–compulsive disorder and treatment-resistant depression.<span class="mw-ref" id="cite_ref-:3_46-1"><a href="#cite_note-:3-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span></p>

<p>Gabapentin is effective in alleviating itching in kidney failure (uremic pruritus)<span class="mw-ref" id="cite_ref-60"><a href="#cite_note-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span> and itching of other causes.<span class="mw-ref" id="cite_ref-61"><a href="#cite_note-61" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span> Gabapentin may be an option in essential or orthostatic tremor.<span class="mw-ref" id="cite_ref-62"><a href="#cite_note-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span><span class="mw-ref" id="cite_ref-63"><a href="#cite_note-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span><span class="mw-ref" id="cite_ref-64"><a href="#cite_note-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span> Evidence does not support the use of gabapentin in tinnitus.<span class="mw-ref" id="cite_ref-65"><a href="#cite_note-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    
<p>The most common side effects of gabapentin include dizziness, fatigue, drowsiness, ataxia, peripheral edema (swelling of extremities), nystagmus, and tremor.<span class="mw-ref" id="cite_ref-Neurontin_label_14-1"><a href="#cite_note-Neurontin_label-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> Gabapentin may also produce sexual dysfunction in some patients, symptoms of which may include loss of libido, inability to reach orgasm, and erectile dysfunction.<span class="mw-ref" id="cite_ref-Aronson2014_66-0"><a href="#cite_note-Aronson2014-66" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span><span class="mw-ref" id="cite_ref-DSM5_67-0"><a href="#cite_note-DSM5-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span> Gabapentin should be used carefully in people with kidney problems due to possible accumulation and toxicity.<span class="mw-ref" id="cite_ref-Neurontin_label_14-2"><a href="#cite_note-Neurontin_label-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></p>

<p>Some have suggested avoiding gabapentin in people with a history of myoclonus or myasthenia gravis, as it may induce or mimic the symptoms of these two conditions.<span class="mw-ref" id="cite_ref-68"><a href="#cite_note-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Suicide">Suicide</h3></summary>
    
<p>In 2009, the U.S. Food and Drug Administration (FDA) issued a warning of an increased risk of suicidal thoughts and behaviors in patients taking some anticonvulsant drugs, including gabapentin,<span class="mw-ref" id="cite_ref-69"><a href="#cite_note-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span> modifying the packaging inserts to reflect this.<span class="mw-ref" id="cite_ref-Neurontin_label_14-3"><a href="#cite_note-Neurontin_label-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> A 2010 meta-analysis supported the increased risk of suicide associated with gabapentin use.<span class="mw-ref" id="cite_ref-70"><a href="#cite_note-70" style="counter-reset: mw-Ref 70;"><span class="mw-reflink-text">[70]</span></a></span></p>

<p>Studies have also shown an almost doubled rate of suicidal ideation in patients with bipolar disorder who are taking gabapentin versus those taking lithium.<span class="mw-ref" id="cite_ref-71"><a href="#cite_note-71" style="counter-reset: mw-Ref 71;"><span class="mw-reflink-text">[71]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Cancer">Cancer</h3></summary>
    
<p>An increase in formation of adenocarcinomas was observed in rats during preclinical trials; however, the clinical significance of these results remains undetermined. Gabapentin is also known to induce pancreatic acinar cell carcinomas in rats through an unknown mechanism, perhaps by stimulation of DNA synthesis; these tumors did not affect the lifespan of the rats and did not metastasize.<span class="mw-ref" id="cite_ref-FDA_72-0"><a href="#cite_note-FDA-72" style="counter-reset: mw-Ref 72;"><span class="mw-reflink-text">[72]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Abuse_and_addiction">Abuse and addiction</h3></summary>
    

<p>Effective 1 July 2017, Kentucky classified gabapentin as a schedule V controlled substance statewide.<span class="mw-ref" id="cite_ref-73"><a href="#cite_note-73" style="counter-reset: mw-Ref 73;"><span class="mw-reflink-text">[73]</span></a></span>  Effective 9 January 2019, Michigan also classified gabapentin as a schedule V controlled substance.<span class="mw-ref" id="cite_ref-74"><a href="#cite_note-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span> Gabapentin is scheduled V drug in other states such as West Virginia,<span class="mw-ref" id="cite_ref-75"><a href="#cite_note-75" style="counter-reset: mw-Ref 75;"><span class="mw-reflink-text">[75]</span></a></span> Tennessee,<span class="mw-ref" id="cite_ref-76"><a href="#cite_note-76" style="counter-reset: mw-Ref 76;"><span class="mw-reflink-text">[76]</span></a></span> Alabama<span class="mw-ref" id="cite_ref-77"><a href="#cite_note-77" style="counter-reset: mw-Ref 77;"><span class="mw-reflink-text">[77]</span></a></span> Effective April 2019, the United Kingdom reclassified the drug as a class C controlled substances.<span class="mw-ref" id="cite_ref-78"><a href="#cite_note-78" style="counter-reset: mw-Ref 78;"><span class="mw-reflink-text">[78]</span></a></span><span class="mw-ref" id="cite_ref-79"><a href="#cite_note-79" style="counter-reset: mw-Ref 79;"><span class="mw-reflink-text">[79]</span></a></span><span class="mw-ref" id="cite_ref-80"><a href="#cite_note-80" style="counter-reset: mw-Ref 80;"><span class="mw-reflink-text">[80]</span></a></span><span class="mw-ref" id="cite_ref-81"><a href="#cite_note-81" style="counter-reset: mw-Ref 81;"><span class="mw-reflink-text">[81]</span></a></span><span class="mw-ref" id="cite_ref-UK_class_C_82-0"><a href="#cite_note-UK_class_C-82" style="counter-reset: mw-Ref 82;"><span class="mw-reflink-text">[82]</span></a></span></p>

<p>While the mechanisms behind its abuse potential are not well understood, gabapentin misuse has been recorded across a range of doses, including those that are considered therapeutic.<span class="mw-ref" id="cite_ref-:1_21-3"><a href="#cite_note-:1-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> Abuse often coincides with other substance use disorders, most commonly opioids. Mechanistically, the GABAmimetic properties of gabapentin can induce a euphoria that augments the effects of the opioid being used, as well aiding in the cessation of commonly experienced opioid-withdrawal symptoms, such as anxiety.<span class="mw-ref" id="cite_ref-83"><a href="#cite_note-83" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span></p>

<p>Misuse of this drug has been recorded for a number of reasons, including self-medication, self-harm and recreational use.<span class="mw-ref" id="cite_ref-:1_21-4"><a href="#cite_note-:1-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> Withdrawal symptoms, often resembling those of benzodiazepine withdrawal, play a role in the physical dependence some users experience.<span class="mw-ref" id="cite_ref-:2_84-0"><a href="#cite_note-:2-84" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span> About 1 percent of the general population and 22 percent of those attending addiction facilities have a history of abuse of gabapentin.<span class="mw-ref" id="cite_ref-pmid26721643_85-0"><a href="#cite_note-pmid26721643-85" style="counter-reset: mw-Ref 85;"><span class="mw-reflink-text">[85]</span></a></span><span class="mw-ref" id="cite_ref-pmid29179227_86-0"><a href="#cite_note-pmid29179227-86" style="counter-reset: mw-Ref 86;"><span class="mw-reflink-text">[86]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Withdrawal_syndrome">Withdrawal syndrome</h3></summary>
    
<div role="note" class="hatnote navigation-not-searchable">See also: <a href="Pregabalin.htm#Withdrawal_symptoms" tppabs="https://ptable.com/wiki/compounds/A/Pregabalin#Withdrawal_symptoms" title="Pregabalin">Pregabalin §<span>&nbsp;</span>Withdrawal symptoms</a></div>

<p>Tolerance and withdrawal symptoms are a common occurrence in prescribed therapeutic users as well as non-medical recreational users. Withdrawal symptoms typically emerge within 12 hours to 7 days after stopping gabapentin.<span class="mw-ref" id="cite_ref-pmid26721643_85-1"><a href="#cite_note-pmid26721643-85" style="counter-reset: mw-Ref 85;"><span class="mw-reflink-text">[85]</span></a></span><span class="mw-ref" id="cite_ref-pmid29179227_86-1"><a href="#cite_note-pmid29179227-86" style="counter-reset: mw-Ref 86;"><span class="mw-reflink-text">[86]</span></a></span> Some of the most commonly reported withdrawal symptoms include agitation, confusion, disorientation, upset stomach and sweating.<span class="mw-ref" id="cite_ref-pmid26721643_85-2"><a href="#cite_note-pmid26721643-85" style="counter-reset: mw-Ref 85;"><span class="mw-reflink-text">[85]</span></a></span> In some cases, users experienced delirium and withdrawal seizures, which may only respond to the re-administration of gabapentin.<span class="mw-ref" id="cite_ref-:2_84-1"><a href="#cite_note-:2-84" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Breathing">Breathing</h3></summary>
    
<p>In December 2019, the U.S. Food and Drug Administration (FDA) warned about serious breathing issues for those taking gabapentin or <a href="Pregabalin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregabalin" title="Pregabalin">pregabalin</a> when used with CNS depressants or for those with lung problems.<span class="mw-ref" id="cite_ref-FDA_breathing_87-0"><a href="#cite_note-FDA_breathing-87" style="counter-reset: mw-Ref 87;"><span class="mw-reflink-text">[87]</span></a></span><span class="mw-ref" id="cite_ref-88"><a href="#cite_note-88" style="counter-reset: mw-Ref 88;"><span class="mw-reflink-text">[88]</span></a></span></p>

<p>The FDA required new warnings about the risk of respiratory depression to be added to the prescribing information of the gabapentinoids.<span class="mw-ref" id="cite_ref-FDA_breathing_87-1"><a href="#cite_note-FDA_breathing-87" style="counter-reset: mw-Ref 87;"><span class="mw-reflink-text">[87]</span></a></span> The FDA also required the drug manufacturers to conduct clinical trials to further evaluate their abuse potential, particularly in combination with opioids, because misuse and abuse of these products together is increasing, and co-use may increase the risk of respiratory depression.<span class="mw-ref" id="cite_ref-FDA_breathing_87-2"><a href="#cite_note-FDA_breathing-87" style="counter-reset: mw-Ref 87;"><span class="mw-reflink-text">[87]</span></a></span></p>

<p>Among 49 case reports submitted to the FDA over the five-year period from 2012 to 2017, twelve people died from respiratory depression with gabapentinoids, all of whom had at least one risk factor.<span class="mw-ref" id="cite_ref-FDA_breathing_87-3"><a href="#cite_note-FDA_breathing-87" style="counter-reset: mw-Ref 87;"><span class="mw-reflink-text">[87]</span></a></span></p>

<p>The FDA reviewed the results of two randomized, double-blind, placebo-controlled clinical trials in healthy people, three observational studies, and several studies in animals.<span class="mw-ref" id="cite_ref-FDA_breathing_87-4"><a href="#cite_note-FDA_breathing-87" style="counter-reset: mw-Ref 87;"><span class="mw-reflink-text">[87]</span></a></span> One trial showed that using pregabalin alone and using it with an opioid pain reliever can depress breathing function.<span class="mw-ref" id="cite_ref-FDA_breathing_87-5"><a href="#cite_note-FDA_breathing-87" style="counter-reset: mw-Ref 87;"><span class="mw-reflink-text">[87]</span></a></span> The other trial showed gabapentin alone increased pauses in breathing during sleep.<span class="mw-ref" id="cite_ref-FDA_breathing_87-6"><a href="#cite_note-FDA_breathing-87" style="counter-reset: mw-Ref 87;"><span class="mw-reflink-text">[87]</span></a></span> The three observational studies at one academic medical center showed a relationship between gabapentinoids given before surgery and respiratory depression occurring after different kinds of surgeries.<span class="mw-ref" id="cite_ref-FDA_breathing_87-7"><a href="#cite_note-FDA_breathing-87" style="counter-reset: mw-Ref 87;"><span class="mw-reflink-text">[87]</span></a></span> The FDA also reviewed several animal studies that showed pregabalin alone and pregabalin plus opioids can depress respiratory function.<span class="mw-ref" id="cite_ref-FDA_breathing_87-8"><a href="#cite_note-FDA_breathing-87" style="counter-reset: mw-Ref 87;"><span class="mw-reflink-text">[87]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Overdose">Overdose</h2></summary>
    
<p>Through excessive ingestion, accidental or otherwise, persons may experience overdose symptoms including drowsiness, sedation, blurred vision, slurred speech, somnolence, uncontrollable jerking motions, anxiety and possibly death, if a very high amount was taken, particularly if combined with alcohol. For overdose considerations, serum gabapentin concentrations may be measured for confirmation.<span class="mw-ref" id="cite_ref-89"><a href="#cite_note-89" style="counter-reset: mw-Ref 89;"><span class="mw-reflink-text">[89]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacodynamics">Pharmacodynamics</h3></summary>
    
<p>Gabapentin is a gabapentinoid, or a ligand of the auxiliary α<sub>2</sub>δ subunit site of certain voltage-dependent calcium channels (VDCCs), and thereby acts as an inhibitor of α<sub>2</sub>δ subunit-containing VDCCs.<span class="mw-ref" id="cite_ref-pmid16376147_90-0"><a href="#cite_note-pmid16376147-90" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span><span class="mw-ref" id="cite_ref-pmid27345098_10-2"><a href="#cite_note-pmid27345098-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> There are two drug-binding α<sub>2</sub>δ subunits, α<sub>2</sub>δ-1 and α<sub>2</sub>δ-2, and gabapentin shows similar affinity for (and hence lack of selectivity between) these two sites.<span class="mw-ref" id="cite_ref-pmid27345098_10-3"><a href="#cite_note-pmid27345098-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> Gabapentin is selective in its binding to the α<sub>2</sub>δ VDCC subunit.<span class="mw-ref" id="cite_ref-pmid16376147_90-1"><a href="#cite_note-pmid16376147-90" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span><span class="mw-ref" id="cite_ref-BenzonRathmell2013_91-0"><a href="#cite_note-BenzonRathmell2013-91" style="counter-reset: mw-Ref 91;"><span class="mw-reflink-text">[91]</span></a></span> Despite the fact that gabapentin is a GABA analogue, and in spite of its name, it does not bind to the GABA receptors, does not convert into <abbr>GABA</abbr> or another GABA receptor agonist <i>in vivo</i>, and does not modulate GABA transport or metabolism.<span class="mw-ref" id="cite_ref-pmid16376147_90-2"><a href="#cite_note-pmid16376147-90" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span><span class="mw-ref" id="cite_ref-pmid21150315_12-1"><a href="#cite_note-pmid21150315-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> There is currently no evidence that the effects of gabapentin are mediated by any mechanism other than inhibition of α<sub>2</sub>δ-containing VDCCs.<span class="mw-ref" id="cite_ref-pmid23642658_92-0"><a href="#cite_note-pmid23642658-92" style="counter-reset: mw-Ref 92;"><span class="mw-reflink-text">[92]</span></a></span><span class="mw-ref" id="cite_ref-pmid16376147_90-3"><a href="#cite_note-pmid16376147-90" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span> In accordance, inhibition of α<sub>2</sub>δ-1-containing VDCCs by gabapentin appears to be responsible for its anticonvulsant, analgesic, and anxiolytic effects.<span class="mw-ref" id="cite_ref-pmid16376147_90-4"><a href="#cite_note-pmid16376147-90" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span><span class="mw-ref" id="cite_ref-pmid23642658_92-1"><a href="#cite_note-pmid23642658-92" style="counter-reset: mw-Ref 92;"><span class="mw-reflink-text">[92]</span></a></span></p>

<p>The endogenous α-amino acids <small>L</small>-leucine and <small>L</small>-isoleucine, which closely resemble gabapentin and the other gabapentinoids in chemical structure, are apparent ligands of the α<sub>2</sub>δ VDCC subunit with similar affinity as the gabapentinoids (e.g., IC<sub>50</sub> = 71<span>&nbsp;</span>nM for <small>L</small>-isoleucine), and are present in human cerebrospinal fluid at micromolar concentrations (e.g., 12.9<span>&nbsp;</span>μM for <small>L</small>-leucine, 4.8<span>&nbsp;</span>μM for <small>L</small>-isoleucine).<span class="mw-ref" id="cite_ref-pmid17222465_93-0"><a href="#cite_note-pmid17222465-93" style="counter-reset: mw-Ref 93;"><span class="mw-reflink-text">[93]</span></a></span> It has been theorized that they may be the endogenous ligands of the subunit and that they may competitively antagonize the effects of gabapentinoids.<span class="mw-ref" id="cite_ref-pmid17222465_93-1"><a href="#cite_note-pmid17222465-93" style="counter-reset: mw-Ref 93;"><span class="mw-reflink-text">[93]</span></a></span><span class="mw-ref" id="cite_ref-pmid17403543_94-0"><a href="#cite_note-pmid17403543-94" style="counter-reset: mw-Ref 94;"><span class="mw-reflink-text">[94]</span></a></span> In accordance, while gabapentinoids like gabapentin and pregabalin have nanomolar affinities for the α<sub>2</sub>δ subunit, their potencies <i>in vivo</i> are in the low micromolar range, and competition for binding by endogenous <small>L</small>-amino acids has been said to likely be responsible for this discrepancy.<span class="mw-ref" id="cite_ref-pmid23642658_92-2"><a href="#cite_note-pmid23642658-92" style="counter-reset: mw-Ref 92;"><span class="mw-reflink-text">[92]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Absorption">Absorption</h4></summary>
    
<p>
Gabapentin is absorbed from the intestines by an active transport process mediated via the large neutral amino acid transporter 1 (LAT1, SLC7A5), a transporter for amino acids such as <small>L</small>-leucine and <a href="Phenylalanine.htm" tppabs="https://ptable.com/wiki/compounds/A/L-phenylalanine" title="L-phenylalanine" class="mw-redirect"><small>L</small>-phenylalanine</a>.<span class="mw-ref" id="cite_ref-pmid27345098_10-4"><a href="#cite_note-pmid27345098-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-pmid16376147_90-5"><a href="#cite_note-pmid16376147-90" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span><span class="mw-ref" id="cite_ref-pmid23567998_95-0"><a href="#cite_note-pmid23567998-95" style="counter-reset: mw-Ref 95;"><span class="mw-reflink-text">[95]</span></a></span> Very few (less than 10<span>&nbsp;</span>drugs) are known to be transported by this transporter.<span class="mw-ref" id="cite_ref-pmid18656534_96-0"><a href="#cite_note-pmid18656534-96" style="counter-reset: mw-Ref 96;"><span class="mw-reflink-text">[96]</span></a></span> Gabapentin is transported solely by the LAT1,<span class="mw-ref" id="cite_ref-pmid23567998_95-1"><a href="#cite_note-pmid23567998-95" style="counter-reset: mw-Ref 95;"><span class="mw-reflink-text">[95]</span></a></span><span class="mw-ref" id="cite_ref-pmid20818832_97-0"><a href="#cite_note-pmid20818832-97" style="counter-reset: mw-Ref 97;"><span class="mw-reflink-text">[97]</span></a></span> and the LAT1 is easily saturable, so the pharmacokinetics of gabapentin are dose-dependent, with diminished bioavailability and delayed peak levels at higher doses.<span class="mw-ref" id="cite_ref-pmid27345098_10-5"><a href="#cite_note-pmid27345098-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> Gabapentin enacarbil is transported not by the LAT1 but by the monocarboxylate transporter 1 (MCT1) and the sodium-dependent multivitamin transporter (SMVT), and no saturation of bioavailability has been observed with the drug up to a dose of 2,800<span>&nbsp;</span>mg.<span class="mw-ref" id="cite_ref-pmid20505847_98-0"><a href="#cite_note-pmid20505847-98" style="counter-reset: mw-Ref 98;"><span class="mw-reflink-text">[98]</span></a></span></p>

<p>The oral bioavailability of gabapentin is approximately 80% at 100<span>&nbsp;</span>mg administered three times daily once every 8<span>&nbsp;</span>hours, but decreases to 60% at 300<span>&nbsp;</span>mg, 47% at 400<span>&nbsp;</span>mg, 34% at 800<span>&nbsp;</span>mg, 33% at 1,200<span>&nbsp;</span>mg, and 27% at 1,600<span>&nbsp;</span>mg, all with the same dosing schedule.<span class="mw-ref" id="cite_ref-pmid20818832_97-1"><a href="#cite_note-pmid20818832-97" style="counter-reset: mw-Ref 97;"><span class="mw-reflink-text">[97]</span></a></span><span class="mw-ref" id="cite_ref-pmid20505847_98-1"><a href="#cite_note-pmid20505847-98" style="counter-reset: mw-Ref 98;"><span class="mw-reflink-text">[98]</span></a></span> Food increases the area-under-curve levels of gabapentin by about 10%.<span class="mw-ref" id="cite_ref-pmid20818832_97-2"><a href="#cite_note-pmid20818832-97" style="counter-reset: mw-Ref 97;"><span class="mw-reflink-text">[97]</span></a></span> Drugs that increase the transit time of gabapentin in the small intestine can increase its oral bioavailability; when gabapentin was co-administered with oral <a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">morphine</a> (which slows intestinal peristalsis),<span class="mw-ref" id="cite_ref-pmid24829664_99-0"><a href="#cite_note-pmid24829664-99" style="counter-reset: mw-Ref 99;"><span class="mw-reflink-text">[99]</span></a></span> the oral bioavailability of a 600<span>&nbsp;</span>mg dose of gabapentin increased by 50%.<span class="mw-ref" id="cite_ref-pmid20818832_97-3"><a href="#cite_note-pmid20818832-97" style="counter-reset: mw-Ref 97;"><span class="mw-reflink-text">[97]</span></a></span> The oral bioavailability of gabapentin enacarbil (as gabapentin) is greater than or equal to 68%, across all doses assessed (up to 2,800<span>&nbsp;</span>mg), with a mean of approximately 75%.<span class="mw-ref" id="cite_ref-pmid20505847_98-2"><a href="#cite_note-pmid20505847-98" style="counter-reset: mw-Ref 98;"><span class="mw-reflink-text">[98]</span></a></span><span class="mw-ref" id="cite_ref-pmid27345098_10-6"><a href="#cite_note-pmid27345098-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>

<p>Gabapentin at a low dose of 100<span>&nbsp;</span>mg has a T<sub>max</sub> (time to peak levels) of approximately 1.7<span>&nbsp;</span>hours, while the T<sub>max</sub> increases to 3 to 4<span>&nbsp;</span>hours at higher doses.<span class="mw-ref" id="cite_ref-pmid27345098_10-7"><a href="#cite_note-pmid27345098-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> Food does not significantly affect the T<sub>max</sub> of gabapentin and increases the C<sub>max</sub> of gabapentin by approximately 10%.<span class="mw-ref" id="cite_ref-pmid20818832_97-4"><a href="#cite_note-pmid20818832-97" style="counter-reset: mw-Ref 97;"><span class="mw-reflink-text">[97]</span></a></span> The T<sub>max</sub> of the instant-release (IR) formulation of gabapentin enacarbil (as active gabapentin) is about 2.1 to 2.6<span>&nbsp;</span>hours across all doses (350–2,800<span>&nbsp;</span>mg) with single administration and 1.6 to 1.9<span>&nbsp;</span>hours across all doses (350–2,100<span>&nbsp;</span>mg) with repeated administration.<span class="mw-ref" id="cite_ref-pmid18827074_100-0"><a href="#cite_note-pmid18827074-100" style="counter-reset: mw-Ref 100;"><span class="mw-reflink-text">[100]</span></a></span> Conversely, the T<sub>max</sub> of the extended-release (XR) formulation of gabapentin enacarbil is about 5.1<span>&nbsp;</span>hours at a single dose of 1,200<span>&nbsp;</span>mg in a fasted state and 8.4<span>&nbsp;</span>hours at a single dose of 1,200<span>&nbsp;</span>mg in a fed state.<span class="mw-ref" id="cite_ref-pmid18827074_100-1"><a href="#cite_note-pmid18827074-100" style="counter-reset: mw-Ref 100;"><span class="mw-reflink-text">[100]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Distribution">Distribution</h4></summary>
    
<p>
Gabapentin can cross the blood–brain barrier and enter the central nervous system.<span class="mw-ref" id="cite_ref-pmid16376147_90-6"><a href="#cite_note-pmid16376147-90" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span> However, due to its low lipophilicity,<span class="mw-ref" id="cite_ref-pmid20818832_97-5"><a href="#cite_note-pmid20818832-97" style="counter-reset: mw-Ref 97;"><span class="mw-reflink-text">[97]</span></a></span> gabapentin requires active transport across the blood–brain barrier.<span class="mw-ref" id="cite_ref-pmid23567998_95-2"><a href="#cite_note-pmid23567998-95" style="counter-reset: mw-Ref 95;"><span class="mw-reflink-text">[95]</span></a></span><span class="mw-ref" id="cite_ref-pmid16376147_90-7"><a href="#cite_note-pmid16376147-90" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span><span class="mw-ref" id="cite_ref-pmid26305616_101-0"><a href="#cite_note-pmid26305616-101" style="counter-reset: mw-Ref 101;"><span class="mw-reflink-text">[101]</span></a></span><span class="mw-ref" id="cite_ref-pmid19937841_102-0"><a href="#cite_note-pmid19937841-102" style="counter-reset: mw-Ref 102;"><span class="mw-reflink-text">[102]</span></a></span> The LAT1 is highly expressed at the blood–brain barrier<span class="mw-ref" id="cite_ref-pmid10518579_103-0"><a href="#cite_note-pmid10518579-103" style="counter-reset: mw-Ref 103;"><span class="mw-reflink-text">[103]</span></a></span> and transports gabapentin across into the brain.<span class="mw-ref" id="cite_ref-pmid23567998_95-3"><a href="#cite_note-pmid23567998-95" style="counter-reset: mw-Ref 95;"><span class="mw-reflink-text">[95]</span></a></span><span class="mw-ref" id="cite_ref-pmid16376147_90-8"><a href="#cite_note-pmid16376147-90" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span><span class="mw-ref" id="cite_ref-pmid26305616_101-1"><a href="#cite_note-pmid26305616-101" style="counter-reset: mw-Ref 101;"><span class="mw-reflink-text">[101]</span></a></span><span class="mw-ref" id="cite_ref-pmid19937841_102-1"><a href="#cite_note-pmid19937841-102" style="counter-reset: mw-Ref 102;"><span class="mw-reflink-text">[102]</span></a></span> As with intestinal absorption of gabapentin mediated by LAT1, transportation  of gabapentin across the blood–brain barrier by LAT1 is saturable.<span class="mw-ref" id="cite_ref-pmid23567998_95-4"><a href="#cite_note-pmid23567998-95" style="counter-reset: mw-Ref 95;"><span class="mw-reflink-text">[95]</span></a></span> It does not bind to other drug transporters such as P-glycoprotein (ABCB1) or OCTN2 (SLC22A5).<span class="mw-ref" id="cite_ref-pmid23567998_95-5"><a href="#cite_note-pmid23567998-95" style="counter-reset: mw-Ref 95;"><span class="mw-reflink-text">[95]</span></a></span> Gabapentin is not significantly bound to plasma proteins (&lt;1%).<span class="mw-ref" id="cite_ref-pmid20818832_97-6"><a href="#cite_note-pmid20818832-97" style="counter-reset: mw-Ref 97;"><span class="mw-reflink-text">[97]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Metabolism">Metabolism</h4></summary>
    
<p>
Gabapentin undergoes little or no metabolism.<span class="mw-ref" id="cite_ref-pmid27345098_10-8"><a href="#cite_note-pmid27345098-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-pmid20818832_97-7"><a href="#cite_note-pmid20818832-97" style="counter-reset: mw-Ref 97;"><span class="mw-reflink-text">[97]</span></a></span> Conversely, gabapentin enacarbil, which acts as a prodrug of gabapentin, must undergo enzymatic hydrolysis to become active.<span class="mw-ref" id="cite_ref-pmid27345098_10-9"><a href="#cite_note-pmid27345098-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-pmid20505847_98-3"><a href="#cite_note-pmid20505847-98" style="counter-reset: mw-Ref 98;"><span class="mw-reflink-text">[98]</span></a></span> This is done via non-specific esterases in the intestines and to a lesser extent in the liver.<span class="mw-ref" id="cite_ref-pmid27345098_10-10"><a href="#cite_note-pmid27345098-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Elimination">Elimination</h4></summary>
    
<p>
Gabapentin is eliminated renally in the urine.<span class="mw-ref" id="cite_ref-pmid20818832_97-8"><a href="#cite_note-pmid20818832-97" style="counter-reset: mw-Ref 97;"><span class="mw-reflink-text">[97]</span></a></span> It has a relatively short elimination half-life, with a reported value of 5.0 to 7.0<span>&nbsp;</span>hours.<span class="mw-ref" id="cite_ref-pmid20818832_97-9"><a href="#cite_note-pmid20818832-97" style="counter-reset: mw-Ref 97;"><span class="mw-reflink-text">[97]</span></a></span> Similarly, the terminal half-life of gabapentin enacarbil IR (as active gabapentin) is short at approximately 4.5 to 6.5<span>&nbsp;</span>hours.<span class="mw-ref" id="cite_ref-pmid18827074_100-2"><a href="#cite_note-pmid18827074-100" style="counter-reset: mw-Ref 100;"><span class="mw-reflink-text">[100]</span></a></span> The elimination half-life of gabapentin has been found to be extended with increasing doses; in one series of studies, it was 5.4<span>&nbsp;</span>hours for 200<span>&nbsp;</span>mg, 6.7<span>&nbsp;</span>hours for 400<span>&nbsp;</span>mg, 7.3<span>&nbsp;</span>hours for 800<span>&nbsp;</span>mg, 9.3<span>&nbsp;</span>hours for 1,200<span>&nbsp;</span>mg, and 8.3<span>&nbsp;</span>hours for 1,400<span>&nbsp;</span>mg, all given in single doses.<span class="mw-ref" id="cite_ref-pmid18827074_100-3"><a href="#cite_note-pmid18827074-100" style="counter-reset: mw-Ref 100;"><span class="mw-reflink-text">[100]</span></a></span> Because of its short elimination half-life, gabapentin must be administered 3 to 4<span>&nbsp;</span>times per day to maintain therapeutic levels.<span class="mw-ref" id="cite_ref-pmid20505847_98-4"><a href="#cite_note-pmid20505847-98" style="counter-reset: mw-Ref 98;"><span class="mw-reflink-text">[98]</span></a></span> Conversely, gabapentin enacarbil is taken twice a day and gabapentin XR (brand name Gralise) is taken once a day.<span class="mw-ref" id="cite_ref-Kaye2017_104-0"><a href="#cite_note-Kaye2017-104" style="counter-reset: mw-Ref 104;"><span class="mw-reflink-text">[104]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:302px"><img src="../I/m/Gabapentinoid-structures.png" tppabs="https://ptable.com/wiki/compounds/I/m/Gabapentinoid-structures.png" data-file-width="2132" data-file-height="2088" data-file-type="bitmap" height="294" width="300"><div class="thumbcaption" style="text-align: left">Chemical structures of GABA, gabapentin, and two other gabapentinoids, <a href="Pregabalin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregabalin" title="Pregabalin">pregabalin</a> and phenibut.</div></div></div>

<p>Gabapentin was designed by researchers at Parke-Davis to be an analogue of the neurotransmitter GABA that could more easily cross the blood–brain barrier.<span class="mw-ref" id="cite_ref-Sneader2005_11-1"><a href="#cite_note-Sneader2005-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> It is a 3-substituted derivative of GABA; hence, it is a GABA analogue, as well as a γ-amino acid.<span class="mw-ref" id="cite_ref-WyllieCascino2012_105-0"><a href="#cite_note-WyllieCascino2012-105" style="counter-reset: mw-Ref 105;"><span class="mw-reflink-text">[105]</span></a></span><span class="mw-ref" id="cite_ref-BenzonRathmell2013_91-1"><a href="#cite_note-BenzonRathmell2013-91" style="counter-reset: mw-Ref 91;"><span class="mw-reflink-text">[91]</span></a></span> Specifically, gabapentin is a derivative of GABA with a <a href="Cyclohexane.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclohexane" title="Cyclohexane">cyclohexane</a> ring at the 3 position (or, somewhat inappropriately named, 3-cyclohexyl-GABA).<span class="mw-ref" id="cite_ref-pmid18221197_106-0"><a href="#cite_note-pmid18221197-106" style="counter-reset: mw-Ref 106;"><span class="mw-reflink-text">[106]</span></a></span><span class="mw-ref" id="cite_ref-pmid11966555_107-0"><a href="#cite_note-pmid11966555-107" style="counter-reset: mw-Ref 107;"><span class="mw-reflink-text">[107]</span></a></span><span class="mw-ref" id="cite_ref-WhelessWillmore2009_108-0"><a href="#cite_note-WhelessWillmore2009-108" style="counter-reset: mw-Ref 108;"><span class="mw-reflink-text">[108]</span></a></span> Gabapentin also closely resembles the α-amino acids <small>L</small>-leucine and <small>L</small>-isoleucine, and this may be of greater relevance in relation to its pharmacodynamics than its structural similarity to GABA.<span class="mw-ref" id="cite_ref-pmid17222465_93-2"><a href="#cite_note-pmid17222465-93" style="counter-reset: mw-Ref 93;"><span class="mw-reflink-text">[93]</span></a></span><span class="mw-ref" id="cite_ref-pmid17403543_94-1"><a href="#cite_note-pmid17403543-94" style="counter-reset: mw-Ref 94;"><span class="mw-reflink-text">[94]</span></a></span><span class="mw-ref" id="cite_ref-pmid18221197_106-1"><a href="#cite_note-pmid18221197-106" style="counter-reset: mw-Ref 106;"><span class="mw-reflink-text">[106]</span></a></span> In accordance, the amine and <span class="new">carboxylic acid groups</span> are not in the same orientation as they are in the GABA,<span class="mw-ref" id="cite_ref-Sneader2005_11-2"><a href="#cite_note-Sneader2005-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> and they are more conformationally constrained.<span class="mw-ref" id="cite_ref-pmid21428817_109-0"><a href="#cite_note-pmid21428817-109" style="counter-reset: mw-Ref 109;"><span class="mw-reflink-text">[109]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Synthesis">Synthesis</h3></summary>
    
<p>A chemical synthesis of gabapentin has been described.<span class="mw-ref" id="cite_ref-Publishing2013_110-0"><a href="#cite_note-Publishing2013-110" style="counter-reset: mw-Ref 110;"><span class="mw-reflink-text">[110]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>Gabapentin was developed at Parke-Davis and was first described in 1975.<span class="mw-ref" id="cite_ref-Sneader2005_11-3"><a href="#cite_note-Sneader2005-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-JohnsonLi2013_111-0"><a href="#cite_note-JohnsonLi2013-111" style="counter-reset: mw-Ref 111;"><span class="mw-reflink-text">[111]</span></a></span> Under the brand name Neurontin, it was first approved in May 1993, for the treatment of epilepsy in the United Kingdom, and was marketed in the United States in 1994.<span class="mw-ref" id="cite_ref-AdisInsight-Gabapentin_112-0"><a href="#cite_note-AdisInsight-Gabapentin-112" style="counter-reset: mw-Ref 112;"><span class="mw-reflink-text">[112]</span></a></span><span class="mw-ref" id="cite_ref-Li2014_113-0"><a href="#cite_note-Li2014-113" style="counter-reset: mw-Ref 113;"><span class="mw-reflink-text">[113]</span></a></span> Subsequently, gabapentin was approved in the United States for the treatment of postherpetic neuralgia in May 2002.<span class="mw-ref" id="cite_ref-pmid23342236_114-0"><a href="#cite_note-pmid23342236-114" style="counter-reset: mw-Ref 114;"><span class="mw-reflink-text">[114]</span></a></span> A generic version of gabapentin first became available in the United States in 2004.<span class="mw-ref" id="cite_ref-Reed2012_115-0"><a href="#cite_note-Reed2012-115" style="counter-reset: mw-Ref 115;"><span class="mw-reflink-text">[115]</span></a></span> An extended-release formulation of gabapentin for once-daily administration, under the brand name Gralise, was approved in the United States for the treatment postherpetic neuralgia in January 2011.<span class="mw-ref" id="cite_ref-GoodRx2013_116-0"><a href="#cite_note-GoodRx2013-116" style="counter-reset: mw-Ref 116;"><span class="mw-reflink-text">[116]</span></a></span><span class="mw-ref" id="cite_ref-AdisInsight-Gabapentin-CR_117-0"><a href="#cite_note-AdisInsight-Gabapentin-CR-117" style="counter-reset: mw-Ref 117;"><span class="mw-reflink-text">[117]</span></a></span> Gabapentin enacarbil was introduced in the United States for the treatment of restless legs syndrome in 2011, and was approved for the treatment of postherpetic neuralgia in 2012.<span class="mw-ref" id="cite_ref-Medscape_118-0"><a href="#cite_note-Medscape-118" style="counter-reset: mw-Ref 118;"><span class="mw-reflink-text">[118]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Sales">Sales</h3></summary>
    
<p>Gabapentin is best known under the brand name Neurontin manufactured by Pfizer subsidiary Parke-Davis. A Pfizer subsidiary named Greenstone markets generic gabapentin.</p>

<p>In December 2004, the FDA granted final approval to a generic equivalent to Neurontin made by the Israeli firm Teva Pharmaceutical Industries (Teva).</p>

<p>Neurontin began as one of Pfizer's best selling drugs; however, Pfizer was criticized and under litigation for its marketing of the drug (see <i>Franklin v. Parke-Davis</i>). Pfizer faced allegations that Parke-Davis marketed the drug for at least a dozen off-label uses that the FDA had not approved.<span class="mw-ref" id="cite_ref-Hen2006_17-1"><a href="#cite_note-Hen2006-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span><span class="mw-ref" id="cite_ref-119"><a href="#cite_note-119" style="counter-reset: mw-Ref 119;"><span class="mw-reflink-text">[119]</span></a></span> It has been used as a mainstay drug for migraines, even though it was not approved for such use in 2004.<span class="mw-ref" id="cite_ref-120"><a href="#cite_note-120" style="counter-reset: mw-Ref 120;"><span class="mw-reflink-text">[120]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="FDA_approval">FDA approval</h3></summary>
    
<p>Gabapentin was originally approved by the U.S. Food and Drug Administration (FDA) in December 1993, for use as an adjuvant (effective when added to other antiseizure drugs) medication to control partial seizures in adults; that indication was extended to children in 2000.<span class="mw-ref" id="cite_ref-Mack_121-0"><a href="#cite_note-Mack-121" style="counter-reset: mw-Ref 121;"><span class="mw-reflink-text">[121]</span></a></span><span class="mw-ref" id="cite_ref-Neurontin_label_14-4"><a href="#cite_note-Neurontin_label-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> In 2004, its use for treating postherpetic neuralgia (neuropathic pain following shingles) was approved.<span class="mw-ref" id="cite_ref-Mack_121-1"><a href="#cite_note-Mack-121" style="counter-reset: mw-Ref 121;"><span class="mw-reflink-text">[121]</span></a></span><span class="mw-ref" id="cite_ref-122"><a href="#cite_note-122" style="counter-reset: mw-Ref 122;"><span class="mw-reflink-text">[122]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Off-label_promotion">Off-label promotion</h3></summary>
    
<p>Although some small, non-controlled studies in the 1990s—mostly sponsored by gabapentin's manufacturer—suggested that treatment for bipolar disorder with gabapentin may be promising,<span class="mw-ref" id="cite_ref-evid_29-1"><a href="#cite_note-evid-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span> the preponderance of evidence suggests that it is not effective.<span class="mw-ref" id="cite_ref-123"><a href="#cite_note-123" style="counter-reset: mw-Ref 123;"><span class="mw-reflink-text">[123]</span></a></span> Subsequent to the corporate acquisition of the original patent holder, the pharmaceutical company Pfizer admitted that there had been violations of FDA guidelines regarding the promotion of unproven off-label uses for gabapentin in the <a href="#Franklin_v._Parke-Davis_case">Franklin v. Parke-Davis</a> case.</p>

<p>Reuters reported on 25 March 2010, that "Pfizer Inc violated federal racketeering law by improperly promoting the epilepsy drug Neurontin ... Under federal RICO law the penalty is automatically tripled, so the finding will cost Pfizer $141 million."<span class="mw-ref" id="cite_ref-Berkrot_20100325_124-0"><a href="#cite_note-Berkrot_20100325-124" style="counter-reset: mw-Ref 124;"><span class="mw-reflink-text">[124]</span></a></span> The case stems from a claim from Kaiser Foundation Health Plan Inc. that "it was misled into believing Neurontin was effective for off-label treatment of migraines, bipolar disorder and other conditions. Pfizer argued that Kaiser physicians still recommend the drug for those uses."<span class="mw-ref" id="cite_ref-125"><a href="#cite_note-125" style="counter-reset: mw-Ref 125;"><span class="mw-reflink-text">[125]</span></a></span></p>

<p>Bloomberg News reported "during the trial, Pfizer argued that Kaiser doctors continued to prescribe the drug even after the health insurer sued Pfizer in 2005. The insurer's website also still lists Neurontin as a drug for neuropathic pain, Pfizer lawyers said in closing argument."<span class="mw-ref" id="cite_ref-126"><a href="#cite_note-126" style="counter-reset: mw-Ref 126;"><span class="mw-reflink-text">[126]</span></a></span></p>

<p><i>The Wall Street Journal</i> noted that Pfizer spokesman Christopher Loder said, "We are disappointed with the verdict and will pursue post-trial motions and an appeal."<span class="mw-ref" id="cite_ref-127"><a href="#cite_note-127" style="counter-reset: mw-Ref 127;"><span class="mw-reflink-text">[127]</span></a></span> He later added that "the verdict and the judge's rulings are not consistent with the facts and the law."<span class="mw-ref" id="cite_ref-Berkrot_20100325_124-1"><a href="#cite_note-Berkrot_20100325-124" style="counter-reset: mw-Ref 124;"><span class="mw-reflink-text">[124]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Franklin_v._Parke-Davis_case"><i>Franklin v. Parke-Davis</i> case</h4></summary>
    
<p></p>


<p>According to the <i>San Francisco Chronicle</i>, <i>off-label</i> prescriptions accounted for roughly 90<span>&nbsp;</span>percent of Neurontin sales.<span class="mw-ref" id="cite_ref-128"><a href="#cite_note-128" style="counter-reset: mw-Ref 128;"><span class="mw-reflink-text">[128]</span></a></span></p>

<p>While off-label prescriptions are common for a number of drugs, marketing of off-label uses of a drug is not.<span class="mw-ref" id="cite_ref-Hen2006_17-2"><a href="#cite_note-Hen2006-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> In 2004, Warner-Lambert (which subsequently was acquired by Pfizer) agreed to plead guilty for activities of its Parke-Davis subsidiary, and to pay $430<span>&nbsp;</span>million in fines to settle civil and criminal charges regarding the marketing of Neurontin for off-label purposes. The 2004 settlement was one of the largest in U.S. history, and the first off-label promotion case brought successfully under the False Claims Act.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Brand_names">Brand names</h3></summary>
    
<p>Gabapentin was originally marketed under the brand name Neurontin. Since it became generic, it has been marketed worldwide using over 300 different brand names.<span class="mw-ref" id="cite_ref-Drugs.com_1-1"><a href="#cite_note-Drugs.com-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> An extended-release formulation of gabapentin for once-daily administration was introduced in 2011 for postherpetic neuralgia under the brand name Gralise.<span class="mw-ref" id="cite_ref-Drugs.com-History_129-0"><a href="#cite_note-Drugs.com-History-129" style="counter-reset: mw-Ref 129;"><span class="mw-reflink-text">[129]</span></a></span></p>

<div class="thumb tright"><div class="thumbinner" style="width:113px"><img src="../I/m/Gabapentin_capsule.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Gabapentin_capsule.jpg" data-file-width="111" data-file-height="79" data-file-type="bitmap" height="79" width="111"><div class="thumbcaption" style="text-align: left">A capsule of gabapentin.</div></div></div>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Related_drugs">Related drugs</h3></summary>
    
<p>Parke-Davis developed a drug called <a href="Pregabalin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregabalin" title="Pregabalin">pregabalin</a> as a successor to gabapentin.<span class="mw-ref" id="cite_ref-Baillie_33–9_130-0"><a href="#cite_note-Baillie_33–9-130" style="counter-reset: mw-Ref 130;"><span class="mw-reflink-text">[130]</span></a></span> Pregabalin was brought to market by Pfizer as <a href="Pregabalin.htm" tppabs="https://ptable.com/wiki/compounds/A/Lyrica" title="Lyrica" class="mw-redirect">Lyrica</a> after the company acquired Warner-Lambert. Pregabalin is related in structure to gabapentin.<span class="mw-ref" id="cite_ref-131"><a href="#cite_note-131" style="counter-reset: mw-Ref 131;"><span class="mw-reflink-text">[131]</span></a></span> Another new drug atagabalin has been trialed by Pfizer as a treatment for insomnia.<span class="mw-ref" id="cite_ref-pmid21681607_132-0"><a href="#cite_note-pmid21681607-132" style="counter-reset: mw-Ref 132;"><span class="mw-reflink-text">[132]</span></a></span></p>

<p>A prodrug form (gabapentin enacarbil)<span class="mw-ref" id="cite_ref-pmid19787095_133-0"><a href="#cite_note-pmid19787095-133" style="counter-reset: mw-Ref 133;"><span class="mw-reflink-text">[133]</span></a></span> was approved by the U.S. Food and Drug Administration (FDA) in 2011 under the brand name Horizant for the treatment of moderate-to-severe restless legs syndrome (RLS)<span class="mw-ref" id="cite_ref-134"><a href="#cite_note-134" style="counter-reset: mw-Ref 134;"><span class="mw-reflink-text">[134]</span></a></span> and in 2012 for postherpetic neuralgia in adults.<span class="mw-ref" id="cite_ref-135"><a href="#cite_note-135" style="counter-reset: mw-Ref 135;"><span class="mw-reflink-text">[135]</span></a></span> In Canada, it has completed Phase 3 trials for RLS (September 2019).<span class="mw-ref" id="cite_ref-DrugBank1_136-0"><a href="#cite_note-DrugBank1-136" style="counter-reset: mw-Ref 136;"><span class="mw-reflink-text">[136]</span></a></span> It was designed for increased oral bioavailability over gabapentin.<span class="mw-ref" id="cite_ref-pmid15146028_137-0"><a href="#cite_note-pmid15146028-137" style="counter-reset: mw-Ref 137;"><span class="mw-reflink-text">[137]</span></a></span><span class="mw-ref" id="cite_ref-pmid15146029_138-0"><a href="#cite_note-pmid15146029-138" style="counter-reset: mw-Ref 138;"><span class="mw-reflink-text">[138]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Recreational_use">Recreational use</h3></summary>
    
<p>Also known on the streets as "Gabbies",<span class="mw-ref" id="cite_ref-139"><a href="#cite_note-139" style="counter-reset: mw-Ref 139;"><span class="mw-reflink-text">[139]</span></a></span> gabapentin is increasingly being abused and misused for its euphoric effects.<span class="mw-ref" id="cite_ref-140"><a href="#cite_note-140" style="counter-reset: mw-Ref 140;"><span class="mw-reflink-text">[140]</span></a></span><span class="mw-ref" id="cite_ref-141"><a href="#cite_note-141" style="counter-reset: mw-Ref 141;"><span class="mw-reflink-text">[141]</span></a></span> Furthermore, its misuse predominantly coincides with the usage of other illicit drugs, namely opioids, benzodiazepines, and alcohol.<span class="mw-ref" id="cite_ref-:1_21-5"><a href="#cite_note-:1-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span></p>

<p>After Kentucky's implementation of stricter legislation regarding opioid prescriptions in 2012, there was an increase in gabapentin-only and multi-drug use in 2012–2015. The majority of these cases were from overdose in suspected suicide attempts. These rates were also accompanied by increases in abuse and recreational use.<span class="mw-ref" id="cite_ref-142"><a href="#cite_note-142" style="counter-reset: mw-Ref 142;"><span class="mw-reflink-text">[142]</span></a></span></p>

<p>Gabapentin misuse, toxicity, and use in suicide attempts among adults in the US increased from 2013 to 2017.<span class="mw-ref" id="cite_ref-143"><a href="#cite_note-143" style="counter-reset: mw-Ref 143;"><span class="mw-reflink-text">[143]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Veterinary_use">Veterinary use</h2></summary>
    
<p>In cats, gabapentin can be used as an analgesic in multi-modal pain management.<span class="mw-ref" id="cite_ref-pmid21831060_144-0"><a href="#cite_note-pmid21831060-144" style="counter-reset: mw-Ref 144;"><span class="mw-reflink-text">[144]</span></a></span> It is also used as an anxiety medication to reduce stress in cats for travel or vet visits.<span class="mw-ref" id="cite_ref-pmid29099247_145-0"><a href="#cite_note-pmid29099247-145" style="counter-reset: mw-Ref 145;"><span class="mw-reflink-text">[145]</span></a></span></p>

<p>Gabapentin is also used in dogs and other animals, but some formulations (especially liquid forms) meant for human use contain the sweetener <a href="Xylitol.htm" tppabs="https://ptable.com/wiki/compounds/A/Xylitol" title="Xylitol">xylitol</a>, which is toxic to dogs.<span class="mw-ref" id="cite_ref-146"><a href="#cite_note-146" style="counter-reset: mw-Ref 146;"><span class="mw-reflink-text">[146]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-Drugs.com-1"> <span id="mw-reference-text-cite_note-Drugs.com-1" class="mw-reference-text"><a href="javascript:if(confirm('https://www.drugs.com/international/gabapentin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/international/gabapentin.html'" tppabs="https://www.drugs.com/international/gabapentin.html" class="external text external">Drugs.com international listings for Gabapentin</a> <a href="javascript:if(confirm('https://web.archive.org/web/20160216074247/http://www.drugs.com/international/gabapentin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160216074247/http://www.drugs.com/international/gabapentin.html'" tppabs="https://web.archive.org/web/20160216074247/http://www.drugs.com/international/gabapentin.html" class="external text external">Archived</a><span> 16 February 2016 at the </span>Wayback Machine Page accessed 9 February 2016</span></li><li id="cite_note-Drugs.com_Pregnancy-2"> <span id="mw-reference-text-cite_note-Drugs.com_Pregnancy-2" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/pregnancy/gabapentin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/pregnancy/gabapentin.html'" tppabs="https://www.drugs.com/pregnancy/gabapentin.html" class="external text external">"Gabapentin Use During Pregnancy"</a>. <i>Drugs.com</i>. 2 December 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">21 December</span> 2019</span>.</cite></span></li><li id="cite_note-MSR-3"> <span id="mw-reference-text-cite_note-MSR-3" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://reference.medscape.com/drug/neurontin-gralise-gabapentin-343011  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://reference.medscape.com/drug/neurontin-gralise-gabapentin-343011#showall'" tppabs="http://reference.medscape.com/drug/neurontin-gralise-gabapentin-343011#showall" class="external text external">"Neurontin, Gralise (gabapentin) dosing, indications, interactions, adverse effects, and more"</a>. <i>Medscape Reference</i>. WebMD. <a href="javascript:if(confirm('https://web.archive.org/web/20141216215811/http://reference.medscape.com/drug/neurontin-gralise-gabapentin-343011  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20141216215811/http://reference.medscape.com/drug/neurontin-gralise-gabapentin-343011#showall'" tppabs="https://web.archive.org/web/20141216215811/http://reference.medscape.com/drug/neurontin-gralise-gabapentin-343011#showall" class="external text external">Archived</a> from the original on 16 December 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">6 April</span> 2014</span>.</cite></span></li><li id="cite_note-drugs93-4"> <span id="mw-reference-text-cite_note-drugs93-4" class="mw-reference-text"><cite id="CITEREFGoaSorkin1993" class="citation journal cs1">Goa KL, Sorkin EM (September 1993). "Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy". <i>Drugs</i>. <b>46</b> (3): 409–427. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003495-199346030-00007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003495-199346030-00007'" tppabs="https://doi.org/10.2165%2F00003495-199346030-00007" class="external text external">10.2165/00003495-199346030-00007</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7693432  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7693432'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7693432" class="external text external">7693432</a>.</cite></span></li><li id="cite_note-AHFS2015-5"> <span id="mw-reference-text-cite_note-AHFS2015-5" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/gabapentin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/gabapentin.html'" tppabs="https://www.drugs.com/monograph/gabapentin.html" class="external text external">"Gabapentin"</a>. The American Society of Health-System Pharmacists. <a href="javascript:if(confirm('https://web.archive.org/web/20170819150204/https://www.drugs.com/monograph/gabapentin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170819150204/https://www.drugs.com/monograph/gabapentin.html'" tppabs="https://web.archive.org/web/20170819150204/https://www.drugs.com/monograph/gabapentin.html" class="external text external">Archived</a> from the original on 19 August 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">23 October</span> 2015</span>.</cite></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><cite id="CITEREFWijemanneJankovic2015" class="citation journal cs1">Wijemanne S, Jankovic J (June 2015). "Restless legs syndrome: clinical presentation diagnosis and treatment". <i>Sleep Medicine</i>. <b>16</b> (6): 678–90. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.sleep.2015.03.002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.sleep.2015.03.002'" tppabs="https://doi.org/10.1016%2Fj.sleep.2015.03.002" class="external text external">10.1016/j.sleep.2015.03.002</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25979181  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25979181'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25979181" class="external text external">25979181</a>.</cite></span></li><li id="cite_note-Attal2010-7"> <span id="mw-reference-text-cite_note-Attal2010-7" class="mw-reference-text"><cite id="CITEREFAttalCruccuBaronHaanpää2010" class="citation journal cs1">Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, Nurmikko T (September 2010). "EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision". <i>European Journal of Neurology</i>. <b>17</b> (9): 1113–e88. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1468-1331.2010.02999.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1468-1331.2010.02999.x'" tppabs="https://doi.org/10.1111%2Fj.1468-1331.2010.02999.x" class="external text external">10.1111/j.1468-1331.2010.02999.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20402746  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20402746'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20402746" class="external text external">20402746</a>.</cite></span></li><li id="cite_note-Wiffen2017-8"> <span id="mw-reference-text-cite_note-Wiffen2017-8" class="mw-reference-text"><cite id="CITEREFWiffenDerryBellRice2017" class="citation journal cs1">Wiffen PJ, Derry S, Bell RF, Rice AS, Tölle TR, Phillips T, Moore RA (June 2017). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452908  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452908'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452908" class="external text external">"Gabapentin for chronic neuropathic pain in adults"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>6</b>: CD007938. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD007938.pub4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD007938.pub4'" tppabs="https://doi.org/10.1002%2F14651858.CD007938.pub4" class="external text external">10.1002/14651858.CD007938.pub4</a>. hdl:<a href="javascript:if(confirm('https://hdl.handle.net/10044%2F1%2F52908  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/10044%2F1%2F52908'" tppabs="https://hdl.handle.net/10044%2F1%2F52908" class="external text external">10044/1/52908</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452908  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452908'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452908" class="external text external">6452908</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28597471  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28597471'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28597471" class="external text external">28597471</a>.</cite></span></li><li id="cite_note-9"> <span id="mw-reference-text-cite_note-9" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/pregnancy/gabapentin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/pregnancy/gabapentin.html'" tppabs="https://www.drugs.com/pregnancy/gabapentin.html" class="external text external">"Gabapentin Pregnancy and Breastfeeding Warnings"</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20170829040336/https://www.drugs.com/pregnancy/gabapentin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170829040336/https://www.drugs.com/pregnancy/gabapentin.html'" tppabs="https://web.archive.org/web/20170829040336/https://www.drugs.com/pregnancy/gabapentin.html" class="external text external">Archived</a> from the original on 29 August 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">13 March</span> 2016</span>.</cite></span></li><li id="cite_note-pmid27345098-10"> <span id="mw-reference-text-cite_note-pmid27345098-10" class="mw-reference-text"><cite id="CITEREFCalandreRico-VillademorosSlim2016" class="citation journal cs1">Calandre EP, Rico-Villademoros F, Slim M (November 2016). "2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use". <i>Expert Review of Neurotherapeutics</i>. <b>16</b> (11): 1263–1277. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F14737175.2016.1202764  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F14737175.2016.1202764'" tppabs="https://doi.org/10.1080%2F14737175.2016.1202764" class="external text external">10.1080/14737175.2016.1202764</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27345098  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27345098'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27345098" class="external text external">27345098</a>.</cite></span></li><li id="cite_note-Sneader2005-11"> <span id="mw-reference-text-cite_note-Sneader2005-11" class="mw-reference-text"><cite id="CITEREFSneader2005" class="citation book cs1">Sneader, Walter (2005). <a href="javascript:if(confirm('https://books.google.com/books?id=jglFsz5EJR8C&pg=PA219  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=jglFsz5EJR8C&pg=PA219'" tppabs="https://books.google.com/books?id=jglFsz5EJR8C&pg=PA219" class="external text external"><i>Drug Discovery: A History</i></a>. John Wiley &amp; Sons. pp.<span>&nbsp;</span>219–220. ISBN<span>&nbsp;</span><bdi>978-0-470-01552-0</bdi>.</cite></span></li><li id="cite_note-pmid21150315-12"> <span id="mw-reference-text-cite_note-pmid21150315-12" class="mw-reference-text"><cite id="CITEREFUchitelDi_GuilmiUrbanoGonzalez-Inchauspe2010" class="citation journal cs1">Uchitel OD, Di Guilmi MN, Urbano FJ, Gonzalez-Inchauspe C (2010). <a href="javascript:if(confirm('https://doi.org/10.4161/chan.4.6.12864  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4161/chan.4.6.12864'" tppabs="https://doi.org/10.4161/chan.4.6.12864" class="external text external">"Acute modulation of calcium currents and synaptic transmission by gabapentinoids"</a>. <i>Channels</i>. <b>4</b> (6): 490–6. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.4161%2Fchan.4.6.12864  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4161%2Fchan.4.6.12864'" tppabs="https://doi.org/10.4161%2Fchan.4.6.12864" class="external text external">10.4161/chan.4.6.12864</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21150315  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21150315'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21150315" class="external text external">21150315</a>.</cite></span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text"><cite id="CITEREFPitkänenSchwartzkroinMoshé2005" class="citation book cs1">Pitkänen A, Schwartzkroin PA, Moshé SL (2005). <a href="javascript:if(confirm('https://books.google.com/books?id=Qw6KqLjwtZQC&pg=PA539  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=Qw6KqLjwtZQC&pg=PA539'" tppabs="https://books.google.com/books?id=Qw6KqLjwtZQC&pg=PA539" class="external text external"><i>Models of Seizures and Epilepsy</i></a>. Burlington: Elsevier. p.<span>&nbsp;</span>539. ISBN<span>&nbsp;</span><bdi>978-0-08-045702-4</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170908192246/https://books.google.com/books?id=Qw6KqLjwtZQC&pg=PA539  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170908192246/https://books.google.com/books?id=Qw6KqLjwtZQC&pg=PA539'" tppabs="https://web.archive.org/web/20170908192246/https://books.google.com/books?id=Qw6KqLjwtZQC&pg=PA539" class="external text external">Archived</a> from the original on 8 September 2017.</cite></span></li><li id="cite_note-Neurontin_label-14"> <span id="mw-reference-text-cite_note-Neurontin_label-14" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388'" tppabs="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388" class="external text external">"Neurontin- gabapentin capsule Neurontin- gabapentin tablet, film coated Neurontin- gabapentin solution"</a>. <i>DailyMed</i>. 11 April 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">21 December</span> 2019</span>.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Top300Drugs.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Top300Drugs.aspx'" tppabs="https://clincalc.com/DrugStats/Top300Drugs.aspx" class="external text external">"The Top 300 of 2020"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">11 April</span> 2020</span>.</cite></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Drugs/Gabapentin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Drugs/Gabapentin'" tppabs="https://clincalc.com/DrugStats/Drugs/Gabapentin" class="external text external">"Gabapentin - Drug Usage Statistics"</a>. <i>ClinCalc</i>. 23 December 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">11 April</span> 2020</span>.</cite></span></li><li id="cite_note-Hen2006-17"> <span id="mw-reference-text-cite_note-Hen2006-17" class="mw-reference-text"><cite id="CITEREFHenney2006" class="citation journal cs1">Henney JE (August 2006). "Safeguarding patient welfare: who's in charge?". <i>Annals of Internal Medicine</i>. <b>145</b> (4): 305–7. doi:<a href="javascript:if(confirm('https://doi.org/10.7326%2F0003-4819-145-4-200608150-00013  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.7326%2F0003-4819-145-4-200608150-00013'" tppabs="https://doi.org/10.7326%2F0003-4819-145-4-200608150-00013" class="external text external">10.7326/0003-4819-145-4-200608150-00013</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16908923  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16908923'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16908923" class="external text external">16908923</a>.</cite></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text"><cite id="CITEREFStempel2014" class="citation news cs1">Stempel J (2 June 2014). <a href="javascript:if(confirm('https://www.reuters.com/article/us-pfizer-neurontin-settlement/pfizer-to-pay-325-million-in-neurontin-settlement-idUSKBN0ED1IS20140602  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.reuters.com/article/us-pfizer-neurontin-settlement/pfizer-to-pay-325-million-in-neurontin-settlement-idUSKBN0ED1IS20140602'" tppabs="https://www.reuters.com/article/us-pfizer-neurontin-settlement/pfizer-to-pay-325-million-in-neurontin-settlement-idUSKBN0ED1IS20140602" class="external text external">"Pfizer to pay $325 million in Neurontin settlement"</a>. <i>Reuters</i><span class="reference-accessdate">. Retrieved <span class="nowrap">11 June</span> 2018</span>.</cite></span></li><li id="cite_note-AHFS-19"> <span id="mw-reference-text-cite_note-AHFS-19" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/gabapentin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/gabapentin.html'" tppabs="https://www.drugs.com/monograph/gabapentin.html" class="external text external">"Gabapentin"</a>. The American Society of Health-System Pharmacists. <a href="javascript:if(confirm('https://web.archive.org/web/20110112011823/http://www.drugs.com/monograph/gabapentin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110112011823/http://www.drugs.com/monograph/gabapentin.html'" tppabs="https://web.archive.org/web/20110112011823/http://www.drugs.com/monograph/gabapentin.html" class="external text external">Archived</a> from the original on 12 January 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">3 April</span> 2011</span>.</cite></span></li><li id="cite_note-:0-20"> <span id="mw-reference-text-cite_note-:0-20" class="mw-reference-text"><cite id="CITEREFPatelDickenson2016" class="citation journal cs1">Patel R, Dickenson AH (April 2016). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804325  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804325'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804325" class="external text external">"Mechanisms of the gabapentinoids and α 2 δ-1 calcium channel subunit in neuropathic pain"</a>. <i>Pharmacology Research &amp; Perspectives</i>. <b>4</b> (2): e00205. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fprp2.205  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fprp2.205'" tppabs="https://doi.org/10.1002%2Fprp2.205" class="external text external">10.1002/prp2.205</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804325  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804325'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804325" class="external text external">4804325</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27069626  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27069626'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27069626" class="external text external">27069626</a>.</cite></span></li><li id="cite_note-:1-21"> <span id="mw-reference-text-cite_note-:1-21" class="mw-reference-text"><cite id="CITEREFSmithHavensWalsh2016" class="citation journal cs1">Smith RV, Havens JR, Walsh SL (July 2016). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573873  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573873'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573873" class="external text external">"Gabapentin misuse, abuse and diversion: a systematic review"</a>. <i>Addiction</i>. <b>111</b> (7): 1160–74. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fadd.13324  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fadd.13324'" tppabs="https://doi.org/10.1111%2Fadd.13324" class="external text external">10.1111/add.13324</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573873  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573873'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573873" class="external text external">5573873</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27265421  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27265421'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27265421" class="external text external">27265421</a>.</cite></span></li><li id="cite_note-22"> <span id="mw-reference-text-cite_note-22" class="mw-reference-text"><cite id="CITEREFKrielBirnbaumCloydRicker1997" class="citation journal cs1">Kriel RL, Birnbaum AK, Cloyd JC, Ricker BJ, Jones Saete C, Caruso KJ (November 1997). "Failure of absorption of gabapentin after rectal administration". <i>Epilepsia</i>. <b>38</b> (11): 1242–4. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1528-1157.1997.tb01223.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1528-1157.1997.tb01223.x'" tppabs="https://doi.org/10.1111%2Fj.1528-1157.1997.tb01223.x" class="external text external">10.1111/j.1528-1157.1997.tb01223.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9579927  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9579927'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9579927" class="external text external">9579927</a>.</cite></span></li><li id="cite_note-Sobel2012-23"> <span id="mw-reference-text-cite_note-Sobel2012-23" class="mw-reference-text"><cite id="CITEREFSobel2012" class="citation book cs1">Sobel SV (5 November 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=dnAlO_Veu2QC&pg=PA124  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=dnAlO_Veu2QC&pg=PA124'" tppabs="https://books.google.com/books?id=dnAlO_Veu2QC&pg=PA124" class="external text external"><i>Successful Psychopharmacology: Evidence-Based Treatment Solutions for Achieving Remission</i></a>. W. W. Norton. p.<span>&nbsp;</span>124. ISBN<span>&nbsp;</span><bdi>978-0-393-70857-8</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20160106173227/https://books.google.com/books?id=dnAlO_Veu2QC&pg=PA124  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160106173227/https://books.google.com/books?id=dnAlO_Veu2QC&pg=PA124'" tppabs="https://web.archive.org/web/20160106173227/https://books.google.com/books?id=dnAlO_Veu2QC&pg=PA124" class="external text external">Archived</a> from the original on 6 January 2016.</cite></span></li><li id="cite_note-ReynoldsColeman2011-24"> <span id="mw-reference-text-cite_note-ReynoldsColeman2011-24" class="mw-reference-text"><cite id="CITEREFReynoldsColemanAronson2011" class="citation book cs1">Reynolds DJ, Coleman J, Aronson J (10 November 2011). <a href="javascript:if(confirm('https://books.google.com/books?id=82oiYYHGNTQC&pg=PA765  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=82oiYYHGNTQC&pg=PA765'" tppabs="https://books.google.com/books?id=82oiYYHGNTQC&pg=PA765" class="external text external"><i>Oxford Handbook of Practical Drug Therapy</i></a>. Oxford University Press. p.<span>&nbsp;</span>765. ISBN<span>&nbsp;</span><bdi>978-0-19-956285-5</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20160106173227/https://books.google.com/books?id=82oiYYHGNTQC&pg=PA765  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160106173227/https://books.google.com/books?id=82oiYYHGNTQC&pg=PA765'" tppabs="https://web.archive.org/web/20160106173227/https://books.google.com/books?id=82oiYYHGNTQC&pg=PA765" class="external text external">Archived</a> from the original on 6 January 2016.</cite></span></li><li id="cite_note-Vedula_1963–71-25"> <span id="mw-reference-text-cite_note-Vedula_1963–71-25" class="mw-reference-text"><cite id="CITEREFVedulaBeroSchererDickersin2009" class="citation journal cs1">Vedula SS, Bero L, Scherer RW, Dickersin K (November 2009). "Outcome reporting in industry-sponsored trials of gabapentin for off-label use". <i>The New England Journal of Medicine</i>. <b>361</b> (20): 1963–71. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJMsa0906126  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJMsa0906126'" tppabs="https://doi.org/10.1056%2FNEJMsa0906126" class="external text external">10.1056/NEJMsa0906126</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19907043  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19907043'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19907043" class="external text external">19907043</a>.</cite></span></li><li id="cite_note-26"> <span id="mw-reference-text-cite_note-26" class="mw-reference-text"><cite id="CITEREFJohannessenBen-Menachem2006" class="citation journal cs1">Johannessen SI, Ben-Menachem E (2006). "Management of focal-onset seizures: an update on drug treatment". <i>Drugs</i>. <b>66</b> (13): 1701–25. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003495-200666130-00004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003495-200666130-00004'" tppabs="https://doi.org/10.2165%2F00003495-200666130-00004" class="external text external">10.2165/00003495-200666130-00004</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16978035  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16978035'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16978035" class="external text external">16978035</a>.</cite></span></li><li id="cite_note-27"> <span id="mw-reference-text-cite_note-27" class="mw-reference-text"><cite id="CITEREFFrenchKannerBautistaAbou-Khalil2004" class="citation journal cs1">French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE, Sachdeo RC, Beydoun A, Glauser TA (May 2004). "Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society". <i>Epilepsia</i>. <b>45</b> (5): 401–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.0013-9580.2004.06204.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.0013-9580.2004.06204.x'" tppabs="https://doi.org/10.1111%2Fj.0013-9580.2004.06204.x" class="external text external">10.1111/j.0013-9580.2004.06204.x</a>. hdl:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://hdl.handle.net/2027.42%2F65231  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/2027.42%2F65231'" tppabs="https://hdl.handle.net/2027.42%2F65231" class="external text external">2027.42/65231</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15101821  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15101821'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15101821" class="external text external">15101821</a>.</cite></span></li><li id="cite_note-28"> <span id="mw-reference-text-cite_note-28" class="mw-reference-text"><cite id="CITEREFEnkeNewNewMathieson2018" class="citation journal cs1">Enke O, New HA, New CH, Mathieson S, McLachlan AJ, Latimer J, Maher CG, Lin CC (July 2018). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028270  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028270'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028270" class="external text external">"Anticonvulsants in the treatment of low back pain and lumbar radicular pain: a systematic review and meta-analysis"</a>. <i>CMAJ</i>. <b>190</b> (26): E786–E793. doi:<a href="javascript:if(confirm('https://doi.org/10.1503%2Fcmaj.171333  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1503%2Fcmaj.171333'" tppabs="https://doi.org/10.1503%2Fcmaj.171333" class="external text external">10.1503/cmaj.171333</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028270  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028270'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028270" class="external text external">6028270</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29970367  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29970367'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29970367" class="external text external">29970367</a>.</cite></span></li><li id="cite_note-evid-29"> <span id="mw-reference-text-cite_note-evid-29" class="mw-reference-text"><cite id="CITEREFMack2003" class="citation journal cs1">Mack, Alicia (2003). "Examination of the evidence for off-label use of gabapentin". <i>Journal of Managed Care Pharmacy</i>. <b>9</b> (6): 559–568. doi:<a href="javascript:if(confirm('https://doi.org/10.18553%2Fjmcp.2003.9.6.559  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.18553%2Fjmcp.2003.9.6.559'" tppabs="https://doi.org/10.18553%2Fjmcp.2003.9.6.559" class="external text external">10.18553/jmcp.2003.9.6.559</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14664664  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14664664'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14664664" class="external text external">14664664</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:17085492  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:17085492'" tppabs="https://api.semanticscholar.org/CorpusID:17085492" class="external text external">17085492</a>.</cite></span></li><li id="cite_note-30"> <span id="mw-reference-text-cite_note-30" class="mw-reference-text"><cite id="CITEREFShanthannaGilronRajarathinamAlAmri2017" class="citation journal cs1">Shanthanna H, Gilron I, Rajarathinam M, AlAmri R, Kamath S, Thabane L, Devereaux PJ, Bhandari M (August 2017). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557428  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557428'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557428" class="external text external">"Benefits and safety of gabapentinoids in chronic low back pain: A systematic review and meta-analysis of randomized controlled trials"</a>. <i>PLOS Medicine</i>. <b>14</b> (8): e1002369. doi:<a href="javascript:if(confirm('https://doi.org/10.1371%2Fjournal.pmed.1002369  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1371%2Fjournal.pmed.1002369'" tppabs="https://doi.org/10.1371%2Fjournal.pmed.1002369" class="external text external">10.1371/journal.pmed.1002369</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557428  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557428'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557428" class="external text external">5557428</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28809936  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28809936'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28809936" class="external text external">28809936</a>.</cite></span></li><li id="cite_note-31"> <span id="mw-reference-text-cite_note-31" class="mw-reference-text"><cite id="CITEREFBar_Ad2010" class="citation journal cs1">Bar Ad V (September 2010). "Gabapentin for the treatment of cancer-related pain syndromes". <i>Reviews on Recent Clinical Trials</i>. <b>5</b> (3): 174–8. doi:<a href="javascript:if(confirm('https://doi.org/10.2174%2F157488710792007310  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2174%2F157488710792007310'" tppabs="https://doi.org/10.2174%2F157488710792007310" class="external text external">10.2174/157488710792007310</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20482492  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20482492'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20482492" class="external text external">20482492</a>.</cite></span></li><li id="cite_note-32"> <span id="mw-reference-text-cite_note-32" class="mw-reference-text"><cite id="CITEREFPhillipsCherryCoxMarshall2010" class="citation journal cs1">Phillips TJ, Cherry CL, Cox S, Marshall SJ, Rice AS (December 2010).  Pai (ed.). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010990  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010990'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010990" class="external text external">"Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials"</a>. <i>PLOS ONE</i>. <b>5</b> (12): e14433. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/2010PLoSO...514433P  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/2010PLoSO...514433P'" tppabs="https://ui.adsabs.harvard.edu/abs/2010PLoSO...514433P" class="external text external">2010PLoSO...514433P</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1371%2Fjournal.pone.0014433  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1371%2Fjournal.pone.0014433'" tppabs="https://doi.org/10.1371%2Fjournal.pone.0014433" class="external text external">10.1371/journal.pone.0014433</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010990  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010990'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010990" class="external text external">3010990</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21203440  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21203440'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21203440" class="external text external">21203440</a>.</cite></span></li><li id="cite_note-33"> <span id="mw-reference-text-cite_note-33" class="mw-reference-text"><cite id="CITEREFTranDuongBertiniFinlayson2010" class="citation journal cs1">Tran DQ, Duong S, Bertini P, Finlayson RJ (February 2010). <a href="javascript:if(confirm('https://doi.org/10.1007/s12630-009-9237-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007/s12630-009-9237-0'" tppabs="https://doi.org/10.1007/s12630-009-9237-0" class="external text external">"Treatment of complex regional pain syndrome: a review of the evidence"</a>. <i>Canadian Journal of Anaesthesia</i>. <b>57</b> (2): 149–66. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1007%2Fs12630-009-9237-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs12630-009-9237-0'" tppabs="https://doi.org/10.1007%2Fs12630-009-9237-0" class="external text external">10.1007/s12630-009-9237-0</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20054678  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20054678'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20054678" class="external text external">20054678</a>.</cite></span></li><li id="cite_note-ReferenceA-34"> <span id="mw-reference-text-cite_note-ReferenceA-34" class="mw-reference-text"><cite id="CITEREFDauriFariaGattiCelidonio2009" class="citation journal cs1">Dauri M, Faria S, Gatti A, Celidonio L, Carpenedo R, Sabato AF (August 2009). <a href="javascript:if(confirm('https://art.torvergata.it/bitstream/2108/10507/1/Dauri_CDT%2c%202009.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://art.torvergata.it/bitstream/2108/10507/1/Dauri_CDT%2c%202009.pdf'" tppabs="https://art.torvergata.it/bitstream/2108/10507/1/Dauri_CDT%2c%202009.pdf" class="external text external">"Gabapentin and pregabalin for the acute post-operative pain management. A systematic-narrative review of the recent clinical evidences"</a> <span class="cs1-format">(PDF)</span>. <i>Current Drug Targets</i>. <b>10</b> (8): 716–33. doi:<a href="javascript:if(confirm('https://doi.org/10.2174%2F138945009788982513  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2174%2F138945009788982513'" tppabs="https://doi.org/10.2174%2F138945009788982513" class="external text external">10.2174/138945009788982513</a>. hdl:<a href="javascript:if(confirm('https://hdl.handle.net/2108%2F10507  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/2108%2F10507'" tppabs="https://hdl.handle.net/2108%2F10507" class="external text external">2108/10507</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19702520  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19702520'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19702520" class="external text external">19702520</a>.</cite></span></li><li id="cite_note-35"> <span id="mw-reference-text-cite_note-35" class="mw-reference-text"><cite id="CITEREFHamiltonStricklandPandit2016" class="citation journal cs1">Hamilton TW, Strickland LH, Pandit HG (August 2016). "A Meta-Analysis on the Use of Gabapentinoids for the Treatment of Acute Postoperative Pain Following Total Knee Arthroplasty". <i>The Journal of Bone and Joint Surgery. American Volume</i>. <b>98</b> (16): 1340–50. doi:<a href="javascript:if(confirm('https://doi.org/10.2106%2Fjbjs.15.01202  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2106%2Fjbjs.15.01202'" tppabs="https://doi.org/10.2106%2Fjbjs.15.01202" class="external text external">10.2106/jbjs.15.01202</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27535436  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27535436'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27535436" class="external text external">27535436</a>.</cite></span></li><li id="cite_note-36"> <span id="mw-reference-text-cite_note-36" class="mw-reference-text"><cite id="CITEREFFinnerupSindrupJensen2010" class="citation journal cs1">Finnerup NB, Sindrup SH, Jensen TS (September 2010). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0029530/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0029530/'" tppabs="https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0029530/" class="external text external">"The evidence for pharmacological treatment of neuropathic pain"</a>. <i>Pain</i>. <b>150</b> (3): 573–81. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.pain.2010.06.019  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.pain.2010.06.019'" tppabs="https://doi.org/10.1016%2Fj.pain.2010.06.019" class="external text external">10.1016/j.pain.2010.06.019</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20705215  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20705215'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20705215" class="external text external">20705215</a>.</cite></span></li><li id="cite_note-37"> <span id="mw-reference-text-cite_note-37" class="mw-reference-text"><cite id="CITEREFFinnerupAttalHaroutounianMcNicol2015" class="citation journal cs1">Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, Gilron I, Haanpää M, Hansson P, Jensen TS, Kamerman PR, Lund K, Moore A, Raja SN, Rice AS, Rowbotham M, Sena E, Siddall P, Smith BH, Wallace M (February 2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493167  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493167'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493167" class="external text external">"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis"</a>. <i>The Lancet. Neurology</i>. <b>14</b> (2): 162–73. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS1474-4422%2814%2970251-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS1474-4422%2814%2970251-0'" tppabs="https://doi.org/10.1016%2FS1474-4422%2814%2970251-0" class="external text external">10.1016/S1474-4422(14)70251-0</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493167  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493167'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493167" class="external text external">4493167</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25575710  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25575710'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25575710" class="external text external">25575710</a>. <q>There was no evidence for a dose-response effect.</q></cite></span></li><li id="cite_note-38"> <span id="mw-reference-text-cite_note-38" class="mw-reference-text"><cite id="CITEREFLoderBurchRizzoli2012" class="citation journal cs1">Loder E, Burch R, Rizzoli P (June 2012). "The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines". <i>Headache</i>. <b>52</b> (6): 930–45. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1526-4610.2012.02185.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1526-4610.2012.02185.x'" tppabs="https://doi.org/10.1111%2Fj.1526-4610.2012.02185.x" class="external text external">10.1111/j.1526-4610.2012.02185.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22671714  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22671714'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22671714" class="external text external">22671714</a>.</cite></span></li><li id="cite_note-39"> <span id="mw-reference-text-cite_note-39" class="mw-reference-text"><cite id="CITEREFLindeMullenersChronicleMcCrory2013" class="citation journal cs1">Linde M, Mulleners WM, Chronicle EP, McCrory DC (June 2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599858  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599858'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599858" class="external text external">"Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>6</b> (6): CD010609. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD010609  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD010609'" tppabs="https://doi.org/10.1002%2F14651858.CD010609" class="external text external">10.1002/14651858.CD010609</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599858  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599858'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599858" class="external text external">6599858</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23797675  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23797675'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23797675" class="external text external">23797675</a>.</cite></span></li><li id="cite_note-pmid17502773-40"> <span id="mw-reference-text-cite_note-pmid17502773-40" class="mw-reference-text"><cite id="CITEREFMulaPiniCassano2007" class="citation journal cs1">Mula M, Pini S, Cassano GB (June 2007). "The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence". <i>Journal of Clinical Psychopharmacology</i>. <b>27</b> (3): 263–72. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2Fjcp.0b013e318059361a  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2Fjcp.0b013e318059361a'" tppabs="https://doi.org/10.1097%2Fjcp.0b013e318059361a" class="external text external">10.1097/jcp.0b013e318059361a</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17502773  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17502773'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17502773" class="external text external">17502773</a>.</cite></span></li><li id="cite_note-SchatzbergCole2010-41"> <span id="mw-reference-text-cite_note-SchatzbergCole2010-41" class="mw-reference-text"><cite id="CITEREFSchatzbergColeDeBattista2010" class="citation book cs1">Schatzberg AF, Cole JO, DeBattista C (2010). <a href="javascript:if(confirm('https://books.google.com/books?id=D3zz1NCm3qcC&pg=PA345  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=D3zz1NCm3qcC&pg=PA345'" tppabs="https://books.google.com/books?id=D3zz1NCm3qcC&pg=PA345" class="external text external"><i>Manual of Clinical Psychopharmacology</i></a>. American Psychiatric Pub. pp.<span>&nbsp;</span>344–345. ISBN<span>&nbsp;</span><bdi>978-1-58562-377-8</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20160425074824/https://books.google.com/books?id=D3zz1NCm3qcC&pg=PA345  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160425074824/https://books.google.com/books?id=D3zz1NCm3qcC&pg=PA345'" tppabs="https://web.archive.org/web/20160425074824/https://books.google.com/books?id=D3zz1NCm3qcC&pg=PA345" class="external text external">Archived</a> from the original on 25 April 2016.</cite></span></li><li id="cite_note-42"> <span id="mw-reference-text-cite_note-42" class="mw-reference-text"><cite id="CITEREFGreenblattGreenblatt2018" class="citation journal cs1">Greenblatt HK, Greenblatt DJ (March 2018). "Gabapentin and Pregabalin for the Treatment of Anxiety Disorders". <i>Clinical Pharmacology in Drug Development</i>. <b>7</b> (3): 228–232. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fcpdd.446  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fcpdd.446'" tppabs="https://doi.org/10.1002%2Fcpdd.446" class="external text external">10.1002/cpdd.446</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29579375  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29579375'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29579375" class="external text external">29579375</a>.</cite></span></li><li id="cite_note-GoldbergHarrow1999-43"> <span id="mw-reference-text-cite_note-GoldbergHarrow1999-43" class="mw-reference-text"><cite id="CITEREFGoldbergHarrow1999" class="citation book cs1">Goldberg JF, Harrow M (1999). <a href="javascript:if(confirm('https://books.google.com/books?id=vVx058k0SMAC&pg=PA98  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=vVx058k0SMAC&pg=PA98'" tppabs="https://books.google.com/books?id=vVx058k0SMAC&pg=PA98" class="external text external"><i>Bipolar Disorders: Clinical Course and Outcome</i></a>. American Psychiatric Pub. p.<span>&nbsp;</span>98. ISBN<span>&nbsp;</span><bdi>978-0-88048-768-9</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20160106173227/https://books.google.com/books?id=vVx058k0SMAC&pg=PA98  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160106173227/https://books.google.com/books?id=vVx058k0SMAC&pg=PA98'" tppabs="https://web.archive.org/web/20160106173227/https://books.google.com/books?id=vVx058k0SMAC&pg=PA98" class="external text external">Archived</a> from the original on 6 January 2016.</cite></span></li><li id="cite_note-pmid11869778-44"> <span id="mw-reference-text-cite_note-pmid11869778-44" class="mw-reference-text"><cite id="CITEREFFreemanFreemanMcElroy2002" class="citation journal cs1">Freeman MP, Freeman SA, McElroy SL (February 2002). "The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues". <i>Journal of Affective Disorders</i>. <b>68</b> (1): 1–23. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs0165-0327%2800%2900299-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs0165-0327%2800%2900299-8'" tppabs="https://doi.org/10.1016%2Fs0165-0327%2800%2900299-8" class="external text external">10.1016/s0165-0327(00)00299-8</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11869778  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11869778'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11869778" class="external text external">11869778</a>.</cite></span></li><li id="cite_note-45"> <span id="mw-reference-text-cite_note-45" class="mw-reference-text"><cite id="CITEREFMuncieYasinianOge'2013" class="citation journal cs1">Muncie HL, Yasinian Y, Oge' L (November 2013). "Outpatient management of alcohol withdrawal syndrome". <i>American Family Physician</i>. <b>88</b> (9): 589–95. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24364635  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24364635'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24364635" class="external text external">24364635</a>.</cite></span></li><li id="cite_note-:3-46"> <span id="mw-reference-text-cite_note-:3-46" class="mw-reference-text"><cite id="CITEREFBerlinButlerPerloff2015" class="citation journal cs1">Berlin RK, Butler PM, Perloff MD (2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732322  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732322'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732322" class="external text external">"Gabapentin Therapy in Psychiatric Disorders: A Systematic Review"</a>. <i>The Primary Care Companion for CNS Disorders</i>. <b>17</b> (5). doi:<a href="javascript:if(confirm('https://doi.org/10.4088%2FPCC.15r01821  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4088%2FPCC.15r01821'" tppabs="https://doi.org/10.4088%2FPCC.15r01821" class="external text external">10.4088/PCC.15r01821</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732322  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732322'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732322" class="external text external">4732322</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26835178  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26835178'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26835178" class="external text external">26835178</a>.</cite></span></li><li id="cite_note-47"> <span id="mw-reference-text-cite_note-47" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.healthquality.va.gov/guidelines/MH/sud/VADoDSUDCPGRevised22216.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.healthquality.va.gov/guidelines/MH/sud/VADoDSUDCPGRevised22216.pdf'" tppabs="https://www.healthquality.va.gov/guidelines/MH/sud/VADoDSUDCPGRevised22216.pdf" class="external text external">"VA/DoD Clinical Practice Guideline for the management of substance use disorders"</a> <span class="cs1-format">(PDF)</span>. 31 December 2015. <a href="javascript:if(confirm('https://web.archive.org/web/20170831041618/https://www.healthquality.va.gov/guidelines/MH/sud/VADoDSUDCPGRevised22216.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170831041618/https://www.healthquality.va.gov/guidelines/MH/sud/VADoDSUDCPGRevised22216.pdf'" tppabs="https://web.archive.org/web/20170831041618/https://www.healthquality.va.gov/guidelines/MH/sud/VADoDSUDCPGRevised22216.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 31 August 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">30 August</span> 2017</span>.</cite></span></li><li id="cite_note-48"> <span id="mw-reference-text-cite_note-48" class="mw-reference-text"><cite id="CITEREFSoodEbbertSchroederCroghan2007" class="citation journal cs1">Sood A, Ebbert JO, Schroeder DR, Croghan IT, Sood R, Vander Weg MW, Wong GY, Hays JT (February 2007). "Gabapentin for smoking cessation: a preliminary investigation of efficacy". <i>Nicotine &amp; Tobacco Research</i>. <b>9</b> (2): 291–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F14622200601080307  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F14622200601080307'" tppabs="https://doi.org/10.1080%2F14622200601080307" class="external text external">10.1080/14622200601080307</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17365760  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17365760'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17365760" class="external text external">17365760</a>.</cite></span></li><li id="cite_note-49"> <span id="mw-reference-text-cite_note-49" class="mw-reference-text"><cite id="CITEREFSoodEbbertWyattCroghan2010" class="citation journal cs1">Sood A, Ebbert JO, Wyatt KD, Croghan IT, Schroeder DR, Sood R, Hays JT (March 2010). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825098  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825098'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825098" class="external text external">"Gabapentin for smoking cessation"</a>. <i>Nicotine &amp; Tobacco Research</i>. <b>12</b> (3): 300–4. doi:<a href="javascript:if(confirm('https://doi.org/10.1093%2Fntr%2Fntp195  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fntr%2Fntp195'" tppabs="https://doi.org/10.1093%2Fntr%2Fntp195" class="external text external">10.1093/ntr/ntp195</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825098  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825098'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825098" class="external text external">2825098</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20081039  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20081039'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20081039" class="external text external">20081039</a>.</cite></span></li><li id="cite_note-50"> <span id="mw-reference-text-cite_note-50" class="mw-reference-text"><cite id="CITEREFNielsenGowingSabioniLe_Foll2019" class="citation journal cs1">Nielsen S, Gowing L, Sabioni P, Le Foll B (January 2019). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360924  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360924'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360924" class="external text external">"Pharmacotherapies for cannabis dependence"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>1</b>: CD008940. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD008940.pub3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD008940.pub3'" tppabs="https://doi.org/10.1002%2F14651858.CD008940.pub3" class="external text external">10.1002/14651858.CD008940.pub3</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360924  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360924'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360924" class="external text external">6360924</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30687936  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30687936'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30687936" class="external text external">30687936</a>.</cite></span></li><li id="cite_note-51"> <span id="mw-reference-text-cite_note-51" class="mw-reference-text"><cite id="CITEREFMcLeanGottlob2009" class="citation journal cs1">McLean RJ, Gottlob I (August 2009). "The pharmacological treatment of nystagmus: a review". <i>Expert Opinion on Pharmacotherapy</i>. <b>10</b> (11): 1805–16. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F14656560902978446  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F14656560902978446'" tppabs="https://doi.org/10.1517%2F14656560902978446" class="external text external">10.1517/14656560902978446</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19601699  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19601699'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19601699" class="external text external">19601699</a>.</cite></span></li><li id="cite_note-52"> <span id="mw-reference-text-cite_note-52" class="mw-reference-text"><cite id="CITEREFStruppBrandt2009" class="citation journal cs1">Strupp M, Brandt T (July 2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002631  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002631'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002631" class="external text external">"Current treatment of vestibular, ocular motor disorders and nystagmus"</a>. <i>Therapeutic Advances in Neurological Disorders</i>. <b>2</b> (4): 223–39. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F1756285609103120  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F1756285609103120'" tppabs="https://doi.org/10.1177%2F1756285609103120" class="external text external">10.1177/1756285609103120</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002631  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002631'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002631" class="external text external">3002631</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21179531  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21179531'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21179531" class="external text external">21179531</a>.</cite></span></li><li id="cite_note-53"> <span id="mw-reference-text-cite_note-53" class="mw-reference-text"><cite id="CITEREFToulisTzellosKouvelasGoulis2009" class="citation journal cs1">Toulis KA, Tzellos T, Kouvelas D, Goulis DG (February 2009). "Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis". <i>Clinical Therapeutics</i>. <b>31</b> (2): 221–35. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.clinthera.2009.02.006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.clinthera.2009.02.006'" tppabs="https://doi.org/10.1016%2Fj.clinthera.2009.02.006" class="external text external">10.1016/j.clinthera.2009.02.006</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19302896  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19302896'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19302896" class="external text external">19302896</a>.</cite></span></li><li id="cite_note-54"> <span id="mw-reference-text-cite_note-54" class="mw-reference-text"><cite id="CITEREFCheemaCoomarasamyEl-Toukhy2007" class="citation journal cs1">Cheema D, Coomarasamy A, El-Toukhy T (November 2007). "Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based review". <i>Archives of Gynecology and Obstetrics</i>. <b>276</b> (5): 463–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00404-007-0390-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00404-007-0390-9'" tppabs="https://doi.org/10.1007%2Fs00404-007-0390-9" class="external text external">10.1007/s00404-007-0390-9</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17593379  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17593379'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17593379" class="external text external">17593379</a>.</cite></span></li><li id="cite_note-55"> <span id="mw-reference-text-cite_note-55" class="mw-reference-text"><cite id="CITEREFRadaCapurroPantojaCorbalán2010" class="citation journal cs1">Rada G, Capurro D, Pantoja T, Corbalán J, Moreno G, Letelier LM, Vera C (September 2010). <a href="javascript:if(confirm('http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802013000200141  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802013000200141'" tppabs="http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802013000200141" class="external text external">"Non-hormonal interventions for hot flushes in women with a history of breast cancer"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>131</b> (9): 141. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD004923.pub2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD004923.pub2'" tppabs="https://doi.org/10.1002%2F14651858.CD004923.pub2" class="external text external">10.1002/14651858.CD004923.pub2</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20824841  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20824841'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20824841" class="external text external">20824841</a>.</cite></span></li><li id="cite_note-pmid23179641-56"> <span id="mw-reference-text-cite_note-pmid23179641-56" class="mw-reference-text"><cite id="CITEREFScott2012" class="citation journal cs1">Scott LJ (December 2012). "Gabapentin enacarbil: in patients with restless legs syndrome". <i>CNS Drugs</i>. <b>26</b> (12): 1073–83. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs40263-012-0020-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs40263-012-0020-3'" tppabs="https://doi.org/10.1007%2Fs40263-012-0020-3" class="external text external">10.1007/s40263-012-0020-3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23179641  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23179641'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23179641" class="external text external">23179641</a>.</cite></span></li><li id="cite_note-57"> <span id="mw-reference-text-cite_note-57" class="mw-reference-text"><cite class="citation journal cs1">"Drugs for chronic insomnia". <i>The Medical Letter on Drugs and Therapeutics</i>. <b>60</b> (1562): 201–205. 17 December 2018. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1523-2859  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1523-2859'" tppabs="https://www.worldcat.org/issn/1523-2859" class="external text external">1523-2859</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30625122  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30625122'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30625122" class="external text external">30625122</a>.</cite></span></li><li id="cite_note-Edinger2013-58"> <span id="mw-reference-text-cite_note-Edinger2013-58" class="mw-reference-text"><cite id="CITEREFEdinger2013" class="citation book cs1">Edinger JD (2013). <a href="javascript:if(confirm('https://books.google.com/books?id=O_cxAgAAQBAJ&pg=PA339  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=O_cxAgAAQBAJ&pg=PA339'" tppabs="https://books.google.com/books?id=O_cxAgAAQBAJ&pg=PA339" class="external text external"><i>Insomnia, an Issue of Sleep Medicine Clinics</i></a>. Elsevier Health Sciences. p.<span>&nbsp;</span>339. ISBN<span>&nbsp;</span><bdi>978-0-323-18872-2</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20160106173227/https://books.google.com/books?id=O_cxAgAAQBAJ&pg=PA339  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160106173227/https://books.google.com/books?id=O_cxAgAAQBAJ&pg=PA339'" tppabs="https://web.archive.org/web/20160106173227/https://books.google.com/books?id=O_cxAgAAQBAJ&pg=PA339" class="external text external">Archived</a> from the original on 6 January 2016.</cite></span></li><li id="cite_note-MorinEspie2012-59"> <span id="mw-reference-text-cite_note-MorinEspie2012-59" class="mw-reference-text"><cite id="CITEREFMorinEspie2012" class="citation book cs1">Morin CM, Espie CA (2 February 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=FNZoAgAAQBAJ&pg=PA544  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=FNZoAgAAQBAJ&pg=PA544'" tppabs="https://books.google.com/books?id=FNZoAgAAQBAJ&pg=PA544" class="external text external"><i>The Oxford Handbook of Sleep and Sleep Disorders</i></a>. Oxford University Press. p.<span>&nbsp;</span>544. ISBN<span>&nbsp;</span><bdi>978-0-19-970442-2</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20160106173227/https://books.google.com/books?id=FNZoAgAAQBAJ&pg=PA544  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160106173227/https://books.google.com/books?id=FNZoAgAAQBAJ&pg=PA544'" tppabs="https://web.archive.org/web/20160106173227/https://books.google.com/books?id=FNZoAgAAQBAJ&pg=PA544" class="external text external">Archived</a> from the original on 6 January 2016.</cite></span></li><li id="cite_note-60"> <span id="mw-reference-text-cite_note-60" class="mw-reference-text"><cite id="CITEREFBergerSteinhoff2011" class="citation journal cs1">Berger TG, Steinhoff M (June 2011). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692272  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692272'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692272" class="external text external">"Pruritus and renal failure"</a>. <i>Seminars in Cutaneous Medicine and Surgery</i>. <b>30</b> (2): 99–100. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.sder.2011.04.005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.sder.2011.04.005'" tppabs="https://doi.org/10.1016%2Fj.sder.2011.04.005" class="external text external">10.1016/j.sder.2011.04.005</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692272  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692272'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692272" class="external text external">3692272</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21767770  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21767770'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21767770" class="external text external">21767770</a>.</cite></span></li><li id="cite_note-61"> <span id="mw-reference-text-cite_note-61" class="mw-reference-text"><cite id="CITEREFAnand2013" class="citation journal cs1">Anand S (March 2013). "Gabapentin for pruritus in palliative care". <i>The American Journal of Hospice &amp; Palliative Care</i>. <b>30</b> (2): 192–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F1049909112445464  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F1049909112445464'" tppabs="https://doi.org/10.1177%2F1049909112445464" class="external text external">10.1177/1049909112445464</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22556282  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22556282'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22556282" class="external text external">22556282</a>.</cite></span></li><li id="cite_note-62"> <span id="mw-reference-text-cite_note-62" class="mw-reference-text"><cite id="CITEREFSchneiderDeuschl2014" class="citation journal cs1">Schneider SA, Deuschl G (January 2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899476  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899476'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899476" class="external text external">"The treatment of tremor"</a>. <i>Neurotherapeutics</i>. <b>11</b> (1): 128–38. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs13311-013-0230-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs13311-013-0230-5'" tppabs="https://doi.org/10.1007%2Fs13311-013-0230-5" class="external text external">10.1007/s13311-013-0230-5</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899476  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899476'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899476" class="external text external">3899476</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24142589  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24142589'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24142589" class="external text external">24142589</a>.</cite></span></li><li id="cite_note-63"> <span id="mw-reference-text-cite_note-63" class="mw-reference-text"><cite id="CITEREFZesiewiczElbleLouisGronseth2011" class="citation journal cs1">Zesiewicz TA, Elble RJ, Louis ED, Gronseth GS, Ondo WG, Dewey RB, Okun MS, Sullivan KL, Weiner WJ (November 2011). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208950  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208950'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208950" class="external text external">"Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology"</a>. <i>Neurology</i>. <b>77</b> (19): 1752–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1212%2FWNL.0b013e318236f0fd  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1212%2FWNL.0b013e318236f0fd'" tppabs="https://doi.org/10.1212%2FWNL.0b013e318236f0fd" class="external text external">10.1212/WNL.0b013e318236f0fd</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208950  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208950'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208950" class="external text external">3208950</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22013182  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22013182'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22013182" class="external text external">22013182</a>.</cite></span></li><li id="cite_note-64"> <span id="mw-reference-text-cite_note-64" class="mw-reference-text"><cite id="CITEREFSadeghiOndo2010" class="citation journal cs1">Sadeghi R, Ondo WG (December 2010). "Pharmacological management of essential tremor". <i>Drugs</i>. <b>70</b> (17): 2215–28. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F11538180-000000000-00000  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F11538180-000000000-00000'" tppabs="https://doi.org/10.2165%2F11538180-000000000-00000" class="external text external">10.2165/11538180-000000000-00000</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21080739  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21080739'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21080739" class="external text external">21080739</a>.</cite></span></li><li id="cite_note-65"> <span id="mw-reference-text-cite_note-65" class="mw-reference-text"><cite id="CITEREFAazhEl_RefaieHumphriss2011" class="citation journal cs1">Aazh H, El Refaie A, Humphriss R (December 2011). "Gabapentin for tinnitus: a systematic review". <i>American Journal of Audiology</i>. <b>20</b> (2): 151–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1044%2F1059-0889%282011%2F10-0041%29  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1044%2F1059-0889%282011%2F10-0041%29'" tppabs="https://doi.org/10.1044%2F1059-0889%282011%2F10-0041%29" class="external text external">10.1044/1059-0889(2011/10-0041)</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21940981  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21940981'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21940981" class="external text external">21940981</a>.</cite></span></li><li id="cite_note-Aronson2014-66"> <span id="mw-reference-text-cite_note-Aronson2014-66" class="mw-reference-text"><cite id="CITEREFAronson2014" class="citation book cs1">Aronson JK (4 March 2014). <a href="javascript:if(confirm('https://books.google.com/books?id=jTc3AAAAQBAJ&pg=PA137  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=jTc3AAAAQBAJ&pg=PA137'" tppabs="https://books.google.com/books?id=jTc3AAAAQBAJ&pg=PA137" class="external text external"><i>Side Effects of Drugs Annual: A worldwide yearly survey of new data in adverse drug reactions</i></a>. Newnes. p.<span>&nbsp;</span>137. ISBN<span>&nbsp;</span><bdi>978-0-444-62636-3</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20160106173227/https://books.google.com/books?id=jTc3AAAAQBAJ&pg=PA137  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160106173227/https://books.google.com/books?id=jTc3AAAAQBAJ&pg=PA137'" tppabs="https://web.archive.org/web/20160106173227/https://books.google.com/books?id=jTc3AAAAQBAJ&pg=PA137" class="external text external">Archived</a> from the original on 6 January 2016.</cite></span></li><li id="cite_note-DSM5-67"> <span id="mw-reference-text-cite_note-DSM5-67" class="mw-reference-text"><cite id="CITEREFAmerican_Psychiatric_Association2013" class="citation book cs1">American Psychiatric Association (22 May 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=-JivBAAAQBAJ&printsec=frontcover  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=-JivBAAAQBAJ&printsec=frontcover'" tppabs="https://books.google.com/books?id=-JivBAAAQBAJ&printsec=frontcover" class="external text external"><i>The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.: DSM 5</i></a>. CiteSeerX<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.988.5627  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.988.5627'" tppabs="https://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.988.5627" class="external text external">10.1.1.988.5627</a></span>. doi:<a href="javascript:if(confirm('https://doi.org/10.1176%2Fappi.books.9780890425596  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1176%2Fappi.books.9780890425596'" tppabs="https://doi.org/10.1176%2Fappi.books.9780890425596" class="external text external">10.1176/appi.books.9780890425596</a>. ISBN<span>&nbsp;</span><bdi>9780890425572</bdi>.</cite></span></li><li id="cite_note-68"> <span id="mw-reference-text-cite_note-68" class="mw-reference-text"><cite id="CITEREFQuintero2017" class="citation journal cs1">Quintero GC (2017). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308580  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308580'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308580" class="external text external">"Review about gabapentin misuse, interactions, contraindications and side effects"</a>. <i>Journal of Experimental Pharmacology</i>. <b>9</b>: 13–21. doi:<a href="javascript:if(confirm('https://doi.org/10.2147%2FJEP.S124391  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2147%2FJEP.S124391'" tppabs="https://doi.org/10.2147%2FJEP.S124391" class="external text external">10.2147/JEP.S124391</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308580  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308580'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308580" class="external text external">5308580</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28223849  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28223849'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28223849" class="external text external">28223849</a>.</cite></span></li><li id="cite_note-69"> <span id="mw-reference-text-cite_note-69" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20090801102726/https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm100190.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20090801102726/https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm100190.htm'" tppabs="https://web.archive.org/web/20090801102726/https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm100190.htm" class="external text external">"Suicidal Behavior and Ideation and Antiepileptic Drugs"</a>. U.S. Food and Drug Administration (FDA). Archived from <a href="javascript:if(confirm('https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm100190.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm100190.htm'" tppabs="https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm100190.htm" class="external text external">the original</a> on 1 August 2009.</cite></span></li><li id="cite_note-70"> <span id="mw-reference-text-cite_note-70" class="mw-reference-text"><cite id="CITEREFPatornoBohnWahlAvorn2010" class="citation journal cs1">Patorno E, Bohn RL, Wahl PM, Avorn J, Patrick AR, Liu J, Schneeweiss S (April 2010). <a href="javascript:if(confirm('https://doi.org/10.1001/jama.2010.410  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001/jama.2010.410'" tppabs="https://doi.org/10.1001/jama.2010.410" class="external text external">"Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death"</a>. <i>JAMA</i>. <b>303</b> (14): 1401–9. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1001%2Fjama.2010.410  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjama.2010.410'" tppabs="https://doi.org/10.1001%2Fjama.2010.410" class="external text external">10.1001/jama.2010.410</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20388896  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20388896'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20388896" class="external text external">20388896</a>.</cite></span></li><li id="cite_note-71"> <span id="mw-reference-text-cite_note-71" class="mw-reference-text"><cite id="CITEREFLeithLambertBoehnleinFreeman2019" class="citation journal cs1">Leith WM, Lambert WE, Boehnlein JK, Freeman MD (January 2019). "The association between gabapentin and suicidality in bipolar patients". <i>International Clinical Psychopharmacology</i>. <b>34</b> (1): 27–32. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2FYIC.0000000000000242  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FYIC.0000000000000242'" tppabs="https://doi.org/10.1097%2FYIC.0000000000000242" class="external text external">10.1097/YIC.0000000000000242</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30383553  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30383553'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30383553" class="external text external">30383553</a>.</cite></span></li><li id="cite_note-FDA-72"> <span id="mw-reference-text-cite_note-FDA-72" class="mw-reference-text"><a href="javascript:if(confirm('https://www.drugs.com/pro/gabapentin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/pro/gabapentin.html'" tppabs="https://www.drugs.com/pro/gabapentin.html" class="external text external">Gabapentin Official FDA information, side effects and uses</a> <a href="javascript:if(confirm('https://web.archive.org/web/20071227024954/http://www.drugs.com/pro/gabapentin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20071227024954/http://www.drugs.com/pro/gabapentin.html'" tppabs="https://web.archive.org/web/20071227024954/http://www.drugs.com/pro/gabapentin.html" class="external text external">Archived</a><span> 27 December 2007 at the </span>Wayback Machine</span></li><li id="cite_note-73"> <span id="mw-reference-text-cite_note-73" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://pharmacy.ky.gov/Documents/Gabapentin%20-%20Schedule%20V%20Controlled%20Substance.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pharmacy.ky.gov/Documents/Gabapentin%20-%20Schedule%20V%20Controlled%20Substance.pdf'" tppabs="https://pharmacy.ky.gov/Documents/Gabapentin%20-%20Schedule%20V%20Controlled%20Substance.pdf" class="external text external">"Important Notice: Gabapentin Becomes a Schedule 5 Controlled Substance in Kentucky"</a> <span class="cs1-format">(PDF)</span>. <i>Kentucky State Board of Pharmacy</i>. March 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">18 June</span> 2018</span>.</cite></span></li><li id="cite_note-74"> <span id="mw-reference-text-cite_note-74" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.michigan.gov/lara/0,4601,7-154-11472-487050--,00.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.michigan.gov/lara/0,4601,7-154-11472-487050--,00.html'" tppabs="https://www.michigan.gov/lara/0,4601,7-154-11472-487050--,00.html" class="external text external">"Gabapentin Scheduled as Controlled Substance to help with State's Opioid Epidemic"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">16 April</span> 2019</span>.</cite></span></li><li id="cite_note-75"> <span id="mw-reference-text-cite_note-75" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.wvlegislature.gov/WVCODE/ChapterEntire.cfm?chap=60a&art=2&section=212  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.wvlegislature.gov/WVCODE/ChapterEntire.cfm?chap=60a&art=2&section=212'" tppabs="http://www.wvlegislature.gov/WVCODE/ChapterEntire.cfm?chap=60a&art=2&section=212" class="external text external">"WV Code 212"</a>. <i>www.wvlegislature.gov</i><span class="reference-accessdate">. Retrieved <span class="nowrap">30 May</span> 2020</span>.</cite></span></li><li id="cite_note-76"> <span id="mw-reference-text-cite_note-76" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.tn.gov/content/dam/tn/health/healthprofboards/New%20Statue%20Gabapentin%2006-18.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.tn.gov/content/dam/tn/health/healthprofboards/New%20Statue%20Gabapentin%2006-18.pdf'" tppabs="https://www.tn.gov/content/dam/tn/health/healthprofboards/New%20Statue%20Gabapentin%2006-18.pdf" class="external text external">"Gabapentin will be a Schedule V controlled substance in Tennessee effective July 1, 2018"</a> <span class="cs1-format">(PDF)</span>. <i>tn.gov</i><span class="reference-accessdate">. Retrieved <span class="nowrap">30 May</span> 2020</span>.</cite></span></li><li id="cite_note-77"> <span id="mw-reference-text-cite_note-77" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.alabamapublichealth.gov/pharmacy/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.alabamapublichealth.gov/pharmacy/'" tppabs="http://www.alabamapublichealth.gov/pharmacy/" class="external text external">"Pharmacy Division | Alabama Department of Public Health (ADPH)"</a>. <i>www.alabamapublichealth.gov</i><span class="reference-accessdate">. Retrieved <span class="nowrap">30 May</span> 2020</span>.</cite></span></li><li id="cite_note-78"> <span id="mw-reference-text-cite_note-78" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://nursingnotes.co.uk/pregabalin-gabapentin-will-become-controlled-drugs-april/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://nursingnotes.co.uk/pregabalin-gabapentin-will-become-controlled-drugs-april/'" tppabs="https://nursingnotes.co.uk/pregabalin-gabapentin-will-become-controlled-drugs-april/" class="external text external">"Pregabalin and gabapentin will become controlled drugs in April"</a>. <i>NursingNotes</i>. 17 October 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">16 June</span> 2019</span>.</cite></span></li><li id="cite_note-79"> <span id="mw-reference-text-cite_note-79" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/491854/ACMD_Advice_-_Pregabalin_and_gabapentin.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/491854/ACMD_Advice_-_Pregabalin_and_gabapentin.pdf'" tppabs="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/491854/ACMD_Advice_-_Pregabalin_and_gabapentin.pdf" class="external text external">"Re: Pregabalin and Gabapentin advice"</a> <span class="cs1-format">(PDF)</span>. <i>GOV.UK</i>. 14 January 2016.</cite></span></li><li id="cite_note-80"> <span id="mw-reference-text-cite_note-80" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.gov.uk/government/consultations/pregabalin-and-gabapentin-proposal-to-schedule-under-the-misuse-of-drugs-regulations-2001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.gov.uk/government/consultations/pregabalin-and-gabapentin-proposal-to-schedule-under-the-misuse-of-drugs-regulations-2001'" tppabs="https://www.gov.uk/government/consultations/pregabalin-and-gabapentin-proposal-to-schedule-under-the-misuse-of-drugs-regulations-2001" class="external text external">"Pregabalin and gabapentin: proposal to schedule under the Misuse of Drugs Regulations 2001"</a>. <i>GOV.UK</i>. 10 November 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">2 April</span> 2020</span>.</cite></span></li><li id="cite_note-81"> <span id="mw-reference-text-cite_note-81" class="mw-reference-text"><cite id="CITEREFMayor2018" class="citation journal cs1">Mayor, Susan (16 October 2018). <a href="javascript:if(confirm('https://www.bmj.com/content/363/bmj.k4364  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.bmj.com/content/363/bmj.k4364'" tppabs="https://www.bmj.com/content/363/bmj.k4364" class="external text external">"Pregabalin and gabapentin become controlled drugs to cut deaths from misuse"</a>. <i>British Medical Journal</i>. <b>363</b>: k4364. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fbmj.k4364  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fbmj.k4364'" tppabs="https://doi.org/10.1136%2Fbmj.k4364" class="external text external">10.1136/bmj.k4364</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0959-8138  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0959-8138'" tppabs="https://www.worldcat.org/issn/0959-8138" class="external text external">0959-8138</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30327316  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30327316'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30327316" class="external text external">30327316</a>.</cite></span></li><li id="cite_note-UK_class_C-82"> <span id="mw-reference-text-cite_note-UK_class_C-82" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.gov.uk/government/news/pregabalin-and-gabapentin-to-be-controlled-as-class-c-drugs  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.gov.uk/government/news/pregabalin-and-gabapentin-to-be-controlled-as-class-c-drugs'" tppabs="https://www.gov.uk/government/news/pregabalin-and-gabapentin-to-be-controlled-as-class-c-drugs" class="external text external">"Pregabalin and gabapentin to be controlled as Class C drugs"</a>. <i>GOV.UK</i>. 15 October 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">2 April</span> 2020</span>.</cite></span></li><li id="cite_note-83"> <span id="mw-reference-text-cite_note-83" class="mw-reference-text"><cite id="CITEREFBonnetRichterIsbruchScherbaum2018" class="citation journal cs1">Bonnet U, Richter EL, Isbruch K, Scherbaum N (June 2018). <a href="javascript:if(confirm('http://www.psychiatria-danubina.com/UserDocsImages/pdf/dnb_vol30_no2/dnb_vol30_no2_142.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.psychiatria-danubina.com/UserDocsImages/pdf/dnb_vol30_no2/dnb_vol30_no2_142.pdf'" tppabs="http://www.psychiatria-danubina.com/UserDocsImages/pdf/dnb_vol30_no2/dnb_vol30_no2_142.pdf" class="external text external">"On the addictive power of gabapentinoids: a mini-review"</a> <span class="cs1-format">(PDF)</span>. <i>Psychiatria Danubina</i>. <b>30</b> (2): 142–149. doi:<a href="javascript:if(confirm('https://doi.org/10.24869%2Fpsyd.2018.142  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.24869%2Fpsyd.2018.142'" tppabs="https://doi.org/10.24869%2Fpsyd.2018.142" class="external text external">10.24869/psyd.2018.142</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29930223  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29930223'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29930223" class="external text external">29930223</a>.</cite></span></li><li id="cite_note-:2-84"> <span id="mw-reference-text-cite_note-:2-84" class="mw-reference-text"><cite id="CITEREFBonnetScherbaum2017" class="citation journal cs1">Bonnet U, Scherbaum N (December 2017). "How addictive are gabapentin and pregabalin? A systematic review". <i>European Neuropsychopharmacology</i>. <b>27</b> (12): 1185–1215. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.euroneuro.2017.08.430  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.euroneuro.2017.08.430'" tppabs="https://doi.org/10.1016%2Fj.euroneuro.2017.08.430" class="external text external">10.1016/j.euroneuro.2017.08.430</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28988943  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28988943'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28988943" class="external text external">28988943</a>.</cite></span></li><li id="cite_note-pmid26721643-85"> <span id="mw-reference-text-cite_note-pmid26721643-85" class="mw-reference-text"><cite id="CITEREFMersfelderNichols2016" class="citation journal cs1">Mersfelder TL, Nichols WH (March 2016). "Gabapentin: Abuse, Dependence, and Withdrawal". <i>The Annals of Pharmacotherapy</i>. <b>50</b> (3): 229–33. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F1060028015620800  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F1060028015620800'" tppabs="https://doi.org/10.1177%2F1060028015620800" class="external text external">10.1177/1060028015620800</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26721643  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26721643'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26721643" class="external text external">26721643</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:21108959  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:21108959'" tppabs="https://api.semanticscholar.org/CorpusID:21108959" class="external text external">21108959</a>.</cite></span></li><li id="cite_note-pmid29179227-86"> <span id="mw-reference-text-cite_note-pmid29179227-86" class="mw-reference-text"><cite id="CITEREFBonnetScherbaum2018" class="citation journal cs1">Bonnet U, Scherbaum N (February 2018). "[On the risk of dependence on gabapentinoids]". <i>Fortschritte der Neurologie-Psychiatrie</i> (in German). <b>86</b> (2): 82–105. doi:<a href="javascript:if(confirm('https://doi.org/10.1055%2Fs-0043-122392  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1055%2Fs-0043-122392'" tppabs="https://doi.org/10.1055%2Fs-0043-122392" class="external text external">10.1055/s-0043-122392</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29179227  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29179227'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29179227" class="external text external">29179227</a>.</cite></span></li><li id="cite_note-FDA_breathing-87"> <span id="mw-reference-text-cite_note-FDA_breathing-87" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-serious-breathing-problems-seizure-and-nerve-pain-medicines-gabapentin-neurontin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-serious-breathing-problems-seizure-and-nerve-pain-medicines-gabapentin-neurontin'" tppabs="https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-serious-breathing-problems-seizure-and-nerve-pain-medicines-gabapentin-neurontin" class="external text external">"FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR)"</a>. <i>U.S. Food and Drug Administration (FDA)</i>. 19 December 2019. <a href="javascript:if(confirm('https://web.archive.org/web/20191222091828/https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-serious-breathing-problems-seizure-and-nerve-pain-medicines-gabapentin-neurontin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20191222091828/https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-serious-breathing-problems-seizure-and-nerve-pain-medicines-gabapentin-neurontin'" tppabs="https://web.archive.org/web/20191222091828/https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-serious-breathing-problems-seizure-and-nerve-pain-medicines-gabapentin-neurontin" class="external text external">Archived</a> from the original on 22 December 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">21 December</span> 2019</span>.</cite> <figure-inline><span><img src="../I/m/PD-icon.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/PD-icon.svg.png" data-file-width="196" data-file-height="196" data-file-type="drawing" height="15" width="15"></span></figure-inline><span> </span><i>This article incorporates text from this source, which is in the public domain.</i></span></li><li id="cite_note-88"> <span id="mw-reference-text-cite_note-88" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/media/133681/download  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/media/133681/download'" tppabs="https://www.fda.gov/media/133681/download" class="external text external">"FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR) When used with CNS depressants or in patients with lung problems"</a> <span class="cs1-format">(PDF)</span>. 19 December 2019. <a href="javascript:if(confirm('https://web.archive.org/web/20191222091828/https://www.fda.gov/media/133681/download  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20191222091828/https://www.fda.gov/media/133681/download'" tppabs="https://web.archive.org/web/20191222091828/https://www.fda.gov/media/133681/download" class="external text external">Archived</a> from the original on 22 December 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">22 December</span> 2019</span>.</cite> <figure-inline><span><img src="../I/m/PD-icon.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/PD-icon.svg.png" data-file-width="196" data-file-height="196" data-file-type="drawing" height="15" width="15"></span></figure-inline><span> </span><i>This article incorporates text from this source, which is in the public domain.</i></span></li><li id="cite_note-89"> <span id="mw-reference-text-cite_note-89" class="mw-reference-text">R.C. Baselt, <i>Disposition of Toxic Drugs and Chemicals in Man</i>, 8th edition, Biomedical Publications, Foster City, CA, 2008, pp. 677–8. ISBN<span>&nbsp;</span>978-0-9626523-7-0.</span></li><li id="cite_note-pmid16376147-90"> <span id="mw-reference-text-cite_note-pmid16376147-90" class="mw-reference-text"><cite id="CITEREFSills2006" class="citation journal cs1">Sills GJ (February 2006). "The mechanisms of action of gabapentin and pregabalin". <i>Current Opinion in Pharmacology</i>. <b>6</b> (1): 108–13. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.coph.2005.11.003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.coph.2005.11.003'" tppabs="https://doi.org/10.1016%2Fj.coph.2005.11.003" class="external text external">10.1016/j.coph.2005.11.003</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16376147  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16376147'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16376147" class="external text external">16376147</a>.</cite></span></li><li id="cite_note-BenzonRathmell2013-91"> <span id="mw-reference-text-cite_note-BenzonRathmell2013-91" class="mw-reference-text"><cite id="CITEREFBenzonRathmellWuTurk2013" class="citation book cs1">Benzon H, Rathmell JP, Wu CL, Turk DC, Argoff CE, Hurley RW (11 September 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=kfcDAQAAQBAJ&pg=PA1006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=kfcDAQAAQBAJ&pg=PA1006'" tppabs="https://books.google.com/books?id=kfcDAQAAQBAJ&pg=PA1006" class="external text external"><i>Practical Management of Pain</i></a>. Elsevier Health Sciences. p.<span>&nbsp;</span>1006. ISBN<span>&nbsp;</span><bdi>978-0-323-17080-2</bdi>.</cite></span></li><li id="cite_note-pmid23642658-92"> <span id="mw-reference-text-cite_note-pmid23642658-92" class="mw-reference-text"><cite id="CITEREFStahlPorrecaTaylorCheung2013" class="citation journal cs1">Stahl SM, Porreca F, Taylor CP, Cheung R, Thorpe AJ, Clair A (2013). "The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities?". <i>Trends Pharmacol. Sci</i>. <b>34</b> (6): 332–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.tips.2013.04.001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.tips.2013.04.001'" tppabs="https://doi.org/10.1016%2Fj.tips.2013.04.001" class="external text external">10.1016/j.tips.2013.04.001</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23642658  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23642658'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23642658" class="external text external">23642658</a>.</cite></span></li><li id="cite_note-pmid17222465-93"> <span id="mw-reference-text-cite_note-pmid17222465-93" class="mw-reference-text"><cite id="CITEREFDooleyTaylorDonevanFeltner2007" class="citation journal cs1">Dooley DJ, Taylor CP, Donevan S, Feltner D (February 2007). "Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission". <i>Trends in Pharmacological Sciences</i>. <b>28</b> (2): 75–82. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.tips.2006.12.006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.tips.2006.12.006'" tppabs="https://doi.org/10.1016%2Fj.tips.2006.12.006" class="external text external">10.1016/j.tips.2006.12.006</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17222465  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17222465'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17222465" class="external text external">17222465</a>.</cite></span></li><li id="cite_note-pmid17403543-94"> <span id="mw-reference-text-cite_note-pmid17403543-94" class="mw-reference-text"><cite id="CITEREFDaviesHendrichVan_MinhWratten2007" class="citation journal cs1">Davies A, Hendrich J, Van Minh AT, Wratten J, Douglas L, Dolphin AC (May 2007). "Functional biology of the alpha(2)delta subunits of voltage-gated calcium channels". <i>Trends in Pharmacological Sciences</i>. <b>28</b> (5): 220–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.tips.2007.03.005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.tips.2007.03.005'" tppabs="https://doi.org/10.1016%2Fj.tips.2007.03.005" class="external text external">10.1016/j.tips.2007.03.005</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17403543  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17403543'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17403543" class="external text external">17403543</a>.</cite></span></li><li id="cite_note-pmid23567998-95"> <span id="mw-reference-text-cite_note-pmid23567998-95" class="mw-reference-text"><cite id="CITEREFDickensWebbAntonyukGiannoudis2013" class="citation journal cs1">Dickens D, Webb SD, Antonyuk S, Giannoudis A, Owen A, Rädisch S, Hasnain SS, Pirmohamed M (June 2013). "Transport of gabapentin by LAT1 (SLC7A5)". <i>Biochemical Pharmacology</i>. <b>85</b> (11): 1672–83. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.bcp.2013.03.022  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.bcp.2013.03.022'" tppabs="https://doi.org/10.1016%2Fj.bcp.2013.03.022" class="external text external">10.1016/j.bcp.2013.03.022</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23567998  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23567998'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23567998" class="external text external">23567998</a>.</cite></span></li><li id="cite_note-pmid18656534-96"> <span id="mw-reference-text-cite_note-pmid18656534-96" class="mw-reference-text"><cite id="CITEREFdel_AmoUrttiYliperttula2008" class="citation journal cs1">del Amo EM, Urtti A, Yliperttula M (October 2008). "Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2". <i>European Journal of Pharmaceutical Sciences</i>. <b>35</b> (3): 161–74. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ejps.2008.06.015  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ejps.2008.06.015'" tppabs="https://doi.org/10.1016%2Fj.ejps.2008.06.015" class="external text external">10.1016/j.ejps.2008.06.015</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18656534  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18656534'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18656534" class="external text external">18656534</a>.</cite></span></li><li id="cite_note-pmid20818832-97"> <span id="mw-reference-text-cite_note-pmid20818832-97" class="mw-reference-text"><cite id="CITEREFBockbraderWescheMillerChapel2010" class="citation journal cs1">Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P (October 2010). "A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin". <i>Clinical Pharmacokinetics</i>. <b>49</b> (10): 661–9. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F11536200-000000000-00000  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F11536200-000000000-00000'" tppabs="https://doi.org/10.2165%2F11536200-000000000-00000" class="external text external">10.2165/11536200-000000000-00000</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20818832  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20818832'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20818832" class="external text external">20818832</a>.</cite></span></li><li id="cite_note-pmid20505847-98"> <span id="mw-reference-text-cite_note-pmid20505847-98" class="mw-reference-text"><cite id="CITEREFAgarwalGriffithCostantinoVaish2010" class="citation journal cs1">Agarwal P, Griffith A, Costantino HR, Vaish N (May 2010). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874339  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874339'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874339" class="external text external">"Gabapentin enacarbil - clinical efficacy in restless legs syndrome"</a>. <i>Neuropsychiatric Disease and Treatment</i>. <b>6</b>: 151–8. doi:<a href="javascript:if(confirm('https://doi.org/10.2147%2FNDT.S5712  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2147%2FNDT.S5712'" tppabs="https://doi.org/10.2147%2FNDT.S5712" class="external text external">10.2147/NDT.S5712</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874339  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874339'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874339" class="external text external">2874339</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20505847  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20505847'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20505847" class="external text external">20505847</a>.</cite></span></li><li id="cite_note-pmid24829664-99"> <span id="mw-reference-text-cite_note-pmid24829664-99" class="mw-reference-text"><cite id="CITEREFKhansariSohrabiZamani2013" class="citation journal cs1">Khansari M, Sohrabi M, Zamani F (January 2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990131  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990131'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990131" class="external text external">"The Useage of Opioids and their Adverse Effects in Gastrointestinal Practice: A Review"</a>. <i>Middle East Journal of Digestive Diseases</i>. <b>5</b> (1): 5–16. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990131  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990131'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990131" class="external text external">3990131</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24829664  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24829664'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24829664" class="external text external">24829664</a>.</cite></span></li><li id="cite_note-pmid18827074-100"> <span id="mw-reference-text-cite_note-pmid18827074-100" class="mw-reference-text"><cite id="CITEREFCundySastryLuoZou2008" class="citation journal cs1">Cundy KC, Sastry S, Luo W, Zou J, Moors TL, Canafax DM (December 2008). "Clinical pharmacokinetics of XP13512, a novel transported prodrug of gabapentin". <i>Journal of Clinical Pharmacology</i>. <b>48</b> (12): 1378–88. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F0091270008322909  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F0091270008322909'" tppabs="https://doi.org/10.1177%2F0091270008322909" class="external text external">10.1177/0091270008322909</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18827074  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18827074'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18827074" class="external text external">18827074</a>.</cite></span></li><li id="cite_note-pmid26305616-101"> <span id="mw-reference-text-cite_note-pmid26305616-101" class="mw-reference-text"><cite id="CITEREFGeldenhuysMohammadAdkinsLockman2015" class="citation journal cs1">Geldenhuys WJ, Mohammad AS, Adkins CE, Lockman PR (2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675962  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675962'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675962" class="external text external">"Molecular determinants of blood-brain barrier permeation"</a>. <i>Therapeutic Delivery</i>. <b>6</b> (8): 961–71. doi:<a href="javascript:if(confirm('https://doi.org/10.4155%2Ftde.15.32  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4155%2Ftde.15.32'" tppabs="https://doi.org/10.4155%2Ftde.15.32" class="external text external">10.4155/tde.15.32</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675962  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675962'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675962" class="external text external">4675962</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26305616  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26305616'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26305616" class="external text external">26305616</a>.</cite></span></li><li id="cite_note-pmid19937841-102"> <span id="mw-reference-text-cite_note-pmid19937841-102" class="mw-reference-text"><cite id="CITEREFMüller2009" class="citation journal cs1">Müller CE (November 2009). "Prodrug approaches for enhancing the bioavailability of drugs with low solubility". <i>Chemistry &amp; Biodiversity</i>. <b>6</b> (11): 2071–83. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fcbdv.200900114  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fcbdv.200900114'" tppabs="https://doi.org/10.1002%2Fcbdv.200900114" class="external text external">10.1002/cbdv.200900114</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19937841  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19937841'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19937841" class="external text external">19937841</a>.</cite></span></li><li id="cite_note-pmid10518579-103"> <span id="mw-reference-text-cite_note-pmid10518579-103" class="mw-reference-text"><cite id="CITEREFBoadoLiNagayaZhang1999" class="citation journal cs1">Boado RJ, Li JY, Nagaya M, Zhang C, Pardridge WM (October 1999). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC18415  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC18415'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC18415" class="external text external">"Selective expression of the large neutral amino acid transporter at the blood-brain barrier"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>96</b> (21): 12079–84. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/1999PNAS...9612079B  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/1999PNAS...9612079B'" tppabs="https://ui.adsabs.harvard.edu/abs/1999PNAS...9612079B" class="external text external">1999PNAS...9612079B</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1073%2Fpnas.96.21.12079  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1073%2Fpnas.96.21.12079'" tppabs="https://doi.org/10.1073%2Fpnas.96.21.12079" class="external text external">10.1073/pnas.96.21.12079</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC18415  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC18415'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC18415" class="external text external">18415</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10518579  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10518579'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10518579" class="external text external">10518579</a>.</cite></span></li><li id="cite_note-Kaye2017-104"> <span id="mw-reference-text-cite_note-Kaye2017-104" class="mw-reference-text"><cite id="CITEREFKaye2017" class="citation book cs1">Kaye AD (5 June 2017). <a href="javascript:if(confirm('https://books.google.com/books?id=lsUmDwAAQBAJ&pg=PT98  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=lsUmDwAAQBAJ&pg=PT98'" tppabs="https://books.google.com/books?id=lsUmDwAAQBAJ&pg=PT98" class="external text external"><i>Pharmacology, An Issue of Anesthesiology Clinics E-Book</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>98–. ISBN<span>&nbsp;</span><bdi>978-0-323-52998-3</bdi>.</cite></span></li><li id="cite_note-WyllieCascino2012-105"> <span id="mw-reference-text-cite_note-WyllieCascino2012-105" class="mw-reference-text"><cite id="CITEREFWyllieCascinoGidalGoodkin2012" class="citation book cs1">Wyllie E, Cascino GD, Gidal BE, Goodkin HP (17 February 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=j9t6Qg0kkuUC&pg=RA1-PA423  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=j9t6Qg0kkuUC&pg=RA1-PA423'" tppabs="https://books.google.com/books?id=j9t6Qg0kkuUC&pg=RA1-PA423" class="external text external"><i>Wyllie's Treatment of Epilepsy: Principles and Practice</i></a>. Lippincott Williams &amp; Wilkins. p.<span>&nbsp;</span>423. ISBN<span>&nbsp;</span><bdi>978-1-4511-5348-4</bdi>.</cite></span></li><li id="cite_note-pmid18221197-106"> <span id="mw-reference-text-cite_note-pmid18221197-106" class="mw-reference-text"><cite id="CITEREFYogeeswariRagavendranSriram2006" class="citation journal cs1">Yogeeswari P, Ragavendran JV, Sriram D (January 2006). "An update on GABA analogs for CNS drug discovery". <i>Recent Patents on CNS Drug Discovery</i>. <b>1</b> (1): 113–8. doi:<a href="javascript:if(confirm('https://doi.org/10.2174%2F157488906775245291  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2174%2F157488906775245291'" tppabs="https://doi.org/10.2174%2F157488906775245291" class="external text external">10.2174/157488906775245291</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18221197  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18221197'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18221197" class="external text external">18221197</a>.</cite></span></li><li id="cite_note-pmid11966555-107"> <span id="mw-reference-text-cite_note-pmid11966555-107" class="mw-reference-text"><cite id="CITEREFRoseKam2002" class="citation journal cs1">Rose MA, Kam PC (May 2002). "Gabapentin: pharmacology and its use in pain management". <i>Anaesthesia</i>. <b>57</b> (5): 451–62. doi:<a href="javascript:if(confirm('https://doi.org/10.1046%2Fj.0003-2409.2001.02399.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1046%2Fj.0003-2409.2001.02399.x'" tppabs="https://doi.org/10.1046%2Fj.0003-2409.2001.02399.x" class="external text external">10.1046/j.0003-2409.2001.02399.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11966555  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11966555'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11966555" class="external text external">11966555</a>.</cite></span></li><li id="cite_note-WhelessWillmore2009-108"> <span id="mw-reference-text-cite_note-WhelessWillmore2009-108" class="mw-reference-text"><cite id="CITEREFWhelessWillmoreBrumback2009" class="citation book cs1">Wheless JW, Willmore J, Brumback RA (2009). <a href="javascript:if(confirm('https://books.google.com/books?id=4W7UI-FPZmoC&pg=PA302  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=4W7UI-FPZmoC&pg=PA302'" tppabs="https://books.google.com/books?id=4W7UI-FPZmoC&pg=PA302" class="external text external"><i>Advanced Therapy in Epilepsy</i></a>. PMPH-USA. pp.<span>&nbsp;</span>302–. ISBN<span>&nbsp;</span><bdi>978-1-60795-004-2</bdi>.</cite></span></li><li id="cite_note-pmid21428817-109"> <span id="mw-reference-text-cite_note-pmid21428817-109" class="mw-reference-text"><cite id="CITEREFLevandovskiySharapaShamotaRodionov2011" class="citation journal cs1">Levandovskiy IA, Sharapa DI, Shamota TV, Rodionov VN, Shubina TE (February 2011). "Conformationally restricted GABA analogs: from rigid carbocycles to cage hydrocarbons". <i>Future Medicinal Chemistry</i>. <b>3</b> (2): 223–41. doi:<a href="javascript:if(confirm('https://doi.org/10.4155%2Ffmc.10.287  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4155%2Ffmc.10.287'" tppabs="https://doi.org/10.4155%2Ffmc.10.287" class="external text external">10.4155/fmc.10.287</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21428817  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21428817'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21428817" class="external text external">21428817</a>.</cite></span></li><li id="cite_note-Publishing2013-110"> <span id="mw-reference-text-cite_note-Publishing2013-110" class="mw-reference-text"><cite id="CITEREFWilliam_Andrew_Publishing2013" class="citation book cs1">William Andrew Publishing (22 October 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=_J2ti4EkYpkC&pg=PA1737  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=_J2ti4EkYpkC&pg=PA1737'" tppabs="https://books.google.com/books?id=_J2ti4EkYpkC&pg=PA1737" class="external text external"><i>Pharmaceutical Manufacturing Encyclopedia, 3rd Edition</i></a>. Elsevier. pp.<span>&nbsp;</span>1737–. ISBN<span>&nbsp;</span><bdi>978-0-8155-1856-3</bdi>.</cite></span></li><li id="cite_note-JohnsonLi2013-111"> <span id="mw-reference-text-cite_note-JohnsonLi2013-111" class="mw-reference-text"><cite id="CITEREFJohnsonLi2013" class="citation book cs1">Johnson DS, Li JJ (26 February 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=zvruBDAulWEC&pg=SA13-PA41  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=zvruBDAulWEC&pg=SA13-PA41'" tppabs="https://books.google.com/books?id=zvruBDAulWEC&pg=SA13-PA41" class="external text external"><i>The Art of Drug Synthesis</i></a>. John Wiley &amp; Sons. pp.<span>&nbsp;</span>13–. ISBN<span>&nbsp;</span><bdi>978-1-118-67846-6</bdi>.</cite></span></li><li id="cite_note-AdisInsight-Gabapentin-112"> <span id="mw-reference-text-cite_note-AdisInsight-Gabapentin-112" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://adisinsight.springer.com/drugs/800002421  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://adisinsight.springer.com/drugs/800002421'" tppabs="https://adisinsight.springer.com/drugs/800002421" class="external text external">"Drug Profile: Gabapentin"</a>. <i>Adis Insight</i>.</cite></span></li><li id="cite_note-Li2014-113"> <span id="mw-reference-text-cite_note-Li2014-113" class="mw-reference-text"><cite id="CITEREFLi2014" class="citation book cs1">Li JJ (2014). <a href="javascript:if(confirm('https://books.google.com/books?id=7XH1AQAAQBAJ&pg=PA158  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=7XH1AQAAQBAJ&pg=PA158'" tppabs="https://books.google.com/books?id=7XH1AQAAQBAJ&pg=PA158" class="external text external"><i>Blockbuster Drugs: The Rise and Fall of the Pharmaceutical Industry</i></a>. OUP USA. pp.<span>&nbsp;</span>158–. ISBN<span>&nbsp;</span><bdi>978-0-19-973768-0</bdi>.</cite></span></li><li id="cite_note-pmid23342236-114"> <span id="mw-reference-text-cite_note-pmid23342236-114" class="mw-reference-text"><cite id="CITEREFIrving2012" class="citation journal cs1">Irving G (September 2012). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539268  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539268'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539268" class="external text external">"Once-daily gastroretentive gabapentin for the management of postherpetic neuralgia: an update for clinicians"</a>. <i>Therapeutic Advances in Chronic Disease</i>. <b>3</b> (5): 211–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F2040622312452905  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F2040622312452905'" tppabs="https://doi.org/10.1177%2F2040622312452905" class="external text external">10.1177/2040622312452905</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539268  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539268'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539268" class="external text external">3539268</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23342236  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23342236'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23342236" class="external text external">23342236</a>.</cite></span></li><li id="cite_note-Reed2012-115"> <span id="mw-reference-text-cite_note-Reed2012-115" class="mw-reference-text"><cite id="CITEREFReed2012" class="citation book cs1">Reed D (2 March 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=HkICcDDz0qQC&pg=PA63  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=HkICcDDz0qQC&pg=PA63'" tppabs="https://books.google.com/books?id=HkICcDDz0qQC&pg=PA63" class="external text external"><i>The Other End of the Stethoscope: The Physician's Perspective on the Health Care Crisis</i></a>. AuthorHouse. pp.<span>&nbsp;</span>63–. ISBN<span>&nbsp;</span><bdi>978-1-4685-4410-7</bdi>.</cite></span></li><li id="cite_note-GoodRx2013-116"> <span id="mw-reference-text-cite_note-GoodRx2013-116" class="mw-reference-text"><cite id="CITEREFOrrange2013" class="citation web cs1">Orrange S (31 May 2013). <a href="javascript:if(confirm('https://web.archive.org/web/20180623032739/https://www.goodrx.com/blog/yabba-dabba-gabapentin-are-gralise-and-horizant-worth-the-cost/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20180623032739/https://www.goodrx.com/blog/yabba-dabba-gabapentin-are-gralise-and-horizant-worth-the-cost/'" tppabs="https://web.archive.org/web/20180623032739/https://www.goodrx.com/blog/yabba-dabba-gabapentin-are-gralise-and-horizant-worth-the-cost/" class="external text external">"Yabba Dabba Gabapentin: Are Gralise and Horizant Worth the Cost?"</a>. GoodRx, Inc. Archived from <a href="javascript:if(confirm('https://www.goodrx.com/blog/yabba-dabba-gabapentin-are-gralise-and-horizant-worth-the-cost/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.goodrx.com/blog/yabba-dabba-gabapentin-are-gralise-and-horizant-worth-the-cost/'" tppabs="https://www.goodrx.com/blog/yabba-dabba-gabapentin-are-gralise-and-horizant-worth-the-cost/" class="external text external">the original</a> on 23 June 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">22 June</span> 2018</span>.</cite></span></li><li id="cite_note-AdisInsight-Gabapentin-CR-117"> <span id="mw-reference-text-cite_note-AdisInsight-Gabapentin-CR-117" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://adisinsight.springer.com/drugs/800019682  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://adisinsight.springer.com/drugs/800019682'" tppabs="http://adisinsight.springer.com/drugs/800019682" class="external text external">"Gabapentin controlled release - Depomed"</a>. <i>Adis Insight</i>.</cite></span></li><li id="cite_note-Medscape-118"> <span id="mw-reference-text-cite_note-Medscape-118" class="mw-reference-text"><cite id="CITEREFJeffrey" class="citation web cs1">Jeffrey S. <a href="javascript:if(confirm('http://www.medscape.com/viewarticle/765233  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.medscape.com/viewarticle/765233'" tppabs="http://www.medscape.com/viewarticle/765233" class="external text external">"FDA Approves Gabapentin Enacarbil for Postherpetic Neuralgia"</a>. Medscape.</cite></span></li><li id="cite_note-119"> <span id="mw-reference-text-cite_note-119" class="mw-reference-text"><cite class="citation pressrelease cs1"><a href="javascript:if(confirm('http://www.usdoj.gov/opa/pr/2004/May/04_civ_322.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.usdoj.gov/opa/pr/2004/May/04_civ_322.htm'" tppabs="http://www.usdoj.gov/opa/pr/2004/May/04_civ_322.htm" class="external text external">"Warner–Lambert to pay $430<span>&nbsp;</span>million to resolve criminal &amp; civil health care liability relating to off-label promotion"</a> (Press release). Department of Justice. 13 May 2004. <a href="javascript:if(confirm('https://web.archive.org/web/20090717111709/http://www.usdoj.gov/opa/pr/2004/May/04_civ_322.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20090717111709/http://www.usdoj.gov/opa/pr/2004/May/04_civ_322.htm'" tppabs="https://web.archive.org/web/20090717111709/http://www.usdoj.gov/opa/pr/2004/May/04_civ_322.htm" class="external text external">Archived</a> from the original on 17 July 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">2 December</span> 2009</span>.</cite></span></li><li id="cite_note-120"> <span id="mw-reference-text-cite_note-120" class="mw-reference-text"><cite id="CITEREFMathewRapoportSaperMagnus2001" class="citation journal cs1">Mathew NT, Rapoport A, Saper J, Magnus L, Klapper J, Ramadan N, Stacey B, Tepper S (February 2001). "Efficacy of gabapentin in migraine prophylaxis". <i>Headache</i>. <b>41</b> (2): 119–128. doi:<a href="javascript:if(confirm('https://doi.org/10.1046%2Fj.1526-4610.2001.111006119.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1046%2Fj.1526-4610.2001.111006119.x'" tppabs="https://doi.org/10.1046%2Fj.1526-4610.2001.111006119.x" class="external text external">10.1046/j.1526-4610.2001.111006119.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11251695  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11251695'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11251695" class="external text external">11251695</a>.</cite></span></li><li id="cite_note-Mack-121"> <span id="mw-reference-text-cite_note-Mack-121" class="mw-reference-text"><cite class="citation journal cs1">Mack A (2003). <a href="javascript:if(confirm('https://web.archive.org/web/20100917222044/http://amcp.org/data/jmcp/Contemporary%20Subject-559-568.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20100917222044/http://amcp.org/data/jmcp/Contemporary%20Subject-559-568.pdf'" tppabs="https://web.archive.org/web/20100917222044/http://amcp.org/data/jmcp/Contemporary%20Subject-559-568.pdf" class="external text external">"Examination of the evidence for off-label use of gabapentin"</a> <span class="cs1-format">(PDF)</span>. <i>Journal of Managed Care Pharmacy</i>. <b>9</b> (6): 559–68. doi:<a href="javascript:if(confirm('https://doi.org/10.18553%2Fjmcp.2003.9.6.559  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.18553%2Fjmcp.2003.9.6.559'" tppabs="https://doi.org/10.18553%2Fjmcp.2003.9.6.559" class="external text external">10.18553/jmcp.2003.9.6.559</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14664664  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14664664'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14664664" class="external text external">14664664</a>. Archived from <a href="javascript:if(confirm('http://www.amcp.org/data/jmcp/Contemporary%20Subject-559-568.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.amcp.org/data/jmcp/Contemporary%20Subject-559-568.pdf'" tppabs="http://www.amcp.org/data/jmcp/Contemporary%20Subject-559-568.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 17 September 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">15 August</span> 2006</span>.</cite></span></li><li id="cite_note-122"> <span id="mw-reference-text-cite_note-122" class="mw-reference-text">Pfizer <a href="javascript:if(confirm('http://labeling.pfizer.com/ShowLabeling.aspx?id=630  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://labeling.pfizer.com/ShowLabeling.aspx?id=630'" tppabs="http://labeling.pfizer.com/ShowLabeling.aspx?id=630" class="external text external">Neurontin Label, Revised: 5/2013</a> <a href="javascript:if(confirm('https://web.archive.org/web/20140810040212/http://labeling.pfizer.com/ShowLabeling.aspx?id=630  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20140810040212/http://labeling.pfizer.com/ShowLabeling.aspx?id=630'" tppabs="https://web.archive.org/web/20140810040212/http://labeling.pfizer.com/ShowLabeling.aspx?id=630" class="external text external">Archived</a><span> 10 August 2014 at the </span>Wayback Machine Retrieved 9 August 2014</span></li><li id="cite_note-123"> <span id="mw-reference-text-cite_note-123" class="mw-reference-text"><cite id="CITEREFReinaresRosaFrancoGoikolea2013" class="citation journal cs1">Reinares M, Rosa AR, Franco C, Goikolea JM, Fountoulakis K, Siamouli M, Gonda X, Frangou S, Vieta E (March 2013). <a href="javascript:if(confirm('https://doi.org/10.1017/S1461145712000491  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1017/S1461145712000491'" tppabs="https://doi.org/10.1017/S1461145712000491" class="external text external">"A systematic review on the role of anticonvulsants in the treatment of acute bipolar depression"</a>. <i>The International Journal of Neuropsychopharmacology</i>. <b>16</b> (2): 485–96. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1017%2FS1461145712000491  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1017%2FS1461145712000491'" tppabs="https://doi.org/10.1017%2FS1461145712000491" class="external text external">10.1017/S1461145712000491</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22575611  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22575611'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22575611" class="external text external">22575611</a>.</cite></span></li><li id="cite_note-Berkrot_20100325-124"> <span id="mw-reference-text-cite_note-Berkrot_20100325-124" class="mw-reference-text"><cite id="CITEREFBerkrot2010" class="citation news cs1">Berkrot B (25 March 2010). <a href="javascript:if(confirm('https://www.reuters.com/article/2010/03/25/pfizer-neurontin-idUSN259778920100325  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.reuters.com/article/2010/03/25/pfizer-neurontin-idUSN259778920100325'" tppabs="https://www.reuters.com/article/2010/03/25/pfizer-neurontin-idUSN259778920100325" class="external text external">"US jury's Neurontin ruling to cost Pfizer $141 mln"</a>. Reuters. <a href="javascript:if(confirm('https://web.archive.org/web/20151019112249/http://www.reuters.com/article/2010/03/25/pfizer-neurontin-idUSN259778920100325  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20151019112249/http://www.reuters.com/article/2010/03/25/pfizer-neurontin-idUSN259778920100325'" tppabs="https://web.archive.org/web/20151019112249/http://www.reuters.com/article/2010/03/25/pfizer-neurontin-idUSN259778920100325" class="external text external">Archived</a> from the original on 19 October 2015.</cite></span></li><li id="cite_note-125"> <span id="mw-reference-text-cite_note-125" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20151019112248/http://www.businessweek.com/ap/financialnews/D9ELVKG80.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20151019112248/http://www.businessweek.com/ap/financialnews/D9ELVKG80.htm'" tppabs="https://web.archive.org/web/20151019112248/http://www.businessweek.com/ap/financialnews/D9ELVKG80.htm" class="external text external">"Pfizer faces $142M in damages for drug fraud"</a>. <i>Bloomberg Businessweek</i>. 25 March 2010. Archived from <a href="javascript:if(confirm('http://www.businessweek.com/ap/financialnews/D9ELVKG80.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.businessweek.com/ap/financialnews/D9ELVKG80.htm'" tppabs="http://www.businessweek.com/ap/financialnews/D9ELVKG80.htm" class="external text external">the original</a> on 19 October 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">13 January</span> 2012</span>.</cite></span></li><li id="cite_note-126"> <span id="mw-reference-text-cite_note-126" class="mw-reference-text"><cite id="CITEREFVan_VorisLawrence2010" class="citation news cs1">Van Voris B, Lawrence J (26 March 2010). <a href="javascript:if(confirm('https://web.archive.org/web/20130513232138/http://www.bloomberg.com/apps/news?pid=email_en&sid=a_9aVylZQGjU  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20130513232138/http://www.bloomberg.com/apps/news?pid=email_en&sid=a_9aVylZQGjU'" tppabs="https://web.archive.org/web/20130513232138/http://www.bloomberg.com/apps/news?pid=email_en&sid=a_9aVylZQGjU" class="external text external">"Pfizer Told to Pay $142.1 Million for Neurontin Marketing Fraud"</a>. <i>Bloomberg News</i>. Archived from <a href="javascript:if(confirm('https://www.bloomberg.com/apps/news?pid=email_en&sid=a_9aVylZQGjU  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.bloomberg.com/apps/news?pid=email_en&sid=a_9aVylZQGjU'" tppabs="https://www.bloomberg.com/apps/news?pid=email_en&sid=a_9aVylZQGjU" class="external text external">the original</a> on 13 May 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">13 January</span> 2012</span>.</cite></span></li><li id="cite_note-127"> <span id="mw-reference-text-cite_note-127" class="mw-reference-text"><cite id="CITEREFKamp2010" class="citation news cs1">Kamp J (25 March 2010). <span class="cs1-lock-subscription"><a href="javascript:if(confirm('https://www.wsj.com/articles/SB10001424052748704094104575144223583428414  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wsj.com/articles/SB10001424052748704094104575144223583428414'" tppabs="https://www.wsj.com/articles/SB10001424052748704094104575144223583428414" class="external text external">"Jury Rules Against Pfizer in Marketing Case"</a></span>. <i>The Wall Street Journal</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20151019112250/http://www.wsj.com/articles/SB10001424052748704094104575144223583428414  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20151019112250/http://www.wsj.com/articles/SB10001424052748704094104575144223583428414'" tppabs="https://web.archive.org/web/20151019112250/http://www.wsj.com/articles/SB10001424052748704094104575144223583428414" class="external text external">Archived</a> from the original on 19 October 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">13 January</span> 2012</span>.</cite></span></li><li id="cite_note-128"> <span id="mw-reference-text-cite_note-128" class="mw-reference-text"><cite id="CITEREFTansey2004" class="citation news cs1">Tansey B (14 May 2004). <a href="javascript:if(confirm('http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2004/05/14/BUGKK6L0LB1.DTL  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2004/05/14/BUGKK6L0LB1.DTL'" tppabs="http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2004/05/14/BUGKK6L0LB1.DTL" class="external text external">"Huge penalty in drug fraud, Pfizer settles felony case in Neurontin off-label promotion"</a>. <i>San Francisco Chronicle</i>. p.<span>&nbsp;</span>C-1. <a href="javascript:if(confirm('https://web.archive.org/web/20060623103021/http://www.sfgate.com/cgi-bin/article.cgi?f=%2Fc%2Fa%2F2004%2F05%2F14%2FBUGKK6L0LB1.DTL  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20060623103021/http://www.sfgate.com/cgi-bin/article.cgi?f=%2Fc%2Fa%2F2004%2F05%2F14%2FBUGKK6L0LB1.DTL'" tppabs="https://web.archive.org/web/20060623103021/http://www.sfgate.com/cgi-bin/article.cgi?f=%2Fc%2Fa%2F2004%2F05%2F14%2FBUGKK6L0LB1.DTL" class="external text external">Archived</a> from the original on 23 June 2006.</cite></span></li><li id="cite_note-Drugs.com-History-129"> <span id="mw-reference-text-cite_note-Drugs.com-History-129" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/history/gralise.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/history/gralise.html'" tppabs="https://www.drugs.com/history/gralise.html" class="external text external">"Gralise Approval History"</a>. Drugs.com.</cite></span></li><li id="cite_note-Baillie_33–9-130"> <span id="mw-reference-text-cite_note-Baillie_33–9-130" class="mw-reference-text"><cite id="CITEREFBailliePower2006" class="citation journal cs1">Baillie JK, Power I (January 2006). "The mechanism of action of gabapentin in neuropathic pain". <i>Current Opinion in Investigational Drugs</i>. <b>7</b> (1): 33–9. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16425669  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16425669'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16425669" class="external text external">16425669</a>.</cite></span></li><li id="cite_note-131"> <span id="mw-reference-text-cite_note-131" class="mw-reference-text">Jensen B, Regier LD, editors. RxFiles<span>&nbsp;</span>: Drug comparison charts. 7th ed. Saskatoon, SK: RxFiles, 2010; p.78</span></li><li id="cite_note-pmid21681607-132"> <span id="mw-reference-text-cite_note-pmid21681607-132" class="mw-reference-text"><cite id="CITEREFKjellssonOuelletCorriganKarlsson2011" class="citation journal cs1">Kjellsson MC, Ouellet D, Corrigan B, Karlsson MO (October 2011). "Modeling sleep data for a new drug in development using markov mixed-effects models". <i>Pharmaceutical Research</i>. <b>28</b> (10): 2610–27. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs11095-011-0490-x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs11095-011-0490-x'" tppabs="https://doi.org/10.1007%2Fs11095-011-0490-x" class="external text external">10.1007/s11095-011-0490-x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21681607  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21681607'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21681607" class="external text external">21681607</a>.</cite></span></li><li id="cite_note-pmid19787095-133"> <span id="mw-reference-text-cite_note-pmid19787095-133" class="mw-reference-text"><cite id="CITEREFLandmarkJohannessen2008" class="citation journal cs1">Landmark CJ, Johannessen SI (February 2008). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746576  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746576'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746576" class="external text external">"Modifications of antiepileptic drugs for improved tolerability and efficacy"</a>. <i>Perspectives in Medicinal Chemistry</i>. <b>2</b>: 21–39. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F1177391X0800200001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F1177391X0800200001'" tppabs="https://doi.org/10.1177%2F1177391X0800200001" class="external text external">10.1177/1177391X0800200001</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746576  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746576'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746576" class="external text external">2746576</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19787095  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19787095'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19787095" class="external text external">19787095</a>.</cite></span></li><li id="cite_note-134"> <span id="mw-reference-text-cite_note-134" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://archive.today/20120713102633/http://phx.corporate-ir.net/phoenix.zhtml?c=187883&p=RssLanding&cat=news&id=1547555  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.today/20120713102633/http://phx.corporate-ir.net/phoenix.zhtml?c=187883&p=RssLanding&cat=news&id=1547555'" tppabs="https://archive.today/20120713102633/http://phx.corporate-ir.net/phoenix.zhtml?c=187883&p=RssLanding&cat=news&id=1547555" class="external text external">"GlaxoSmithKline and XenoPort Receive FDA Approval for Horizant"</a>. GlaxoSmithKline and XenoPort, Inc. Archived from <a href="javascript:if(confirm('http://phx.corporate-ir.net/phoenix.zhtml?c=187883&p=RssLanding&cat=news&id=1547555  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://phx.corporate-ir.net/phoenix.zhtml?c=187883&p=RssLanding&cat=news&id=1547555'" tppabs="http://phx.corporate-ir.net/phoenix.zhtml?c=187883&p=RssLanding&cat=news&id=1547555" class="external text external">the original</a> on 13 July 2012.</cite></span></li><li id="cite_note-135"> <span id="mw-reference-text-cite_note-135" class="mw-reference-text"><cite class="citation web cs1">Jeffrey S. <a href="javascript:if(confirm('http://www.medscape.com/viewarticle/765233  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.medscape.com/viewarticle/765233'" tppabs="http://www.medscape.com/viewarticle/765233" class="external text external">"FDA Approves Gabapentin Enacarbil for Postherpetic Neuralgia"</a>. Medscape. <a href="javascript:if(confirm('https://web.archive.org/web/20121120002718/http://www.medscape.com/viewarticle/765233  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20121120002718/http://www.medscape.com/viewarticle/765233'" tppabs="https://web.archive.org/web/20121120002718/http://www.medscape.com/viewarticle/765233" class="external text external">Archived</a> from the original on 20 November 2012.</cite></span></li><li id="cite_note-DrugBank1-136"> <span id="mw-reference-text-cite_note-DrugBank1-136" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB08872/clinical_trials?conditions=DBCOND0032885&phase=3&purpose=treatment&status=completed  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB08872/clinical_trials?conditions=DBCOND0032885&phase=3&purpose=treatment&status=completed'" tppabs="https://www.drugbank.ca/drugs/DB08872/clinical_trials?conditions=DBCOND0032885&phase=3&purpose=treatment&status=completed" class="external text external">"Gabapentin enacarbil Completed Phase 3 Trials for Restless Legs Syndrome (RLS) Treatment"</a>. <i>DrugBank</i><span class="reference-accessdate">. Retrieved <span class="nowrap">18 September</span> 2019</span>.</cite></span></li><li id="cite_note-pmid15146028-137"> <span id="mw-reference-text-cite_note-pmid15146028-137" class="mw-reference-text"><cite id="CITEREFCundyBranchChernov-RoganDias2004" class="citation journal cs1">Cundy KC, Branch R, Chernov-Rogan T, Dias T, Estrada T, Hold K, Koller K, Liu X, Mann A, Panuwat M, Raillard SP, Upadhyay S, Wu QQ, Xiang JN, Yan H, Zerangue N, Zhou CX, Barrett RW, Gallop MA (October 2004). "XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: I. Design, synthesis, enzymatic conversion to gabapentin, and transport by intestinal solute transporters". <i>The Journal of Pharmacology and Experimental Therapeutics</i>. <b>311</b> (1): 315–23. doi:<a href="javascript:if(confirm('https://doi.org/10.1124%2Fjpet.104.067934  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1124%2Fjpet.104.067934'" tppabs="https://doi.org/10.1124%2Fjpet.104.067934" class="external text external">10.1124/jpet.104.067934</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15146028  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15146028'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15146028" class="external text external">15146028</a>.</cite></span></li><li id="cite_note-pmid15146029-138"> <span id="mw-reference-text-cite_note-pmid15146029-138" class="mw-reference-text"><cite id="CITEREFCundyAnnamalaiBuDe_Vera2004" class="citation journal cs1">Cundy KC, Annamalai T, Bu L, De Vera J, Estrela J, Luo W, Shirsat P, Torneros A, Yao F, Zou J, Barrett RW, Gallop MA (October 2004). "XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: II. Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkeys". <i>The Journal of Pharmacology and Experimental Therapeutics</i>. <b>311</b> (1): 324–33. doi:<a href="javascript:if(confirm('https://doi.org/10.1124%2Fjpet.104.067959  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1124%2Fjpet.104.067959'" tppabs="https://doi.org/10.1124%2Fjpet.104.067959" class="external text external">10.1124/jpet.104.067959</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15146029  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15146029'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15146029" class="external text external">15146029</a>.</cite></span></li><li id="cite_note-139"> <span id="mw-reference-text-cite_note-139" class="mw-reference-text">Oxford Textbook of Correctional Psychiatry. Robert L. Trestman, Kenneth L. Appelbaum, Jeffrey L. Metzner. Oxford University Press, 9 Apr 2015. p. 167.  ISBN<span>&nbsp;</span>978-0199360574</span></li><li id="cite_note-140"> <span id="mw-reference-text-cite_note-140" class="mw-reference-text"><cite id="CITEREFGoodmanBrett2017" class="citation journal cs1">Goodman CW, Brett AS (August 2017). <a href="javascript:if(confirm('https://doi.org/10.1056/NEJMp1704633  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056/NEJMp1704633'" tppabs="https://doi.org/10.1056/NEJMp1704633" class="external text external">"Gabapentin and Pregabalin for Pain – Is Increased Prescribing a Cause for Concern?"</a>. <i>The New England Journal of Medicine</i>. <b>377</b> (5): 411–414. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJMp1704633  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJMp1704633'" tppabs="https://doi.org/10.1056%2FNEJMp1704633" class="external text external">10.1056/NEJMp1704633</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28767350  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28767350'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28767350" class="external text external">28767350</a>.</cite></span></li><li id="cite_note-141"> <span id="mw-reference-text-cite_note-141" class="mw-reference-text"><cite id="CITEREFEvoyMorrisonSaklad2017" class="citation journal cs1">Evoy KE, Morrison MD, Saklad SR (March 2017). "Abuse and Misuse of Pregabalin and Gabapentin". <i>Drugs</i>. <b>77</b> (4): 403–426. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs40265-017-0700-x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs40265-017-0700-x'" tppabs="https://doi.org/10.1007%2Fs40265-017-0700-x" class="external text external">10.1007/s40265-017-0700-x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28144823  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28144823'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28144823" class="external text external">28144823</a>.</cite></span></li><li id="cite_note-142"> <span id="mw-reference-text-cite_note-142" class="mw-reference-text"><cite id="CITEREFFaryarWebbBhandariPrice2019" class="citation journal cs1">Faryar KA, Webb AN, Bhandari B, Price TG, Bosse GM (June 2019). "Trending gabapentin exposures in Kentucky after legislation requiring use of the state prescription drug monitoring program for all opioid prescriptions". <i>Clinical Toxicology</i>. <b>57</b> (6): 398–403. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F15563650.2018.1538518  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F15563650.2018.1538518'" tppabs="https://doi.org/10.1080%2F15563650.2018.1538518" class="external text external">10.1080/15563650.2018.1538518</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30676102  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30676102'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30676102" class="external text external">30676102</a>.</cite></span></li><li id="cite_note-143"> <span id="mw-reference-text-cite_note-143" class="mw-reference-text"><cite id="CITEREFReynoldsKaufmanKorenoskiFennimore2019" class="citation journal cs1">Reynolds, Kimberly; Kaufman, Robert; Korenoski, Amanda; Fennimore, Laura; Shulman, Joshua; Lynch, Michael (1 December 2019). "Trends in gabapentin and baclofen exposures reported to U.S. poison centers". <i>Clinical Toxicology</i>. <b>0</b> (7): 763–772. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F15563650.2019.1687902  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F15563650.2019.1687902'" tppabs="https://doi.org/10.1080%2F15563650.2019.1687902" class="external text external">10.1080/15563650.2019.1687902</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1556-3650  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1556-3650'" tppabs="https://www.worldcat.org/issn/1556-3650" class="external text external">1556-3650</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/31786961  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/31786961'" tppabs="https://pubmed.ncbi.nlm.nih.gov/31786961" class="external text external">31786961</a>.</cite></span></li><li id="cite_note-pmid21831060-144"> <span id="mw-reference-text-cite_note-pmid21831060-144" class="mw-reference-text"><cite id="CITEREFVettoratoCorletto2011" class="citation journal cs1">Vettorato E, Corletto F (September 2011). "Gabapentin as part of multi-modal analgesia in two cats suffering multiple injuries". <i>Veterinary Anaesthesia and Analgesia</i>. <b>38</b> (5): 518–20. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1467-2995.2011.00638.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1467-2995.2011.00638.x'" tppabs="https://doi.org/10.1111%2Fj.1467-2995.2011.00638.x" class="external text external">10.1111/j.1467-2995.2011.00638.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21831060  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21831060'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21831060" class="external text external">21831060</a>.</cite></span></li><li id="cite_note-pmid29099247-145"> <span id="mw-reference-text-cite_note-pmid29099247-145" class="mw-reference-text"><cite id="CITEREFvan_HaaftenForsytheStelowBain2017" class="citation journal cs1">van Haaften KA, Forsythe LR, Stelow EA, Bain MJ (November 2017). "Effects of a single preappointment dose of gabapentin on signs of stress in cats during transportation and veterinary examination". <i>Journal of the American Veterinary Medical Association</i>. <b>251</b> (10): 1175–1181. doi:<a href="javascript:if(confirm('https://doi.org/10.2460%2Fjavma.251.10.1175  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2460%2Fjavma.251.10.1175'" tppabs="https://doi.org/10.2460%2Fjavma.251.10.1175" class="external text external">10.2460/javma.251.10.1175</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29099247  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29099247'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29099247" class="external text external">29099247</a>.</cite></span></li><li id="cite_note-146"> <span id="mw-reference-text-cite_note-146" class="mw-reference-text"><cite id="CITEREFForney" class="citation web cs1">Forney B. <a href="javascript:if(confirm('http://www.wedgewoodpetrx.com/learning-center/professional-monographs/gabapentin-for-veterinary-use.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.wedgewoodpetrx.com/learning-center/professional-monographs/gabapentin-for-veterinary-use.html'" tppabs="http://www.wedgewoodpetrx.com/learning-center/professional-monographs/gabapentin-for-veterinary-use.html" class="external text external">"Gabapentin for Veterinary Use"</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20120106123234/http://www.wedgewoodpetrx.com/learning-center/professional-monographs/gabapentin-for-veterinary-use.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120106123234/http://www.wedgewoodpetrx.com/learning-center/professional-monographs/gabapentin-for-veterinary-use.html'" tppabs="https://web.archive.org/web/20120106123234/http://www.wedgewoodpetrx.com/learning-center/professional-monographs/gabapentin-for-veterinary-use.html" class="external text external">Archived</a> from the original on 6 January 2012.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    

<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/gabapentin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/gabapentin'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/gabapentin" class="external text external">"Gabapentin"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Medical_uses" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2" style="background:#e8e8ff;background:#ccccff"><div id="Medical_uses" style="font-size:114%;margin:0 4em">Medical uses</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;font-size:114%"><div style="padding:0px">
<div role="navigation" class="navbox" aria-labelledby="Anticonvulsants_(N03)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Anticonvulsants_(N03)" style="font-size:114%;margin:0 4em">Anticonvulsants (N03)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">GABAergics</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">GABA<sub>A</sub>R PAMs</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b><a href="Barbiturate.htm" tppabs="https://ptable.com/wiki/compounds/A/Barbiturate" title="Barbiturate">Barbiturates</a>:</b> Barbexaclone</li>
<li><a href="Metharbital.htm" tppabs="https://ptable.com/wiki/compounds/A/Metharbital" title="Metharbital">Metharbital</a></li>
<li><a href="Methylphenobarbital.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylphenobarbital" title="Methylphenobarbital">Methylphenobarbital</a></li>
<li><a href="Pentobarbital.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentobarbital" title="Pentobarbital">Pentobarbital</a></li>
<li><a href="Phenobarbital.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenobarbital" title="Phenobarbital">Phenobarbital</a><sup>#</sup></li>
<li><a href="Primidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Primidone" title="Primidone">Primidone</a>; <b>Carbamates</b>: Cenobamate</li>
<li><a href="Felbamate.htm" tppabs="https://ptable.com/wiki/compounds/A/Felbamate" title="Felbamate">Felbamate</a>; <b>Benzodiazepines</b>: <a href="Clobazam.htm" tppabs="https://ptable.com/wiki/compounds/A/Clobazam" title="Clobazam">Clobazam</a></li>
<li><a href="Clonazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Clonazepam" title="Clonazepam">Clonazepam</a></li>
<li><a href="Clorazepate.htm" tppabs="https://ptable.com/wiki/compounds/A/Clorazepate" title="Clorazepate">Clorazepate</a></li>
<li><a href="Diazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Diazepam" title="Diazepam">Diazepam</a><sup>#</sup></li>
<li><a href="Lorazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Lorazepam" title="Lorazepam">Lorazepam</a><sup>#</sup></li>
<li><a href="Midazolam.htm" tppabs="https://ptable.com/wiki/compounds/A/Midazolam" title="Midazolam">Midazolam</a></li>
<li>Nimetazepam</li>
<li><a href="Nitrazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrazepam" title="Nitrazepam">Nitrazepam</a></li>
<li><a href="Temazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Temazepam" title="Temazepam">Temazepam</a>; <b>Others:</b> Bromide (<a href="Potassium_bromide.htm" tppabs="https://ptable.com/wiki/compounds/A/Potassium_bromide" title="Potassium bromide">potassium bromide</a>, <a href="Sodium_bromide.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium_bromide" title="Sodium bromide">sodium bromide</a>)</li>
<li>Imepitoin</li>
<li><a href="Paraldehyde.htm" tppabs="https://ptable.com/wiki/compounds/A/Paraldehyde" title="Paraldehyde">Paraldehyde</a></li>
<li>Stiripentol</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">GABA-T inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Fatty acids (and related):</b> Valproate</li>
<li><a href="Valpromide.htm" tppabs="https://ptable.com/wiki/compounds/A/Valpromide" title="Valpromide">Valpromide</a></li>
<li>Valproate pivoxil</li>
<li><a href="Vigabatrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Vigabatrin" title="Vigabatrin">Vigabatrin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>GABAR agonists</b>: <a href="Progabide.htm" tppabs="https://ptable.com/wiki/compounds/A/Progabide" title="Progabide">Progabide</a>; <b>GAT-1 inhibitors:</b> <a href="Tiagabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tiagabine" title="Tiagabine">Tiagabine</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Channel<br>modulators</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Sodium blockers</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b><a href="Hydantoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydantoin" title="Hydantoin">Hydantoins</a>:</b> <a href="Ethotoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethotoin" title="Ethotoin">Ethotoin</a></li>
<li><a href="Fosphenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Fosphenytoin" title="Fosphenytoin">Fosphenytoin</a></li>
<li><a href="Mephenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mephenytoin" title="Mephenytoin">Mephenytoin</a></li>
<li><a href="Phenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenytoin" title="Phenytoin">Phenytoin</a><sup>#</sup>; <b>Ureides:</b> <span class="new">Acetylpheneturide</span></li>
<li>Chlorphenacemide</li>
<li><a href="Phenacemide.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenacemide" title="Phenacemide">Phenacemide</a><sup>‡</sup></li>
<li>Pheneturide; <b>Fatty acids:</b> Valproate</li>
<li><a href="Valpromide.htm" tppabs="https://ptable.com/wiki/compounds/A/Valpromide" title="Valpromide">Valpromide</a></li>
<li>Valproate pivoxil; <b>Carboxamides:</b> Brivaracetam</li>
<li><a href="Carbamazepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbamazepine" title="Carbamazepine">Carbamazepine</a><sup>#</sup></li>
<li>Eslicarbazepine acetate</li>
<li><a href="Oxcarbazepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxcarbazepine" title="Oxcarbazepine">Oxcarbazepine</a>; <b>Others:</b> Lacosamide</li>
<li><a href="Lamotrigine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lamotrigine" title="Lamotrigine">Lamotrigine</a><sup>#</sup></li>
<li>Rufinamide</li>
<li><a href="Topiramate.htm" tppabs="https://ptable.com/wiki/compounds/A/Topiramate" title="Topiramate">Topiramate</a></li>
<li><a href="Zonisamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Zonisamide" title="Zonisamide">Zonisamide</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Calcium blockers</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Oxazolidinediones:</b> Ethadione</li>
<li><a href="Paramethadione.htm" tppabs="https://ptable.com/wiki/compounds/A/Paramethadione" title="Paramethadione">Paramethadione</a></li>
<li><a href="Trimethadione.htm" tppabs="https://ptable.com/wiki/compounds/A/Trimethadione" title="Trimethadione">Trimethadione</a>; <b><a href="Succinimide.htm" tppabs="https://ptable.com/wiki/compounds/A/Succinimide" title="Succinimide">Succinimides</a></b>: <a href="Ethosuximide.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethosuximide" title="Ethosuximide">Ethosuximide</a><sup>#</sup></li>
<li><a href="Mesuximide.htm" tppabs="https://ptable.com/wiki/compounds/A/Mesuximide" title="Mesuximide">Mesuximide</a></li>
<li><a href="Phensuximide.htm" tppabs="https://ptable.com/wiki/compounds/A/Phensuximide" title="Phensuximide">Phensuximide</a>; <b>Gabapentinoids:</b> <a href="Gabapentin.htm" tppabs="https://ptable.com/wiki/compounds/A/Gabapentin" title="Gabapentin">Gabapentin</a></li>
<li><a href="Pregabalin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregabalin" title="Pregabalin">Pregabalin</a>; <b>Others:</b> Imepitoin</li>
<li><a href="Lamotrigine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lamotrigine" title="Lamotrigine">Lamotrigine</a><sup>#</sup></li>
<li><a href="Topiramate.htm" tppabs="https://ptable.com/wiki/compounds/A/Topiramate" title="Topiramate">Topiramate</a></li>
<li><a href="Zonisamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Zonisamide" title="Zonisamide">Zonisamide</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Potassium openers</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Retigabine</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">CA inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Sulfonamides:</b> <a href="Acetazolamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetazolamide" title="Acetazolamide">Acetazolamide</a></li>
<li><a href="Ethoxzolamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethoxzolamide" title="Ethoxzolamide">Ethoxzolamide</a></li>
<li>Sultiame</li>
<li><a href="Topiramate.htm" tppabs="https://ptable.com/wiki/compounds/A/Topiramate" title="Topiramate">Topiramate</a></li>
<li><a href="Zonisamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Zonisamide" title="Zonisamide">Zonisamide</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Albutoin</li>
<li>Beclamide</li>
<li><a href="Cannabidiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cannabidiol" title="Cannabidiol">Cannabidiol</a></li>
<li><a href="Etiracetam.htm" tppabs="https://ptable.com/wiki/compounds/A/Etiracetam" title="Etiracetam">Etiracetam</a></li>
<li><a href="Levetiracetam.htm" tppabs="https://ptable.com/wiki/compounds/A/Levetiracetam" title="Levetiracetam">Levetiracetam</a></li>
<li>Perampanel</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Anxiolytics_(N05B)" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Anxiolytics_(N05B)" style="font-size:114%;margin:0 4em">Anxiolytics (N05B)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>5-HT<sub>1A</sub>R</abbr> agonists</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Buspirone.htm" tppabs="https://ptable.com/wiki/compounds/A/Buspirone" title="Buspirone">Buspirone</a></li>
<li>Gepirone<sup>†</sup></li>
<li>Tandospirone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>GABA<sub>A</sub>R</abbr> <abbr>PAMs</abbr></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Benzodiazepines:</i> <a href="Adinazolam.htm" tppabs="https://ptable.com/wiki/compounds/A/Adinazolam" title="Adinazolam">Adinazolam</a></li>
<li><a href="Alprazolam.htm" tppabs="https://ptable.com/wiki/compounds/A/Alprazolam" title="Alprazolam">Alprazolam</a></li>
<li><a href="Bromazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Bromazepam" title="Bromazepam">Bromazepam</a></li>
<li><a href="Camazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Camazepam" title="Camazepam">Camazepam</a></li>
<li><a href="Chlordiazepoxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlordiazepoxide" title="Chlordiazepoxide">Chlordiazepoxide</a></li>
<li><a href="Clobazam.htm" tppabs="https://ptable.com/wiki/compounds/A/Clobazam" title="Clobazam">Clobazam</a></li>
<li><a href="Clonazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Clonazepam" title="Clonazepam">Clonazepam</a></li>
<li><a href="Clorazepate.htm" tppabs="https://ptable.com/wiki/compounds/A/Clorazepate" title="Clorazepate">Clorazepate</a></li>
<li><a href="Clotiazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Clotiazepam" title="Clotiazepam">Clotiazepam</a></li>
<li><a href="Cloxazolam.htm" tppabs="https://ptable.com/wiki/compounds/A/Cloxazolam" title="Cloxazolam">Cloxazolam</a></li>
<li><a href="Diazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Diazepam" title="Diazepam">Diazepam</a><sup>#</sup></li>
<li><a href="Ethyl_loflazepate.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethyl_loflazepate" title="Ethyl loflazepate">Ethyl loflazepate</a></li>
<li>Etizolam</li>
<li><a href="Fludiazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Fludiazepam" title="Fludiazepam">Fludiazepam</a></li>
<li><a href="Halazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Halazepam" title="Halazepam">Halazepam</a></li>
<li><a href="Ketazolam.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketazolam" title="Ketazolam">Ketazolam</a></li>
<li><a href="Lorazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Lorazepam" title="Lorazepam">Lorazepam</a><sup>#</sup></li>
<li>Medazepam</li>
<li><a href="Nordazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Nordazepam" title="Nordazepam">Nordazepam</a></li>
<li><a href="Oxazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxazepam" title="Oxazepam">Oxazepam</a></li>
<li>Pinazepam</li>
<li><a href="Prazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Prazepam" title="Prazepam">Prazepam</a>; <i>Others:</i> Alpidem<sup>‡</sup></li>
<li><a href="Barbiturate.htm" tppabs="https://ptable.com/wiki/compounds/A/Barbiturate" title="Barbiturate">Barbiturates</a> (e.g., <a href="Phenobarbital.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenobarbital" title="Phenobarbital">phenobarbital</a>)</li>
<li><a href="Carisoprodol.htm" tppabs="https://ptable.com/wiki/compounds/A/Carisoprodol" title="Carisoprodol">Carisoprodol</a></li>
<li>Carbamates (e.g., <a href="Meprobamate.htm" tppabs="https://ptable.com/wiki/compounds/A/Meprobamate" title="Meprobamate">meprobamate</a>)</li>
<li><a href="Chlormezanone.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlormezanone" title="Chlormezanone">Chlormezanone</a><sup>‡</sup></li>
<li>Ethanol (alcohol)</li>
<li>Etifoxine</li>
<li>Imepitoin; <i>Herbs:</i></li>
<li><a href="Kava.htm" tppabs="https://ptable.com/wiki/compounds/A/Kava" title="Kava">Kava</a></li>
<li>Skullcap</li>
<li>Valerian</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Gabapentinoids<br><span style="font-size:85%;">(<abbr>α<sub>2</sub>δ</abbr> <abbr>VDCC</abbr> blockers)</span></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Gabapentin.htm" tppabs="https://ptable.com/wiki/compounds/A/Gabapentin" title="Gabapentin">Gabapentin</a></li>
<li>Gabapentin enacarbil</li>
<li>Phenibut</li>
<li><a href="Pregabalin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregabalin" title="Pregabalin">Pregabalin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Antidepressants</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><abbr>SSRIs</abbr> (e.g., <a href="Escitalopram.htm" tppabs="https://ptable.com/wiki/compounds/A/Escitalopram" title="Escitalopram">escitalopram</a>)</li>
<li><abbr>SNRIs</abbr> (e.g., <a href="Duloxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Duloxetine" title="Duloxetine">duloxetine</a>)</li>
<li><abbr>SARIs</abbr> (e.g., <a href="Trazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Trazodone" title="Trazodone">trazodone</a>)</li>
<li><abbr>TCAs</abbr> (e.g., <a href="Clomipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomipramine" title="Clomipramine">clomipramine</a><sup>#</sup>)</li>
<li><abbr>TeCAs</abbr> (e.g., <a href="Mirtazapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mirtazapine" title="Mirtazapine">mirtazapine</a>)</li>
<li><abbr>MAOIs</abbr> (e.g., <a href="Phenelzine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenelzine" title="Phenelzine">phenelzine</a>); <i>Others:</i> Agomelatine</li>
<li><a href="Bupropion.htm" tppabs="https://ptable.com/wiki/compounds/A/Bupropion" title="Bupropion">Bupropion</a></li>
<li>Tianeptine</li>
<li>Vilazodone</li>
<li>Vortioxetine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Sympatholytics<br><span style="font-size:85%;">(Antiadrenergics)</span></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Alpha-1 blockers (e.g., <a href="Prazosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Prazosin" title="Prazosin">prazosin</a>)</li>
<li>Alpha-2 agonists (e.g., <a href="Clonidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clonidine" title="Clonidine">clonidine</a>, <a href="Dexmedetomidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexmedetomidine" title="Dexmedetomidine">dexmedetomidine</a>, <a href="Guanfacine.htm" tppabs="https://ptable.com/wiki/compounds/A/Guanfacine" title="Guanfacine">guanfacine</a>)</li>
<li>Beta blockers (e.g., <a href="Propranolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Propranolol" title="Propranolol">propranolol</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Benzoctamine</li>
<li><a href="Cannabidiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cannabidiol" title="Cannabidiol">Cannabidiol</a></li>
<li><a href="Cycloserine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cycloserine" title="Cycloserine">Cycloserine</a></li>
<li>Fabomotizole</li>
<li><a href="Hydroxyzine.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydroxyzine" title="Hydroxyzine">Hydroxyzine</a></li>
<li>Kanna</li>
<li>Lavender</li>
<li>Lorpiprazole</li>
<li>Mebicar</li>
<li>Mepiprazole</li>
<li><a href="Nicotine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotine" title="Nicotine">Nicotine</a></li>
<li>Opipramol</li>
<li>Oxaflozane<sup>‡</sup></li>
<li>Phenaglycodol</li>
<li>Phenibut</li>
<li>Picamilon</li>
<li>Selank</li>
<li><a href="Tiagabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tiagabine" title="Tiagabine">Tiagabine</a></li>
<li>Tofisopam</li>
<li>Validolum</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>

<div role="navigation" class="navbox" aria-labelledby="Neuropathic_pain_and_fibromyalgia_pharmacotherapies" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Neuropathic_pain_and_fibromyalgia_pharmacotherapies" style="font-size:114%;margin:0 4em">Neuropathic pain and fibromyalgia pharmacotherapies</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Monoaminergics</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><abbr>SNRIs</abbr> (e.g., <a href="Duloxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Duloxetine" title="Duloxetine">duloxetine</a>, <a href="Milnacipran.htm" tppabs="https://ptable.com/wiki/compounds/A/Milnacipran" title="Milnacipran">milnacipran</a>)</li>
<li><abbr>TCAs</abbr> (e.g., <a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">amitriptyline</a>, <a href="Nortriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Nortriptyline" title="Nortriptyline">nortriptyline</a>, dosulepin)</li>
<li>Opioid <abbr>MRIs</abbr> (e.g., tapentadol, <a href="Tramadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tramadol" title="Tramadol">tramadol</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Ion channel blockers</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Anticonvulsants (e.g., <a href="Gabapentin.htm" tppabs="https://ptable.com/wiki/compounds/A/Gabapentin" title="Gabapentin">gabapentin</a>, <a href="Pregabalin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregabalin" title="Pregabalin">pregabalin</a>, mirogabalin, <a href="Carbamazepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbamazepine" title="Carbamazepine">carbamazepine</a>, <a href="Oxcarbazepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxcarbazepine" title="Oxcarbazepine">oxcarbazepine</a>, lacosamide, <a href="Lamotrigine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lamotrigine" title="Lamotrigine">lamotrigine</a>)</li>
<li>Local anesthetics (e.g., <a href="Lidocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lidocaine" title="Lidocaine">lidocaine</a>)</li>
<li><a href="Mexiletine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mexiletine" title="Mexiletine">Mexiletine</a></li>
<li><abbr>TCAs</abbr> (e.g., <a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">amitriptyline</a>, <a href="Nortriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Nortriptyline" title="Nortriptyline">nortriptyline</a>, desipramine)</li>
<li>Ziconotide</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Alpha lipoic acid</li>
<li>Benfotiamine</li>
<li>Botulinum toxin A</li>
<li><a href="Bupropion.htm" tppabs="https://ptable.com/wiki/compounds/A/Bupropion" title="Bupropion">Bupropion</a></li>
<li>Cannabinoids (e.g., cannabis, dronabinol, <a href="Nabilone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nabilone" title="Nabilone">nabilone</a>)</li>
<li>NMDA receptor antagonists (e.g., <a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">ketamine</a>, <a href="Dextromethorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextromethorphan" title="Dextromethorphan">dextromethorphan</a>, <a href="Methadone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methadone" title="Methadone">methadone</a>)</li>
<li>Opioids (e.g., <a href="Hydrocodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrocodone" title="Hydrocodone">hydrocodone</a>, <a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">morphine</a>, <a href="Oxycodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxycodone" title="Oxycodone">oxycodone</a>, <a href="Methadone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methadone" title="Methadone">methadone</a>, <a href="Buprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buprenorphine" title="Buprenorphine">buprenorphine</a>, <a href="Tramadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tramadol" title="Tramadol">tramadol</a>, tapentadol)</li>
<li>Sodium oxybate (<abbr>GHB</abbr>)</li></ul>
</div></td></tr></tbody></table></div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Recreational_uses" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2" style="background:#e8e8ff;background:#ccccff"><div id="Recreational_uses" style="font-size:114%;margin:0 4em">Recreational uses</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;font-size:114%"><div style="padding:0px">
<div role="navigation" class="navbox" aria-labelledby="Drugs_which_induce_euphoria" style="padding:3px"><table class="nowraplinks hlist mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Drugs_which_induce_euphoria" style="font-size:114%;margin:0 4em">Drugs which induce euphoria</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>μ-Opioid receptor agonists (opioids) (e.g., <a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">morphine</a>, <a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">heroin</a>, <a href="Hydrocodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrocodone" title="Hydrocodone">hydrocodone</a>, <a href="Oxycodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxycodone" title="Oxycodone">oxycodone</a>, opium, kratom)</li>
<li>α<sub>2</sub>δ subunit-containing voltage-dependent calcium channels blockers (gabapentinoids) (e.g., <a href="Gabapentin.htm" tppabs="https://ptable.com/wiki/compounds/A/Gabapentin" title="Gabapentin">gabapentin</a>, <a href="Pregabalin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregabalin" title="Pregabalin">pregabalin</a>, phenibut)</li>
<li>AMPA receptor antagonists (e.g., perampanel)</li>
<li>CB<sub>1</sub> receptor agonists (cannabinoids) (e.g., <a href="Tetrahydrocannabinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrahydrocannabinol" title="Tetrahydrocannabinol">THC</a>, cannabis)</li>
<li>Dopamine receptor agonists (e.g., levodopa)</li>
<li>Dopamine releasing agents (e.g., <a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">amphetamine</a>, <a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">methamphetamine</a>, <a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA</a>, mephedrone)</li>
<li>Dopamine reuptake inhibitors (e.g., <a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">cocaine</a>, <a href="Methylphenidate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylphenidate" title="Methylphenidate">methylphenidate</a>)</li>
<li>GABA<sub>A</sub> receptor positive allosteric modulators (e.g., <a href="Barbiturate.htm" tppabs="https://ptable.com/wiki/compounds/A/Barbiturate" title="Barbiturate">barbiturates</a>, benzodiazepines, carbamates, ethanol (alcohol) (alcoholic drink), inhalants, nonbenzodiazepines, quinazolinones)</li>
<li><a href="Gamma-Hydroxybutyric_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Gamma-Hydroxybutyric_acid" title="Gamma-Hydroxybutyric acid">GHB</a> (sodium oxybate) and analogues</li>
<li>Glucocorticoids (corticosteroids) (e.g., <a href="Dexamethasone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexamethasone" title="Dexamethasone">dexamethasone</a>, <a href="Prednisone.htm" tppabs="https://ptable.com/wiki/compounds/A/Prednisone" title="Prednisone">prednisone</a>)</li>
<li>nACh receptor agonists (e.g., <a href="Nicotine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotine" title="Nicotine">nicotine</a>, tobacco, <a href="Arecoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Arecoline" title="Arecoline">arecoline</a>, areca nut)</li>
<li>Nitric oxide prodrugs (e.g., alkyl nitrites (poppers))</li>
<li>NMDA receptor antagonists (e.g., <a href="Dextromethorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextromethorphan" title="Dextromethorphan">DXM</a>, <a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">ketamine</a>, methoxetamine, <a href="Nitrous_oxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrous_oxide" title="Nitrous oxide">nitrous oxide</a>, <a href="Phencyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phencyclidine" title="Phencyclidine">phencyclidine</a>, inhalants)</li>
<li>Orexin receptor antagonists (e.g., suvorexant)</li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><i><b>See also:</b> Recreational drug use</i></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Recreational_drug_use" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2" style="text-align:center;"><div id="Recreational_drug_use" style="font-size:114%;margin:0 4em">Recreational drug use</div></th></tr><tr><th scope="row" class="navbox-group" style="text-align:center;;width:1%">Major<br> recreational<br> drugs</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Depressants</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Barbiturate.htm" tppabs="https://ptable.com/wiki/compounds/A/Barbiturate" title="Barbiturate">Barbiturates</a></li>
<li>Benzodiazepines</li>
<li>Carbamates</li>
<li>Ethanol (alcohol)
<ul><li>Alcoholic drinks</li>
<li>Beer</li>
<li>Wine</li></ul></li>
<li>Gabapentinoids</li>
<li><a href="Gamma-Hydroxybutyric_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Gamma-Hydroxybutyric_acid" title="Gamma-Hydroxybutyric acid">GHB</a></li>
<li>Inhalants
<ul><li>Medical
<ul><li><a href="Nitrous_oxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrous_oxide" title="Nitrous oxide">Nitrous oxide</a></li></ul></li>
<li>Hazardous solvents
<ul><li>contact adhesives</li>
<li>Gasoline</li>
<li>nail polish remover</li>
<li>Paint thinner</li></ul></li>
<li>Other
<ul><li>Freon</li></ul></li></ul></li>
<li><a href="Kava.htm" tppabs="https://ptable.com/wiki/compounds/A/Kava" title="Kava">Kava</a></li>
<li>Nonbenzodiazepines</li>
<li>Quinazolinones</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Opioids</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Buprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buprenorphine" title="Buprenorphine">Buprenorphine</a>
<ul><li>Suboxone</li>
<li>Subutex</li></ul></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Codeine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Codeine'" tppabs="https://ptable.com/wiki/compounds/A/Codeine" title="Codeine">Codeine</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Desomorphine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Desomorphine'" tppabs="https://ptable.com/wiki/compounds/A/Desomorphine" title="Desomorphine">Desomorphine</a>
<ul><li>Krokodil</li></ul></li>
<li><a href="Dextropropoxyphene.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextropropoxyphene" title="Dextropropoxyphene">Dextropropoxyphene</a>
<ul><li>Darvocet</li>
<li>Darvon</li></ul></li>
<li><a href="Fentanyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Fentanyl" title="Fentanyl">Fentanyl</a></li>
<li><a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">Diamorphine</a>
<ul><li>Heroin</li></ul></li>
<li><a href="Hydrocodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrocodone" title="Hydrocodone">Hydrocodone</a></li>
<li><a href="Hydromorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphone" title="Hydromorphone">Hydromorphone</a>
<ul><li>Dilaudid</li></ul></li>
<li><a href="Methadone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methadone" title="Methadone">Methadone</a></li>
<li>Mitragyna speciosa
<ul><li>Kratom</li></ul></li>
<li><a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">Morphine</a>
<ul><li>Opium</li></ul></li>
<li><a href="Oxycodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxycodone" title="Oxycodone">Oxycodone</a>
<ul><li>/paracetamol</li></ul></li>
<li><a href="Tramadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tramadol" title="Tramadol">Tramadol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Stimulants</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">Amphetamine</a></li>
<li><a href="Arecoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Arecoline" title="Arecoline">Arecoline</a>
<ul><li>Areca</li></ul></li>
<li>Betel</li>
<li><a href="Caffeine.htm" tppabs="https://ptable.com/wiki/compounds/A/Caffeine" title="Caffeine">Caffeine</a>
<ul><li>Coffee</li>
<li>Energy drinks</li>
<li>Tea</li></ul></li>
<li><a href="Cathinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Cathinone" title="Cathinone">Cathinone</a>
<ul><li>Khat</li></ul></li>
<li><a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">Cocaine</a>
<ul><li>Coca</li>
<li>Crack</li></ul></li>
<li><a href="Ephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedrine" title="Ephedrine">Ephedrine</a>
<ul><li><a href="Ephedra.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedra" title="Ephedra">Ephedra</a></li></ul></li>
<li>MDPV</li>
<li>Mephedrone</li>
<li><a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">Methamphetamine</a></li>
<li>Methylone</li>
<li><a href="Methylphenidate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylphenidate" title="Methylphenidate">Methylphenidate</a></li>
<li><a href="Modafinil.htm" tppabs="https://ptable.com/wiki/compounds/A/Modafinil" title="Modafinil">Modafinil</a></li>
<li><a href="Nicotine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotine" title="Nicotine">Nicotine</a>
<ul><li>Tobacco</li></ul></li>
<li><a href="Theobromine.htm" tppabs="https://ptable.com/wiki/compounds/A/Theobromine" title="Theobromine">Theobromine</a>
<ul><li>Cocoa</li>
<li>Chocolate</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Entactogens</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>2C series</li>
<li>6-APB
<ul><li>Benzofury</li></ul></li>
<li><a href="Alpha-Methyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Methyltryptamine" title="Alpha-Methyltryptamine">AMT</a></li>
<li><a href="3,4-Methylenedioxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">MDA</a></li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA</a>
<ul><li>Ecstasy</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Hallucinogens</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Psychedelics</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Bufotenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bufotenin" title="Bufotenin">Bufotenin</a>
<ul><li>Psychoactive toads</li>
<li>Vilca</li>
<li>Yopo</li></ul></li>
<li>DMT
<ul><li>Ayahuasca</li></ul></li>
<li>LSA</li>
<li><a href="Lysergic_acid_diethylamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Lysergic_acid_diethylamide" title="Lysergic acid diethylamide">LSD-25</a></li>
<li>Mescaline
<ul><li>Peruvian torch</li>
<li>Peyote</li>
<li>San Pedro</li></ul></li>
<li>Psilocybin / <a href="Psilocin.htm" tppabs="https://ptable.com/wiki/compounds/A/Psilocin" title="Psilocin">Psilocin</a>
<ul><li>Psilocybin mushrooms</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Dissociatives</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Dextromethorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextromethorphan" title="Dextromethorphan">DXM</a></li>
<li>Glaucine</li>
<li>Inhalants
<ul><li><a href="Nitrous_oxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrous_oxide" title="Nitrous oxide">Nitrous oxide</a></li>
<li>alkyl nitrites</li>
<li>poppers</li>
<li><a href="Amyl_nitrite.htm" tppabs="https://ptable.com/wiki/compounds/A/Amyl_nitrite" title="Amyl nitrite">amyl nitrite</a></li></ul></li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li>MXE</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Muscimol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Muscimol'" tppabs="https://ptable.com/wiki/compounds/A/Muscimol" title="Muscimol">Muscimol</a>
<ul><li>Amanita muscaria</li></ul></li>
<li><a href="Phencyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phencyclidine" title="Phencyclidine">PCP</a></li>
<li><a href="Salvinorin_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Salvinorin_A" title="Salvinorin A">Salvinorin A</a>
<ul><li><a href="Salvia_divinorum.htm" tppabs="https://ptable.com/wiki/compounds/A/Salvia_divinorum" title="Salvia divinorum">Salvia divinorum</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Deliriants</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Atropine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atropine" title="Atropine">Atropine</a> and <a href="Scopolamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Scopolamine" title="Scopolamine" class="mw-redirect">Scopolamine</a>
<ul><li>Atropa belladonna</li>
<li>Datura</li>
<li>Hyoscyamus niger</li>
<li>Mandragora officinarum</li></ul></li>
<li><a href="Dimenhydrinate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimenhydrinate" title="Dimenhydrinate">Dimenhydrinate</a></li>
<li><a href="Diphenhydramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diphenhydramine" title="Diphenhydramine">Diphenhydramine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Cannabinoids</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>JWH-018</li>
<li><a href="Tetrahydrocannabinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrahydrocannabinol" title="Tetrahydrocannabinol">THC</a>
<ul><li>Cannabis</li>
<li>Hashish</li>
<li>Hash oil</li>
<li>Marijuana</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Oneirogens</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Calea zacatechichi</li>
<li>Silene capensis</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Club drugs</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">Cocaine</a></li>
<li>Quaaludes</li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA</a> (Ecstasy)</li>
<li><a href="Nitrous_oxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrous_oxide" title="Nitrous oxide">Nitrous oxide</a></li>
<li>Poppers</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="text-align:center;;width:1%">Drug culture</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Cannabis culture</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>420</li>
<li>Cannabis cultivation</li>
<li>Cannabis smoking</li>
<li>Head shop</li>
<li>Legal history of cannabis in the United States</li>
<li>Legality of cannabis</li>
<li>Marijuana Policy Project</li>
<li>Medical cannabis</li>
<li>NORML</li>
<li>Cannabis and religion</li>
<li>Stoner film</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Coffee culture</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Coffee break</li>
<li>Coffeehouse</li>
<li>Latte art</li>
<li>Tea house</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Drinking culture</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Bartending</li>
<li>Beer culture</li>
<li>Beer festival</li>
<li>Binge drinking</li>
<li><a href="Diethyl_ether.htm#Recreational_use" tppabs="https://ptable.com/wiki/compounds/A/Diethyl_ether#Recreational_use" title="Diethyl ether">Diethyl ether</a></li>
<li>Drinking games</li>
<li>Drinking song</li>
<li>Happy hour</li>
<li>Hip flask</li>
<li>Nightclub</li>
<li>Pub</li>
<li>Pub crawl</li>
<li>Sommelier</li>
<li>Sports bar</li>
<li>Tailgate party</li>
<li>Wine bar</li>
<li>Wine tasting</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Psychedelia</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Psychonautics</li>
<li>Art</li>
<li>Drug</li>
<li>Era</li>
<li>Experience</li>
<li>Literature</li>
<li>Music</li>
<li>Microdosing</li>
<li>Therapy</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Smoking culture</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Cigarette card</li>
<li>Fashion cigarettes</li>
<li>Cloud-chasing</li>
<li>Loosie</li>
<li>Smokeasy</li>
<li>Smoking fetishism</li>
<li>Tobacco smoking</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Other</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Club drug</li>
<li>Counterculture of the 1960s</li>
<li>Dance party</li>
<li>Drug paraphernalia</li>
<li>Drug tourism</li>
<li>Entheogen</li>
<li>Hippie</li>
<li>Needle sharing</li>
<li>Nootropic</li>
<li>Party and play</li>
<li>Poly drug use</li>
<li>Rave</li>
<li>Religion and drugs</li>
<li>Self-medication</li>
<li>Sex and drugs</li>
<li>Whoonga</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="text-align:center;;width:1%">Drug<br> production<br> and trade</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Drug<br> production</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Coca production in Colombia</li>
<li>Drug precursors</li>
<li>Opium production in Afghanistan</li>
<li>Rolling meth lab</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Drug trade</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Illegal drug trade
<ul><li>Colombia</li></ul></li>
<li>Darknet market</li>
<li>Drug distribution
<ul><li>Beer shop</li>
<li>Cannabis shop</li>
<li>Liquor store</li>
<li>Liquor license</li></ul></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="text-align:center;;width:1%">Issues with<br> drug use</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Abuse</li>
<li>Date rape drug</li>
<li>Impaired driving</li>
<li>Drug harmfulness
<ul><li>Effects of cannabis</li></ul></li>
<li>Addiction</li>
<li>Dependence
<ul><li>Prevention</li>
<li>Opioid replacement therapy</li>
<li>Rehabilitation</li>
<li>Responsible use</li></ul></li>
<li>Drug-related crime</li>
<li>Fetal alcohol spectrum disorder</li>
<li>Long-term effects of cannabis</li>
<li>Neurotoxicity</li>
<li>Overdose</li>
<li>Passive smoking
<ul><li>of tobacco or other substances</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="text-align:center;;width:1%">Legality of<br> drug use</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">International</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>1961 Narcotic Drugs</li>
<li>1971 Psychotropic Substances</li>
<li>1988 Drug Trafficking</li>
<li>Council of the European Union decisions on designer drugs</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">State level</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Drug policy
<ul><li>Decriminalization</li>
<li>Prohibition</li>
<li>Supply reduction</li></ul></li>
<li>Policy reform
<ul><li>Demand reduction</li>
<li>Drug Policy Alliance</li>
<li>Harm reduction</li>
<li>Law Enforcement Action Partnership</li>
<li>Liberalization
<ul><li>Latin America</li></ul></li>
<li>Students for Sensible Drug Policy</li>
<li>Transform Drug Policy Foundation</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Drug policy<br>by country</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Australia</li>
<li>Canada</li>
<li>Germany</li>
<li>India</li>
<li>Netherlands</li>
<li>Portugal</li>
<li>Slovakia</li>
<li>Soviet Union</li>
<li>Sweden</li>
<li>Switzerland</li>
<li>United States
<ul><li>Just Say No</li>
<li>Office of National Drug Control Policy</li>
<li>School district drug policies</li>
<li>California</li>
<li>Colorado</li>
<li>Maryland</li>
<li>Virginia</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Other</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Arguments for and against drug prohibition</li>
<li>Capital punishment for drug trafficking</li>
<li>Cognitive liberty</li>
<li>Designer drug</li>
<li>Drug court</li>
<li>Drug possession</li>
<li>Drug test</li>
<li>Narc</li>
<li>Politics of drug abuse</li>
<li>War on Drugs
<ul><li>Mexican Drug War</li>
<li>Plan Colombia</li>
<li>Philippine Drug War</li></ul></li>
<li>Zero tolerance</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="text-align:center;;width:1%">Lists of<br> countries by...</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Alcohol legality
<ul><li>Alcohol consumption</li></ul></li>
<li>Anabolic steroid legality</li>
<li>Cannabis legality
<ul><li>Annual use</li>
<li>Lifetime use</li></ul></li>
<li>Cigarette consumption</li>
<li>Cocaine legality
<ul><li>Cocaine use</li></ul></li>
<li>Methamphetamine legality</li>
<li>Opiates use</li>
<li>Psilocybin mushrooms legality</li>
<li>Salvia legality</li></ul>
</div></td></tr></tbody></table></div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Ion_channel_modulators" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Ion_channel_modulators" style="font-size:114%;margin:0 4em">Ion channel modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Calcium</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="VDCCs" scope="row" class="navbox-group" style="width:5em;;text-align:center;"><abbr>VDCCs</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Blockers</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>L-type-selective:</b> <i>Dihydropyridines:</i> <a href="Amlodipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amlodipine" title="Amlodipine">Amlodipine</a></li>
<li>Aranidipine</li>
<li>Azelnidipine</li>
<li>Barnidipine</li>
<li>Clevidipine</li>
<li><span class="new">Cronidipine</span></li>
<li>Darodipine</li>
<li><span class="new">Dexniguldipine</span></li>
<li><span class="new">Elgodipine</span></li>
<li><span class="new">Elnadipine</span></li>
<li><a href="Felodipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Felodipine" title="Felodipine">Felodipine</a></li>
<li><span class="new">Flordipine</span></li>
<li><span class="new">Furnidipine</span></li>
<li><span class="new">Iganidipine</span></li>
<li><a href="Isradipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Isradipine" title="Isradipine">Isradipine</a></li>
<li><a href="Lacidipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lacidipine" title="Lacidipine">Lacidipine</a></li>
<li><span class="new">Lemildipine</span></li>
<li><a href="Lercanidipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lercanidipine" title="Lercanidipine">Lercanidipine</a></li>
<li>Levamlodipine</li>
<li><span class="new">Levniguldipine</span></li>
<li>Manidipine</li>
<li>Mepirodipine</li>
<li><span class="new">Mesudipine</span></li>
<li><a href="Nicardipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicardipine" title="Nicardipine">Nicardipine</a></li>
<li><a href="Nifedipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nifedipine" title="Nifedipine">Nifedipine</a></li>
<li>Niguldipine</li>
<li>Niludipine</li>
<li>Nilvadipine</li>
<li><a href="Nimodipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nimodipine" title="Nimodipine">Nimodipine</a></li>
<li><a href="Nisoldipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nisoldipine" title="Nisoldipine">Nisoldipine</a></li>
<li><a href="Nitrendipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrendipine" title="Nitrendipine">Nitrendipine</a></li>
<li><span class="new">Olradipine</span></li>
<li>Oxodipine</li>
<li><span class="new">Palonidipine</span></li>
<li>Pranidipine</li>
<li>Ryodipine (riodipine)</li>
<li><span class="new">Sagandipine</span></li>
<li><span class="new">Sornidipine</span></li>
<li><span class="new">Teludipine</span></li>
<li><span class="new">Tiamdipine</span></li>
<li><span class="new">Trombodipine</span></li>
<li><span class="new">Vatanidipine</span>; <i><a href="Diltiazem.htm" tppabs="https://ptable.com/wiki/compounds/A/Diltiazem" title="Diltiazem">Diltiazem</a> derivatives:</i> Clentiazem</li>
<li><a href="Diltiazem.htm" tppabs="https://ptable.com/wiki/compounds/A/Diltiazem" title="Diltiazem">Diltiazem</a></li>
<li><span class="new">Iprotiazem</span></li>
<li><span class="new">Nictiazem</span></li>
<li><span class="new">Siratiazem</span>; <i>Phenylalkylamines:</i> Anipamil</li>
<li><span class="new">Dagapamil</span></li>
<li>Devapamil</li>
<li><span class="new">Dexverapamil</span></li>
<li><a href="Emopamil.htm" tppabs="https://ptable.com/wiki/compounds/A/Emopamil" title="Emopamil">Emopamil</a></li>
<li><span class="new">Etripamil</span></li>
<li>Falipamil</li>
<li><a href="Gallopamil.htm" tppabs="https://ptable.com/wiki/compounds/A/Gallopamil" title="Gallopamil">Gallopamil</a></li>
<li><span class="new">Levemopamil</span></li>
<li><span class="new">Nexopamil</span></li>
<li>Norverapamil</li>
<li><span class="new">Ronipamil</span></li>
<li>Tiapamil</li>
<li><a href="Verapamil.htm" tppabs="https://ptable.com/wiki/compounds/A/Verapamil" title="Verapamil">Verapamil</a>; <i>Others:</i> AH-1058</li>
<li><span class="new">Brinazarone</span></li>
<li>Budiodarone</li>
<li>Celivarone</li>
<li><a href="Cyproheptadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyproheptadine" title="Cyproheptadine">Cyproheptadine</a></li>
<li>Dronedarone</li>
<li>Fantofarone</li>
<li><span class="new">SR-33805</span></li>
<li><a href="Tetrahydropalmatine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrahydropalmatine" title="Tetrahydropalmatine">Tetrahydropalmatine</a></li></ul>

<ul><li><b>N-type-selective:</b> ω-Conotoxins</li>
<li><span class="new">ω-Conotoxin GVIA</span></li>
<li>Caroverine</li>
<li><span class="new">Huwentoxin XVI</span></li>
<li>Leconotide (ω-conotoxin CVID)</li>
<li><span class="new">PD-173212</span></li>
<li>Ralfinamide</li>
<li>Safinamide</li>
<li><span class="new">Z160</span></li>
<li>Ziconotide (ω-conotoxin MVIIA)</li></ul>

<ul><li><b>P-type-selective:</b> <span class="new">ω-Agatoxin IVA</span></li>
<li><span class="new">ω-Agatoxin IVB</span></li></ul>

<ul><li><b>R-type-selective:</b> SNX-482</li></ul>

<ul><li><b>T-type-selective:</b> <span class="new">ABT-639</span></li>
<li><span class="new">ML-218</span></li>
<li><a href="Niflumic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Niflumic_acid" title="Niflumic acid">Niflumic acid</a></li>
<li><span class="new">NNC 55-0396</span></li>
<li><span class="new">ProTx I</span></li>
<li><span class="new">Z944</span></li>
<li><a href="Zonisamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Zonisamide" title="Zonisamide">Zonisamide</a></li></ul>

<ul><li><b>Non-selective:</b> <span class="new">ω-Agatoxin TK</span></li>
<li><span class="new">ω-Conotoxin MVIIC</span></li>
<li>Benidipine</li>
<li><a href="Bepridil.htm" tppabs="https://ptable.com/wiki/compounds/A/Bepridil" title="Bepridil">Bepridil</a></li>
<li><a href="Cilnidipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cilnidipine" title="Cilnidipine">Cilnidipine</a></li>
<li><a href="Cinnarizine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cinnarizine" title="Cinnarizine">Cinnarizine</a></li>
<li>Dotarizine</li>
<li>Efonidipine</li>
<li><a href="Flunarizine.htm" tppabs="https://ptable.com/wiki/compounds/A/Flunarizine" title="Flunarizine">Flunarizine</a></li>
<li><a href="Lamotrigine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lamotrigine" title="Lamotrigine">Lamotrigine</a></li>
<li><a href="Levetiracetam.htm" tppabs="https://ptable.com/wiki/compounds/A/Levetiracetam" title="Levetiracetam">Levetiracetam</a></li>
<li>Lomerizine</li>
<li><a href="Loperamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Loperamide" title="Loperamide">Loperamide</a></li>
<li><a href="Mibefradil.htm" tppabs="https://ptable.com/wiki/compounds/A/Mibefradil" title="Mibefradil">Mibefradil</a></li>
<li><span class="new">NP078585</span></li>
<li>Ruthenium red</li>
<li>TROX-1</li></ul>

<ul><li><b>α<sub>2</sub>δ subunit-selective (gabapentinoids):</b> 4-Methylpregabalin</li>
<li>Arbaclofen</li>
<li>Arbaclofen placarbil</li>
<li>Atagabalin</li>
<li><a href="Baclofen.htm" tppabs="https://ptable.com/wiki/compounds/A/Baclofen" title="Baclofen">Baclofen</a></li>
<li><a href="Gabapentin.htm" tppabs="https://ptable.com/wiki/compounds/A/Gabapentin" title="Gabapentin">Gabapentin</a></li>
<li>Gabapentin enacarbil</li>
<li>Imagabalin</li>
<li>Mirogabalin</li>
<li><span class="new">PD-200,347</span></li>
<li>PD-217,014</li>
<li><span class="new">PD-299,685</span></li>
<li>Phenibut</li>
<li><a href="Pregabalin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregabalin" title="Pregabalin">Pregabalin</a></li></ul>

<ul><li><b>Others/unsorted:</b> Bencyclane</li>
<li>Berbamine</li>
<li><a href="Bevantolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Bevantolol" title="Bevantolol">Bevantolol</a></li>
<li>Canadine</li>
<li>Carboxyamidotriazole</li>
<li>Cycleanine</li>
<li>Dauricine</li>
<li>Dimeditiapramine</li>
<li>Diproteverine</li>
<li>Enpiperate</li>
<li>Eperisone</li>
<li><span class="new">Elpetrigine</span></li>
<li>Ethadione</li>
<li>Ethanol (alcohol)</li>
<li><a href="Ethosuximide.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethosuximide" title="Ethosuximide">Ethosuximide</a></li>
<li>Fasudil</li>
<li>Fendiline</li>
<li>Fostedil</li>
<li>Imepitoin</li>
<li><a href="JTV-519.htm" tppabs="https://ptable.com/wiki/compounds/A/JTV-519" title="JTV-519">JTV-519</a></li>
<li><a href="Lidoflazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lidoflazine" title="Lidoflazine">Lidoflazine</a></li>
<li><a href="Magnesium.htm" tppabs="https://ptable.com/wiki/compounds/A/Magnesium" title="Magnesium">Magnesium</a></li>
<li>Manoalide</li>
<li><a href="Mesuximide.htm" tppabs="https://ptable.com/wiki/compounds/A/Mesuximide" title="Mesuximide">Mesuximide</a></li>
<li>Monatepil</li>
<li><a href="Naftopidil.htm" tppabs="https://ptable.com/wiki/compounds/A/Naftopidil" title="Naftopidil">Naftopidil</a></li>
<li><a href="Ochratoxin_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Ochratoxin_A" title="Ochratoxin A">Ochratoxin A</a></li>
<li>Osthol</li>
<li>Otilonium bromide</li>
<li><a href="Paramethadione.htm" tppabs="https://ptable.com/wiki/compounds/A/Paramethadione" title="Paramethadione">Paramethadione</a></li>
<li><a href="Phensuximide.htm" tppabs="https://ptable.com/wiki/compounds/A/Phensuximide" title="Phensuximide">Phensuximide</a></li>
<li>Pinaverium bromide</li>
<li><a href="Prenylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Prenylamine" title="Prenylamine">Prenylamine</a></li>
<li>Rhynchophylline</li>
<li>Sesamodil</li>
<li>Silperisone</li>
<li><span class="new">Sipatrigine</span></li>
<li>Terodiline</li>
<li><a href="Tetrandrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrandrine" title="Tetrandrine">Tetrandrine</a></li>
<li>Tolperisone</li>
<li><a href="Trimethadione.htm" tppabs="https://ptable.com/wiki/compounds/A/Trimethadione" title="Trimethadione">Trimethadione</a></li>
<li>Valperinol</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Activators</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>L-type-selective:</b> Bay K8644</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Potassium</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><abbr>VGKCs</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Blockers</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="3,4-Diaminopyridine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Diaminopyridine" title="3,4-Diaminopyridine" class="mw-redirect">3,4-Diaminopyridine (amifampridine)</a></li>
<li><a href="4-Aminopyridine.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Aminopyridine" title="4-Aminopyridine">4-Aminopyridine (fampridine/dalfampridine)</a></li>
<li><span class="new">Adekalant</span></li>
<li>Almokalant</li>
<li><a href="Amiodarone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amiodarone" title="Amiodarone">Amiodarone</a></li>
<li>Azimilide</li>
<li><a href="Bretylium.htm" tppabs="https://ptable.com/wiki/compounds/A/Bretylium" title="Bretylium">Bretylium</a></li>
<li>Bunaftine</li>
<li>Charybdotoxin</li>
<li><span class="new">Clamikalant</span></li>
<li>Conotoxins</li>
<li><span class="new">Dalazatide</span></li>
<li>Dendrotoxin</li>
<li><a href="Dofetilide.htm" tppabs="https://ptable.com/wiki/compounds/A/Dofetilide" title="Dofetilide">Dofetilide</a></li>
<li>Dronedarone</li>
<li>E-4031</li>
<li>Hanatoxin</li>
<li>HgeTx1</li>
<li>HsTx1</li>
<li><a href="Ibutilide.htm" tppabs="https://ptable.com/wiki/compounds/A/Ibutilide" title="Ibutilide">Ibutilide</a></li>
<li><span class="new">Inakalant</span></li>
<li>Kaliotoxin</li>
<li>Linopirdine</li>
<li>Lolitrem B</li>
<li>Maurotoxin</li>
<li>Nifekalant</li>
<li><span class="new">Notoxin</span></li>
<li><a href="Paxilline.htm" tppabs="https://ptable.com/wiki/compounds/A/Paxilline" title="Paxilline">Paxilline</a></li>
<li><span class="new">Pinokalant</span></li>
<li><a href="Quinidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinidine" title="Quinidine">Quinidine</a></li>
<li><span class="new">ShK-186</span></li>
<li><a href="Sotalol.htm" tppabs="https://ptable.com/wiki/compounds/A/Sotalol" title="Sotalol">Sotalol</a></li>
<li>Tedisamil</li>
<li><span class="new">Terikalant</span></li>
<li><a href="Tetraethylammonium.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetraethylammonium" title="Tetraethylammonium">Tetraethylammonium</a></li>
<li>Vernakalant</li></ul>

<ul><li><b>hERG (KCNH2, K<sub>v</sub>11.1)-specific:</b> <a href="Ajmaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Ajmaline" title="Ajmaline">Ajmaline</a></li>
<li><a href="Amiodarone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amiodarone" title="Amiodarone">Amiodarone</a></li>
<li>AmmTX3</li>
<li><a href="Astemizole.htm" tppabs="https://ptable.com/wiki/compounds/A/Astemizole" title="Astemizole">Astemizole</a></li>
<li>Azaspiracid</li>
<li>AZD1305</li>
<li>Azimilide</li>
<li>Bedaquiline</li>
<li>BeKm-1</li>
<li>BmTx3</li>
<li>BRL-32872</li>
<li><a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li>
<li><a href="Cisapride.htm" tppabs="https://ptable.com/wiki/compounds/A/Cisapride" title="Cisapride">Cisapride</a></li>
<li><a href="Clarithromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Clarithromycin" title="Clarithromycin">Clarithromycin</a></li>
<li><a href="Darifenacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Darifenacin" title="Darifenacin">Darifenacin</a></li>
<li><a href="Dextropropoxyphene.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextropropoxyphene" title="Dextropropoxyphene">Dextropropoxyphene</a></li>
<li>Diallyl trisulfide</li>
<li><a href="Domperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Domperidone" title="Domperidone">Domperidone</a></li>
<li>E-4031</li>
<li>Ergtoxins</li>
<li><a href="Erythromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Erythromycin" title="Erythromycin">Erythromycin</a></li>
<li>Gigactonine</li>
<li><a href="Haloperidol.htm" tppabs="https://ptable.com/wiki/compounds/A/Haloperidol" title="Haloperidol">Haloperidol</a></li>
<li><a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li>
<li>Norpropoxyphene</li>
<li><a href="Orphenadrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Orphenadrine" title="Orphenadrine">Orphenadrine</a></li>
<li><a href="Pimozide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pimozide" title="Pimozide">Pimozide</a></li>
<li>PNU-282,987</li>
<li><a href="Promethazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Promethazine" title="Promethazine">Promethazine</a></li>
<li><a href="Quinidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinidine" title="Quinidine">Quinidine</a></li>
<li><a href="Ranolazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ranolazine" title="Ranolazine">Ranolazine</a></li>
<li><a href="Roxithromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Roxithromycin" title="Roxithromycin">Roxithromycin</a></li>
<li><a href="Sertindole.htm" tppabs="https://ptable.com/wiki/compounds/A/Sertindole" title="Sertindole">Sertindole</a></li>
<li><a href="Solifenacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Solifenacin" title="Solifenacin">Solifenacin</a></li>
<li>Tamulotoxin</li>
<li>Terodiline</li>
<li><a href="Terfenadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Terfenadine" title="Terfenadine">Terfenadine</a></li>
<li><a href="Thioridazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thioridazine" title="Thioridazine">Thioridazine</a></li>
<li><a href="Tolterodine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolterodine" title="Tolterodine">Tolterodine</a></li>
<li><a href="Vanoxerine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vanoxerine" title="Vanoxerine">Vanoxerine</a></li>
<li>Vernakalant</li></ul>

<ul><li><b>KCNQ (K<sub>v</sub>7)-specific:</b> Linopirdine</li>
<li><span class="new">XE-991</span></li>
<li>Spooky toxin (SsTx)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Activators</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>KCNQ (K<sub>v</sub>7)-specific:</b> Flupirtine</li>
<li>Retigabine</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><abbr>IRKs</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Blockers</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b><abbr>K<sub>ATP</sub></abbr>-specific:</b> <a href="Acetohexamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetohexamide" title="Acetohexamide">Acetohexamide</a></li>
<li><a href="Carbutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbutamide" title="Carbutamide">Carbutamide</a></li>
<li><a href="Chlorpropamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpropamide" title="Chlorpropamide">Chlorpropamide</a></li>
<li><a href="Glibenclamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Glibenclamide" title="Glibenclamide">Glibenclamide (glyburide)</a></li>
<li>Glibornuride</li>
<li>Glicaramide</li>
<li><a href="Gliclazide.htm" tppabs="https://ptable.com/wiki/compounds/A/Gliclazide" title="Gliclazide">Gliclazide</a></li>
<li><a href="Glimepiride.htm" tppabs="https://ptable.com/wiki/compounds/A/Glimepiride" title="Glimepiride">Glimepiride</a></li>
<li><a href="Glipizide.htm" tppabs="https://ptable.com/wiki/compounds/A/Glipizide" title="Glipizide">Glipizide</a></li>
<li><a href="Gliquidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gliquidone" title="Gliquidone">Gliquidone</a></li>
<li><a href="Glisoxepide.htm" tppabs="https://ptable.com/wiki/compounds/A/Glisoxepide" title="Glisoxepide">Glisoxepide</a></li>
<li>Glyclopyramide</li>
<li><span class="new">Glycyclamide</span></li>
<li>Metahexamide</li>
<li><a href="Mitiglinide.htm" tppabs="https://ptable.com/wiki/compounds/A/Mitiglinide" title="Mitiglinide">Mitiglinide</a></li>
<li><a href="Nateglinide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nateglinide" title="Nateglinide">Nateglinide</a></li>
<li><a href="Repaglinide.htm" tppabs="https://ptable.com/wiki/compounds/A/Repaglinide" title="Repaglinide">Repaglinide</a></li>
<li><a href="Tolazamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolazamide" title="Tolazamide">Tolazamide</a></li>
<li><a href="Tolbutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolbutamide" title="Tolbutamide">Tolbutamide</a></li></ul>

<ul><li><b><abbr>GIRK</abbr>-specific:</b> <a href="Barium.htm" tppabs="https://ptable.com/wiki/compounds/A/Barium" title="Barium">Barium</a></li>
<li>Caramiphen</li>
<li>Cloperastine</li>
<li><a href="Clozapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clozapine" title="Clozapine">Clozapine</a></li>
<li><a href="Dextromethorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextromethorphan" title="Dextromethorphan">Dextromethorphan</a></li>
<li><a href="Ethosuximide.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethosuximide" title="Ethosuximide">Ethosuximide</a></li>
<li>Ifenprodil</li>
<li>Tertiapin</li>
<li>Tipepidine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Activators</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b><abbr>K<sub>ATP</sub></abbr>-specific:</b> <span class="new">Aprikalim</span></li>
<li>Bimakalim</li>
<li>Cromakalim</li>
<li><a href="Diazoxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Diazoxide" title="Diazoxide">Diazoxide</a></li>
<li><span class="new">Emakalim</span></li>
<li>Levcromakalim</li>
<li><span class="new">Mazokalim</span></li>
<li><a href="Minoxidil.htm" tppabs="https://ptable.com/wiki/compounds/A/Minoxidil" title="Minoxidil">Minoxidil</a></li>
<li><span class="new">Naminidil</span></li>
<li>Nicorandil</li>
<li><a href="Pinacidil.htm" tppabs="https://ptable.com/wiki/compounds/A/Pinacidil" title="Pinacidil">Pinacidil</a></li>
<li><span class="new">Rilmakalim</span></li>
<li><span class="new">Sarakalim</span></li></ul>

<ul><li><b><abbr>GIRK</abbr>-specific:</b> <span class="new">ML-297 (VU0456810)</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><abbr>K<sub>Ca</sub></abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Blockers</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>BK<sub>Ca</sub>-specific:</b> Ethanol (alcohol)</li>
<li>GAL-021</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Activators</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>BK<sub>Ca</sub>-specific:</b> <a href="Flufenamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Flufenamic_acid" title="Flufenamic acid">Flufenamic acid</a></li>
<li><a href="Meclofenamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Meclofenamic_acid" title="Meclofenamic acid">Meclofenamic acid</a></li>
<li><a href="Niflumic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Niflumic_acid" title="Niflumic acid">Niflumic acid</a></li>
<li><a href="Nimesulide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nimesulide" title="Nimesulide">Nimesulide</a></li>
<li><a href="Rottlerin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rottlerin" title="Rottlerin">Rottlerin (mallotoxin)</a></li>
<li><a href="Tolfenamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolfenamic_acid" title="Tolfenamic acid">Tolfenamic acid</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><abbr>K2Ps</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Blockers</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="12-O-Tetradecanoylphorbol-13-acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/12-O-Tetradecanoylphorbol-13-acetate" title="12-O-Tetradecanoylphorbol-13-acetate">12-O-Tetradecanoylphorbol-13-acetate</a></li>
<li><a href="Arachidonic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Arachidonic_acid" title="Arachidonic acid">Arachidonic acid</a></li>
<li><a href="Fluoxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluoxetine" title="Fluoxetine">Fluoxetine</a></li>
<li>Norfluoxetine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Activators</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Riluzole.htm" tppabs="https://ptable.com/wiki/compounds/A/Riluzole" title="Riluzole">Riluzole</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Sodium</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><abbr>VGSCs</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Blockers</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Antianginals:</i> <a href="Ranolazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ranolazine" title="Ranolazine">Ranolazine</a></li></ul>

<ul><li><i>Antiarrhythmics (class I):</i> <a href="Ajmaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Ajmaline" title="Ajmaline">Ajmaline</a></li>
<li><a href="Aprindine.htm" tppabs="https://ptable.com/wiki/compounds/A/Aprindine" title="Aprindine">Aprindine</a></li>
<li><a href="Disopyramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Disopyramide" title="Disopyramide">Disopyramide</a></li>
<li>Dronedarone</li>
<li><a href="Encainide.htm" tppabs="https://ptable.com/wiki/compounds/A/Encainide" title="Encainide">Encainide</a></li>
<li><a href="Flecainide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flecainide" title="Flecainide">Flecainide</a></li>
<li><a href="Lidocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lidocaine" title="Lidocaine">Lidocaine</a></li>
<li>Lorajmine</li>
<li>Lorcainide</li>
<li><a href="Mexiletine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mexiletine" title="Mexiletine">Mexiletine</a></li>
<li><a href="Moracizine.htm" tppabs="https://ptable.com/wiki/compounds/A/Moracizine" title="Moracizine">Moricizine</a></li>
<li>Pilsicainide</li>
<li>Prajmaline</li>
<li><a href="Procainamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Procainamide" title="Procainamide">Procainamide</a></li>
<li><a href="Propafenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Propafenone" title="Propafenone">Propafenone</a></li>
<li><a href="Quinidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinidine" title="Quinidine">Quinidine</a></li>
<li>Sparteine</li>
<li><a href="Tocainide.htm" tppabs="https://ptable.com/wiki/compounds/A/Tocainide" title="Tocainide">Tocainide</a></li></ul>

<ul><li><i>Anticonvulsants:</i> <span class="new">Acetylpheneturide</span></li>
<li><a href="Carbamazepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbamazepine" title="Carbamazepine">Carbamazepine</a></li>
<li>Cenobamate</li>
<li>Chlorphenacemide</li>
<li><span class="new">Elpetrigine</span></li>
<li>Eslicarbazepine acetate</li>
<li><a href="Ethotoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethotoin" title="Ethotoin">Ethotoin</a></li>
<li><a href="Fosphenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Fosphenytoin" title="Fosphenytoin">Fosphenytoin</a></li>
<li>Lacosamide</li>
<li>Licarbazepine</li>
<li><a href="Mephenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mephenytoin" title="Mephenytoin">Mephenytoin</a></li>
<li><a href="Oxcarbazepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxcarbazepine" title="Oxcarbazepine">Oxcarbazepine</a></li>
<li>Oxitriptyline</li>
<li><a href="Phenacemide.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenacemide" title="Phenacemide">Phenacemide</a></li>
<li>Pheneturide</li>
<li><a href="Phenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenytoin" title="Phenytoin">Phenytoin</a></li>
<li>Rufinamide</li>
<li><span class="new">Sipatrigine</span></li>
<li><a href="Topiramate.htm" tppabs="https://ptable.com/wiki/compounds/A/Topiramate" title="Topiramate">Topiramate</a></li>
<li><a href="Sodium_valproate.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium_valproate" title="Sodium valproate" class="mw-redirect">Sodium valproate</a></li>
<li>Valnoctamide</li>
<li>Valproate pivoxil</li>
<li><a href="Valproate_semisodium.htm" tppabs="https://ptable.com/wiki/compounds/A/Valproate_semisodium" title="Valproate semisodium" class="mw-redirect">Valproate semisodium</a></li>
<li><a href="Valproic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Valproic_acid" title="Valproic acid" class="mw-redirect">Valproic acid</a></li>
<li><a href="Valpromide.htm" tppabs="https://ptable.com/wiki/compounds/A/Valpromide" title="Valpromide">Valpromide</a></li>
<li><a href="Zonisamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Zonisamide" title="Zonisamide">Zonisamide</a></li></ul>

<ul><li><i>Local anesthetics:</i> <i>p</i>FBT</li>
<li>Amylocaine</li>
<li>Articaine</li>
<li><a href="Benzocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzocaine" title="Benzocaine">Benzocaine</a></li>
<li><a href="Bupivacaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Bupivacaine" title="Bupivacaine">Bupivacaine</a> (<a href="Levobupivacaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Levobupivacaine" title="Levobupivacaine">Levobupivacaine</a>, <a href="Ropivacaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ropivacaine" title="Ropivacaine">Ropivacaine</a>)</li>
<li><a href="Butacaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Butacaine" title="Butacaine">Butacaine</a></li>
<li><a href="Butamben.htm" tppabs="https://ptable.com/wiki/compounds/A/Butamben" title="Butamben">Butamben</a></li>
<li><a href="Chloroprocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chloroprocaine" title="Chloroprocaine">Chloroprocaine</a></li>
<li>Cinchocaine</li>
<li><a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">Cocaine</a></li>
<li>Cyclomethycaine</li>
<li>Dimethocaine</li>
<li><a href="Diphenhydramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diphenhydramine" title="Diphenhydramine">Diphenhydramine</a></li>
<li>Etidocaine</li>
<li><a href="Hexylcaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Hexylcaine" title="Hexylcaine">Hexylcaine</a></li>
<li>Iontocaine</li>
<li><a href="Lidocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lidocaine" title="Lidocaine">Lidocaine</a></li>
<li><a href="Mepivacaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mepivacaine" title="Mepivacaine">Mepivacaine</a></li>
<li>Meprylcaine</li>
<li>Metabutoxycaine</li>
<li>Orthocaine</li>
<li>Piperocaine</li>
<li><a href="Prilocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Prilocaine" title="Prilocaine">Prilocaine</a></li>
<li><a href="Procaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Procaine" title="Procaine">Procaine</a></li>
<li>Propoxycaine</li>
<li><a href="Proxymetacaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Proxymetacaine" title="Proxymetacaine">Proxymetacaine</a></li>
<li>Risocaine</li>
<li>Tetracaine</li>
<li>Trimecaine</li></ul>

<ul><li><i>Analgesics:</i> <span class="new">AZD-3161</span></li>
<li>DSP-2230</li>
<li>Funapide</li>
<li><span class="new">GDC-0276</span></li>
<li><span class="new">NKTR-171</span></li>
<li><span class="new">PF-04531083</span></li>
<li>PF-05089771</li>
<li>Ralfinamide</li>
<li>Raxatrigine</li>
<li><span class="new">RG7893 (GDC-0287)</span></li></ul>

<ul><li><i>Toxins:</i> Conotoxins</li>
<li>Neosaxitoxin</li>
<li>Saxitoxin</li>
<li><a href="Tetrodotoxin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrodotoxin" title="Tetrodotoxin">Tetrodotoxin</a></li>
<li>Zetekitoxin AB</li></ul>

<ul><li><i>Others:</i> <a href="Buprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buprenorphine" title="Buprenorphine">Buprenorphine</a></li>
<li>Evenamide</li>
<li><a href="Menthol.htm" tppabs="https://ptable.com/wiki/compounds/A/Menthol" title="Menthol">Menthol</a> (mint)</li>
<li>Safinamide</li>
<li>Tricyclic antidepressants</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Activators</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Aconitine.htm" tppabs="https://ptable.com/wiki/compounds/A/Aconitine" title="Aconitine">Aconitine</a></li>
<li>Atracotoxins (ω-Atracotoxin, Robustoxin, <span class="new">Versutoxin</span>)</li>
<li>Batrachotoxin</li>
<li>Ciguatoxins</li>
<li>Grayanotoxins</li>
<li>Poneratoxin</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><abbr>ENaC</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Blockers</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amiloride.htm" tppabs="https://ptable.com/wiki/compounds/A/Amiloride" title="Amiloride">Amiloride</a></li>
<li>Benzamil</li>
<li><a href="Triamterene.htm" tppabs="https://ptable.com/wiki/compounds/A/Triamterene" title="Triamterene">Triamterene</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Activators</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="new">Solnatide</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><abbr>ASICs</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Blockers</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="new">A-317567</span></li>
<li><a href="Amiloride.htm" tppabs="https://ptable.com/wiki/compounds/A/Amiloride" title="Amiloride">Amiloride</a></li>
<li><a href="Aspirin.htm" tppabs="https://ptable.com/wiki/compounds/A/Aspirin" title="Aspirin">Aspirin</a></li>
<li><a href="Ibuprofen.htm" tppabs="https://ptable.com/wiki/compounds/A/Ibuprofen" title="Ibuprofen">Ibuprofen</a></li>
<li><span class="new">PcTX1</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Chloride</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><abbr>CaCCs</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Blockers</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Crofelemer</li>
<li>DIDS</li>
<li>Ethacrynic acid</li>
<li><a href="Flufenamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Flufenamic_acid" title="Flufenamic acid">Flufenamic acid</a></li>
<li><a href="Fluoxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluoxetine" title="Fluoxetine">Fluoxetine</a></li>
<li><a href="Furosemide.htm" tppabs="https://ptable.com/wiki/compounds/A/Furosemide" title="Furosemide">Furosemide</a></li>
<li><a href="Glibenclamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Glibenclamide" title="Glibenclamide">Glibenclamide</a></li>
<li><a href="Mefloquine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mefloquine" title="Mefloquine">Mefloquine</a></li>
<li><a href="Mibefradil.htm" tppabs="https://ptable.com/wiki/compounds/A/Mibefradil" title="Mibefradil">Mibefradil</a></li>
<li><a href="Niflumic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Niflumic_acid" title="Niflumic acid">Niflumic acid</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Activators</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Carbachol.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbachol" title="Carbachol">Carbachol</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><abbr>CFTR</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Blockers</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Glibenclamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Glibenclamide" title="Glibenclamide">Glibenclamide</a></li>
<li><a href="Lonidamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lonidamine" title="Lonidamine">Lonidamine</a></li>
<li><a href="Piretanide.htm" tppabs="https://ptable.com/wiki/compounds/A/Piretanide" title="Piretanide">Piretanide</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Activators</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="new">1,7-Phenanthroline</span></li>
<li><span class="new">1,10-Phenanthroline</span></li>
<li><span class="new">4,7-Phenanthroline</span></li>
<li><span class="new">7,8-Benzoquinoline</span></li>
<li>Ivacaftor</li>
<li><a href="Phenanthridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenanthridine" title="Phenanthridine">Phenanthridine</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Unsorted</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Blockers</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Bumetanide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bumetanide" title="Bumetanide">Bumetanide</a></li>
<li><a href="Flufenamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Flufenamic_acid" title="Flufenamic acid">Flufenamic acid</a></li>
<li><a href="Meclofenamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Meclofenamic_acid" title="Meclofenamic acid">Meclofenamic acid</a></li>
<li><a href="Mefenamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Mefenamic_acid" title="Mefenamic acid">Mefenamic acid</a></li>
<li>Mepacrine</li>
<li><a href="Niflumic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Niflumic_acid" title="Niflumic acid">Niflumic acid</a></li>
<li><span class="new">Talniflumate</span></li>
<li><a href="Tolfenamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolfenamic_acid" title="Tolfenamic acid">Tolfenamic acid</a></li>
<li><a href="Trifluoperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Trifluoperazine" title="Trifluoperazine">Trifluoperazine</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><abbr>TRPs</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>See here instead.</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><abbr>LGICs</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>See here instead.</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><i><b>See also:</b> Receptor/signaling modulators • Transient receptor potential channel modulators</i></div></td></tr></tbody></table></div>










<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-08-01" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Gabapentin&oldid=970569903  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Gabapentin&oldid=970569903'" tppabs="https://en.wikipedia.org/wiki/?title=Gabapentin&oldid=970569903">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>